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Abstract 




Milk phospholipids and non-polar lipids can form conjugations with antioxidants and 
starches, in the matrices of phytosomes and milk lipid-starch complexes, respectively. In 
addition to complexation, milk lipids also interact with starches in food matrices, leading to 
physiochemical changes of associated foods. Milk lipids possess neutral colour, taste, odour, 
natural, clean-label, and non-allergic. However, there has been little research on interactions 
or complexes between milk lipids and other food components when milk lipid was used as an 
ingredients in different food matrices.  
This thesis focuses on the extraction of bovine milk phospholipids from dairy products, 
purification of phospholipids, and preparation of vitamin C and E phytosomes in comparison 
with liposomes, followed by bovine milk phospholipid/triacylglycerol dispersions. 
Subsequently, non-polar lipids were used to prepare milk lipid-starch complexes in two kinds 
of food matrices: firstly bread and secondly starch gels. In the final research chapter, starch 
gel-stabilized milk fats were investigated in terms of lipid digestibility.  
The phytosomes were made by food-grade ethanol evaporation, and were verified by FTIR, 
DSC, UV and CI. In vitro models were used to measure the phospholipid digestibility and 
cellular uptake. Amylose-lipid complexes were prepared by thermal methods. The complexes 
were then verified by spectroscopy analysis. Starch and milk fat digestibility was determined 
by in vitro assays and simulated by a multi-step reaction model. 
The results on milk phospholipids showed that the polar heads of milk phospholipids in 
phytosomes interacted with hydroxyl groups of ascorbic acid resulting in the shifting of major 
bonds in the phosphatidyl residues in phospholipids, and therefore, milk phospholipid-based 
phytosomes had greater encapsulation efficiency and in vitro digestion stability than 
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liposomes. Additionally, in opposition to triacylglycerol, milk phospholipids showed greater 
lipid digestibility and exhibited antioxidant activity due to differences in molecular and 
hydrocolloid structure. Therefore, milk phospholipids have potential application in 
fortification of foods including infant formulas.  
In contrast to milk phospholipid-based complexes, milk fats can interact and complex with 
corn, rice and wheat starches in food matrices. When milk fats were hydrolysed by fungal 
lipase, they  formed starch-fatty acid complexes during baking, delaying bread firming rate 
and extending shelf-life due to reduced re-crystallisation of amylopectin. Hence, lipase 
treatment of milk fats offers a feasible way to improve both textural and physiological 
properties of bread. Also, milk fats-amylose conjugation can be produced by cooking at 95˚C, 
providing a practical method to lower the glycaemic response of starchy foods, reducing 
starch digestibility by 19% in corn starch, 17% in wheat starch, and 25% in rice starch. 
In addition to conjugation with milk fats, starch particles can also be used to stabilize milk fat 
emulsions. In vitro digestion showed that the lipolysis reaction speed and extent of starch gel-
stabilized milk fats were two – three-fold that of milk fat dispersion, confirming the 
calculation by the multi-step enzymatic reaction model. This indicates the possibility to 
regulate lipid digestibility by designing starch-based matrices. 
Beginning with bovine buttermilk, membrane filtration was proposed to manufacture enriched 
milk phospholipid products (11 – 20 g polar lipids/100 g products), with the current, best 
available process efficiency. Supercritical fluid extraction was an effective, food-compatible 
method to produce high purity (65 – 90%) milk phospholipid products. 
Overall, this thesis demonstrates the structure-property-functionality relationship of milk 
phospholipids/lipids in several food matrices. This thesis provided novel approaches to the 
further use of milk lipids as functional food ingredients, such as vesicles (Chapter 4), 
antioxidants for infant formulas (Chapter 5), bakery product textural improvers (Chapter 6), 
glycaemic index reducers of starchy foods (Chapter 7), and lipophilic compound carriers 
using starch-stabilized milk lipid matrices (Chapter 8). Last research chapter (Chapter 9) 
offered practical knowledge to develop new product and processes using milk phospholipids. 
In future research, besides milk phospholipid neuro-functionality, milk lipid interactions with 
proteins and phenolic compounds should provide interesting research questions to explore. 
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Keywords: Phospholipids, bovine milk lipid, phytosomes, complexing index, antioxidant 
activity, amylose-fatty acid complexes, lipolysis, lipase, emulsifier, shortening.  
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Chapter 1: Introduction 
1.1 Background 
In the last decades, a great deal of knowledge has been accumulated on the nutritional value 
and vesicle properties of milk fats and their tri-layered milk fat globule membrane (MFGM) 
structure. In 2005, it has been reported that MFGM acts as an emulsifier and nutrient delivery 
system with anti-microbial activity [1]. For instance, research has shown that MFGM doubles 
the bio-availability of vitamin E [2], improves ascorbic acid absorption via liposomes [3], 
enhances emulsification effects of milk lipids in food system [4], and functions as a bioactive 
component [5].  
Phospholipids in bovine milk are emerging biomaterials with growing appeals in food and 
nutrition academics since the early 2000s. Thompson [6] first used milk phospholipids to 
prepare three kinds of liposomes. Since then, milk phospholipid-based liposomes have been 
prepared to encapsulate ascorbic acid [3] and lactoferrin by Liu et al. [7]. More recently, milk 
phospholipid liposomes were utilized to improve the storage stability of encapsulates [8], to 
enhance the encapsulate solubility and encapsulation efficiency [9, 10], to boost the 
bioavailability of encapsulate [11] and delivery efficiency [10]. Further, recent reports have 
summarized the health benefits of milk phospholipids including therapeutic aspects [12], 
infant’s gut development and cognitive functions [13], and physiological functionalities [14]. 
Additionally, milk lipids and related dairy products, such as butter, anhydrous milk fat 
(AMF), cream, cultured milk fats, and cheese (matrix of milk lipids and proteins), have been 
incorporated into baked goods including bread, cakes, cookies, and biscuits, to improve the 
physiochemical properties of bakery foods [15].  
There have been several reports on milk phospholipid-based liposomes recently. Thus, no 
previous research has investigated phytosomes produced out of milk phospholipids. In 
addition, lipases have been used to treat wheat flour lipids to produce endogenous emulsifiers, 
to improve bakery product quality. Nonetheless, there has been little research on using lipase-
treated milk lipids in the bakery industry. Therefore, it is of interest to survey the interaction 
and complexation of milk polar- and non-polar lipids with starch and antioxidants in food 
systems.  
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1.2 Research gaps 
In the last decades, approximately 400 publications have been published,  dealing with such 
aspects as MFGM structure, MFGM isolation and supplementation to food systems, 
phospholipid composition change with process and lactation, lipid-omics, MFGM 
digestibility and absorption, as listed in Table 1-1. Also, more than ten papers have been 
published, regarding liposomal delivery system using milk phospholipids. Hence, there are 
obvious research gaps in relation to milk phospholipid-derived complexes (e.g. phytosomes).  
Similar to milk polar-lipid complexes, the research on lipid digestion and absorption in 
different food matrices has been gradually broadened, as illustrated in Figure 1-1. However, 
there has been little research on milk lipid-starch complexes and how their interactions affect 
the digestibility of milk lipids and associated starches.  
Table 1-1: Five research gaps of thesis work. 
RG Research Gaps Corresponding 
research chapters  
Gap 1 Though milk phospholipids have been used to prepare 
delivery systems such as liposomes, phytosomes, an 
important phospholipid-bioactive conjugation, have not 
been made from milk lipids.  
Chapter 4 
Gap 2 Milk phospholipids have been highly-purified for 
functional foods such as infant formulas, but the 
digestibility and antioxidant activity of pure phospholipids 
have hardly been studied. 
Chapter 5 
Gap 3 Milk lipids have been frequently used as functional 
ingredients in bread making. Nonetheless, using lipase-
treated milk lipids as bread improvers has not been 
explored. 
Chapter 6 
Gap 4 Milk lipids are major a source of lipid intake, and rice, 
wheat and corn are the main sources of starch in food. Milk 
lipid-starch complexes as a tool to lower glycaemic index 
of starches have been rarely studied. 
Chapter 7 
Gap 5 The outer layer of milk fat-encapsulated starch gel 
structure must be first disrupted to initiate lipolysis, 
therefore inner oil droplets may have a less easily 
digestible structure than untreated controls. Thus far, there 
have been no reports on how this starch-laden interface 
impacts on the internal lipid hydrolysis kinetics and the 
release kinetics of encapsulates inside the oil droplets.  
Chapter 8 
Gap 5 Thus far, no conclusion has been made on manufacture of 






1.4 Specific objectives 
Table 1-2: Five specific research objectives. 
Goal Specific objectives Corresponding 
chapters  
1 To prepare milk phospholipid-complexed antioxidant 
phytosomes with vitamin C and E and to assess phytosomal 
encapsulation capacity and efficiency, digestibility, and cellular 
uptakes. 
Chapter 4 
2 To extract milk phospholipids from dairy products and to 
evaluate their digestibility and antioxidant activity, in 
comparison to triacylglycerols.  
Chapter 5 
3 To hydrolyse milk fats and incorporate hydrolysates into a bread 
recipes as a dough strengtheners and textural improvers.  
Chapter 6 
4 To prepare milk fatty acid-starch complexes by using fungal 
lipase-treated milk lipids to manufacture cheap resistant starch.  
Chapter 7 
5 To encapsulate milk fats into starch gels to regulate the lipolysis 
reaction rate constant of milk lipids and to deliver lipophilic food 
ingredients in starch matrices. 
Chapter 8 
6 To assess three phospholipid-rich milk products, to compare 
available industrial processes, to investigate their process 
intensity, and to account for their carbon footprint. 
Chapter 9 
1.5 Hypotheses 
Milk phospholipids have been extracted for functional food ingredients, and milk fat products 
have been used to produce various bakery products, such as bread, cookie, and cakes. Many 
other phospholipids from soy lecithin have been used for nutrient delivery. Hence, it can 
hypothesized that milk phospholipids can also function as a delivery vesicle for nutrients. In 
addition, milk lipids may also be a valuable source to manipulate the glycaemic load of cereal 
products, by forming complexes with starch particles. In regards to each specific goal, thesis 
hypotheses were made in Table 1-3: 
Table 1-3: Five research hypotheses. 
Goal Hypotheses Corresponding 
chapters  
1 Milk phospholipids-antioxidant phytosomes are more efficient 
carrier systems than liposomes.  
Chapter 4 
2 Hydrolysis rate and extent of milk phospholipids are different 
from triacylglycerol.  
Chapter 5 
3 Milk lipids can fulfil similar roles to flour lipids when lipase is 
added to produce emulsifiers to strengthen bread dough and 
improve loaf volume.  
Chapter 6 
4 Milk lipid-starch inclusion complexes will lower the glycaemic 
load of starches and alter the rheological properties of starch gels 
as well.  
Chapter 7 
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5 Milk lipid lipolysis kinetics will be altered when starch particles 
are used to stabilize the milk fat matrices.  
Chapter 8 
6 Carbon footprint will be a convenient key parameter index to 
compare available milk phospholipid manufacture processes.  
Chapter 9 
1.6 Thesis structure 
This manuscript-orientated thesis consists of five research chapters (Chapter 4, Chapter 5, 
Chapter 6, Chapter 7, and Chapter 8) and two review papers in Chapter 2, with additional 
detailed schematic illustrations and method discription in Chapter 3. The first two research 
chapters (Chapter 4 and Chapter 5) on phytosomal digestiblity and milk phospholipid 
antioxidant activity were submitted to the journals (“Food chemistry” and “Journal of 
functional foods”). The subseqent three research chapters (Chapter 6, Chapter 7, and Chapter 
8) focussed on milk lipid-starch interactions and complexes were submitted to “LWT-Food 
Science and Technology”, “Journal of Agricultural and Food Chemistry”, and “International 
Journal of Food Science and Technology (accepted)”, respectively. The two reviews in 
Chapter 2 on phospholipid-vesicle properties and milk lipid functionalities in bakery products 
have been published in “Journal of Food Bioactives” and “Foods”, respectively. 
Product/process development (Chapter 9) have been submitted to “Foods” journal. In addition 
to journal article submission, the contents of each chapter have been presented at related 
national and international food science conferences, as illustrated in Table 1-4.  
The materials in this thesis were all derived from dairy lipids. Milk polar lipids were 
complexed with antioxidants (ascorbic acid and α-tocopherol) in Chapter 4, whereas milk 
lipid hydrolysate was conjugated with amylose to improve textural properties of bakery 
products (Chapter 6) or to make resistant starch (Chapter 7). Chapter 4 and Chapter 5 dealt 
with polar lipids, and Chapter 6, Chapter 7, and Chapter 8 were related to milk lipid-starch 
interactions, as illustrated in Table 1-4. The related milk lipids were in the form of either 
nutrient complexes (i.e. phytosomes in Chapter 4 and starch-lipid complexes in Chapter 6 and 
Chapter 7) or within starch gel matrices in Chapter 7 and Chapter 8, in which milk lipid-starch 
interactions were elaborated, respectively. 
In vitro digestion and cellular uptake methods were used throughout this thesis. Digestibility 
of milk phospholipid-derived phytosomes and milk phospholipids were studied in Chapter 4 
and Chapter 5, respectively. Digestibility studies of milk lipid-derived resistant starches were 
conducted in Chapter 6 and Chapter 7, and in vitro digestion of milk lipids in starch gels were 
performed in Chapter 8, and product and process development in Chapter 9.  
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Table 1-4: Thesis structure and publication related to each specific research goal. 
Chapter Title Highlights Publication 
Chapter 
1 





Literature review o Phospholipid vesicle properties and 




Materials and methods o Preparation of phytosomal 
complexes 










vitamin C and E 
o Milk phospholipids phytosomes was 
prepared 
o Polar part of phospholipids bonded 
hydroxyl group of ascorbic acid 
o Phytosomes showed higher 
encapsulation efficiency than 
liposomes 
o Phytosomal and liposomal cellular 








kinetics of fatty acids 
and choline release 
o Milk phospholipids extraction and 
purification 
o Assessment of polarity effects on 
lipid digestion 
o Antioxidant activity analysis 
o Comparison of phospholipids and 





The effects of fungal 
lipase-treated milk 
lipids on bread 
making 
o Milk fats lipolysis using fungal 
lipase 
o Adding milk fat hydrolysates into 
bread recipes 
o Bread dough strengthening  
o Improvement of loaf volume and 






lipids on wheat, corn, 




acid complex reduces 
glycaemic index 
o Preparation of resistant starches 
using milk fatty acids 
o Starch-lipid complexes verification 
o Prediction of the complexing 
indexes 






Milk lipids in vitro 
digestibility in wheat, 
corn, and rice starch 
gels 
o Stabilisation of milk fat globules in 
starch gels 
o Measurement of milk fats-laden gel 
viscosity 
o Assay of milk fat lipolysis reaction 
rate constants 







Product and process 
development 
o Assessment of phospholipid-rich 
streams 
o Comparison of process efficiency 




Conclusion o Summary of the research findings 
o Conclusions of both milk 
phospholipid and lipid study in 
Chapter 5 to Chapter 8 
o Technical relevance and 
significance of five research 
chapters (Chapter 5 – Chapter 8) 
o Prospective research topics in the 
future 
N.A. 
This thesis used milk lipids to make functional ingredients and to carry out roles, such as 
reduction of the glycaemic index of starch in foods and to improve the bioavailability of 
bioactive compounds by complexation-based vesicles. Overall, this thesis was focused on the 
structural-properties-functionality relationship, using both nutritional and technical properties 
of milk lipids. 
 
Figure 1-2: Schematic illustration of connections of each research chapter. 
Milk 
phospholipids
Chapters 4 & 5
Milk lipids
Chapters 6, 7 & 8
Milk phospholipid digestibility & antioxidant activity 
(Chapter 5)
Milk lipid lipolysis in starch particle-stabilized matrices
(Chapter 8)
Phytosomal milk phospholipid complexes in Chapter 4 
Milk lipid-starch complexes in baked products (Chapter 6)
Milk lipid-starch complexes and their functionalities  
(Chapter 7)
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Chapter 2: Milk phospholipid vesicle properties and bakery milk 
lipids 
Chapter 2 is a review of current related research on milk phospholipids and milk fats, and has 
been published in two food journals, respectively. 
[1]. Huang, Z., Zhao, H., Guan, W., Liu, J., Brennan, C., Kulasiri, D., & Mohan, M. S. (2019). 
Vesicle properties and health benefits of milk phospholipids: a review. Journal of Food 
Bioactives, 5, 31 – 42. https://doi.org/10.31665/JFB.2019.5176. 
[2]. Zhiguang Huang, Letitia Stipkovits, Haotian Zheng, Luca Serventi, Charles S. Brennan 
(2019). Bovine Milk Fats and Their Replacers in Baked Goods: A review. Foods, 383(8), 
1 – 20. http://doi:10.3390/foods8090383. 
Abstract: Phospholipids are important ingredients in milk. They serve as bioactive 
components with processing functionalities, despite representing only a small proportion of 
total milk lipids. There has been increasing interest in vesicle properties and health effects of 
milk phospholipids. However, there are limited reports on industry-scale manufacturing of 
related commercial products. This contribution aims to elucidate the industrial processes of 
manufacturing milk phospholipid products including phospholipid extraction and fraction as 
well as summarizing determination assays of milk phospholipids. In addition to industrial 
production, this review elaborates on application aspects, such as the biological properties of 
milk phospholipids and their technological importance as delivery vesicles of liposomes and 
phytosomes. In addition, new insights on large-scale production of milk phospholipids and 
new applications such as phytosomes and antioxidant properties are discussed.  
Milk fats, and related dairy products, are multi-functional ingredients in bakeries. Bakeries are 
critical local industries in Western countries, and milk fats represent the most important 
dietary lipids in countries such as New Zealand. Milk fats perform many roles in bakery 
products, including dough strengthening, textural softeners, filling fats, coating lipids, 
laminating fats, and flavour improvers. This review reports on how milk fats interact with the 
ingredients of main bakery products. It also elaborates on recent studies on how to modulate 
the quality and digestibility of baked goods by designing a new type of fat mimetic, to make 
calorie- and saturated fat-reduced bakery products. It provides a quick reference for both 
retailers and industrial manufacturers of milk fat-based bakery products. 
 29 
Keywords: Milk phospholipids; Solvent extraction; Liposome; Phytosome; Health effects; 
Vesicle properties; milk lipids; bakery products; fat replacer; shortening; baking activity 
2.1 Introduction 
2.1.1 Milk phospholipids as vesicles  
Milk is a staple lipid source in the human diet [16]. Milk phospholipids have been used as 
materials for nutrient carriers since the early 2000s. Thompson [6] first used milk 
phospholipids to prepare three kinds of liposomes. Since then, milk phospholipid-based 
liposomes have been prepared to encapsulate ascorbic acid [3] and lactoferrin [7]. More 
recently, milk phospholipid liposomes were applied to improve the storage stability of 
encapsulates [8], the encapsulate solubility and encapsulation efficiency [9, 10] and the 
bioavailability of encapsulate [11], being more efficient than soy lecithin [10]. Furthermore, 
in terms of biological effects, several review papers have summarized various health benefits 
of milk phospholipids, with emphasis on therapeutic aspects [12], infant’s gut development 
and cognitive functions [13], and physiological functionalities [14]. 
This contribution aims to summarize the industrial processes of manufacturing milk 
phospholipids, to update last five-year results on using phytosomes or liposomes to enhance 
bioavailability of bioactive compounds. It also reports on the recent trends on biological 
activities of milk phospholipids including antioxidant potential.  
2.1.2 Milk lipids in bakery foods and their replacers 
Milk plays critical parts in lipid intake of human beings [17]. Milk lipids consist of protein 
and also neutral lipids (tri-, mono-, di-acylglycerols (TAG, MAG, and DAG), free fatty acids 
(FFA)) and polar lipids (phospholipids) [18, 19]. Milk fats and related dairy products, such as 
butter, anhydrous milk fats (AMF), cream, cultured milk fats, and cheese (matrix of milk 
lipids and proteins), have been incorporated into both extruded and baked products, including 
breads, cakes and biscuits [20]. 
There are several reviews on bread lipids functionalities [20], bakery fat replacers [21], 
bakery lipids [22], lipid shortenings [23], bakery emulsifiers [24], bread functional ingredients 
and textural improvers [25], milk lipids in the food system [15], and bread emulsifiers [26]. 
Nonetheless, there has been no review on how milk fats perform their functions in bakery 
products thus far. Therefore, this review aims to summarize milk fat applications in the 
bakery industry, and to update results on using milk fats to enhance the quality and nutritional 
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value of baked goods. It also reports on the recent trends in relation to the health concerns of 
milk fats in baked products, and new ideas to reduce bakery energy density and saturated fatty 
acids (SFA). 
2.2 Structure, composition and occurrence 
2.2.1 Molecular structure 
Milk phospholipids include two subclasses, glycerophospholipids and sphingolipids. 
Glycerophospholipids consist of a glycerol moiety with two fatty acids (lipophilic) esterified 
at positions of sn-1 and sn-2 and a hydroxyl group at sn-3 position, linked to a phosphate 
group and a hydrophilic residue. The structural details of the latter determine the types of 
glycerophospholipids, namely phosphatidylcholine (PC), phosphatidylserine (PS), 
phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidyl-glycerol (PG), and 
phosphatidic acid (PA) [14]. The amphiphilic structure (lipophilic tail and hydrophilic head) 
provides milk phospholipids with emulsification properties. 
Sphingolipids consists of a sphingosine backbone (2-amino-4-octadecene-1,3-diol), linked to 
a fatty acid through an amide bond and a polar head. Sphingomyelin (SM) is a prominent 
subclass of sphingolipids, having a phosphocholine head group. A minor constituent of 
sphingolipids in milk is glycosphingolipid, whose polar group comprises carbohydrate groups 
(glucose, galactcose, and lactose) [13]. 
2.2.2 Composition 
Milk lipids represent approximately 4% of bovine milk [27]. Among total milk fat, only 0.32 
– 1% represents phospholipid compounds [28]. Thus, it takes 2.5 – 8 litres of raw milk to 
produce one gram of phospholipids. Phospholipids are structured, functional lipids [29]. In all 
the three phospholipid sources, PC and PE contributes to the major proportion (52, 55 and 
90% for milk, soy and egg yolk, respectively) of polar lipids. Compared with soy lecithin and 
egg yolk lecithin, milk phospholipids have a more balanced distribution in each subclass. SM 
and PS (24 and 12% in milk phospholipid profile, respectively), being regarded as functional 
ingredients for brain development [12, 30], are virtually absent in other sources, such as soy 
(0 and 0.5%, respectively) and egg yolk lecithin (1.5 and 0%, respectively) [31].  
Apart from SM and PS profile, milk phospholipids have advantages over the other two 
sources due to their natural origin, oxidative stability and colour compatibility. Milk 
phospholipids have lower content of polyunsaturated fatty acids (PUFA 7.2 – 7.9% [32]) than 
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soy lecithin (60.37% [33]) and egg lecithin (23.2% [34]). Unsaturated fatty acids had a 
proportion of approximately 46.14% for mature bovine milk phospholipids [35], and 33 – 
44.8% for two kinds of bovine milk polar lipids fed on maize silage and linseed [32], and 
whereas for the lecithin of soy and egg yolk, this percentage was 79.58 [33] and 54.6 [34], 
respectively. Thus, milk phospholipids are more resistant to oxidation than other 
phospholipids and they also have less colour intensity for this kind of fatty acid profile [36]. 
In terms of fatty acid profile of phospholipids, bovine milk, soy and egg yolk all have a 
predominant distribution of long chain fatty acids (LCFA 13 – 21), and the abundance of their 
LCFA is above 90% [34, 37]. The top two prominent fatty acids of phospholipids for milk 
and egg yolk are oleic and palmitic acids, which together account for more than 60%. The 
principal fatty acids of soy lecithin are linoleic and palmitic acids, contributing to 63.4 and 
16.4%, respectively [38].  
2.2.3 Occurrence 
In intact raw bovine milk, phospholipids take the form of milk fat globule membrane 
(MFGM: 0.1 – 20 μm in diameter, 10 – 50 nm in thickness [39]). The triple-layer membrane 
consists of a surface-active inner monolayer enveloping triacylglycerols (TAG) in the centre, 
and an outer bilayer in contact with the aqueous phase of milk [12]. The milk fat globule 
membrane is composed of polar lipids, proteins, glycoproteins, enzymes and minor neutral 
lipids [40].  
In dairy products, the triple-layer membrane structure becomes disrupted during processing 
and milk phospholipids redistribute into such products as buttermilk (BM) and β-serum 
powder (BSP, >60% lipid), which is an aqueous dairy stream through phase inversion from an 
oil-in-water to a water-in-oil emulsion [41].  
2.3 Industrial manufacturing 
2.3.1 Phospholipid extraction from dairy products 
Milk phospholipid concentrated streams are related to butter processing, anhydrous milk fat 
(AMF) or whey fraction. Commercial milk phospholipid products are usually derived from 
dairy products, such as butter serum AMF, buttermilk, or acid butter whey. The level of 
phospholipids in these streams can be as high as 11.54, 2.03 and 1.84%, respectively [28]. 
Butter serum powder represents the highest level of phospholipid concentrate among those 
dairy streams. Therefore, it is a preferred feed for making milk phospholipid. 
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AMF, derived either from fresh cream or butter, contains purified milk fat (>99.8%) with 
removal of water and non-fat solid [27]. Butter serum AMF consists of highest proportion of 
phospholipids, with 11.54, 1.25 and 48.4% in terms of dry matter (DM), wet base and lipid 
base, respectively [42, 43]. Buttermilk, a product of churning process, is the serum of butter, 
containing the most of original milk whey proteins and less fat than butter [44]. Buttermilk 
phospholipids are less abundant than those of butter serum, with 2.03% of dry matter (DM) 
content. Acid buttermilk whey has a DM-based protein percentage of approximately 84.7%, 
containing 1.84 and 0.1% phospholipids for dry and wet products, respectively [42]. Intact 
milk fat globule membrane contains 30 – 70% polar lipids. However, it is generally only 
regarded as a laboratory source of phospholipids [45, 46]. Typical lipid composition of milk 
fat products is illustrated in Table 2-1.  
 Solvent extraction is one of the common methods to isolate milk phospholipids from dairy 
lipid concentrates. Ethanol is the most used solvent to extract milk lipids, for instance, hot 
alcohol (90%) extraction at 70˚C yields around 90% recovery rate [47]. Ethanolic extraction 
of lipids from proteins results in high purity (75%) phospholipids [48]. In a laboratory up-
scaling test, supercritical carbon dioxide and 20% ethanol was utilized to extract lipids, and 
the final product had a purity of 56.24 ± 0.07% [49]. Supercritical carbon dioxide can only 
dissolve triacylglycerols without phospholipids, but together with near-critical dimethyl ether, 
both neutral and polar lipids are extracted [41]. Hexane is also a solvent that is occasionally 
used for lipid extraction [50]. Phospholipids are acetone-insoluble, but triacylglycerols 
dissolves in acetone. This selectivity of solubility also provides an approach to purify milk 
phospholipids [28, 35].  
To obtain a high purity of phospholipids, lactose and protein (casein and whey protein) need 
to be isolated from lipids. Proteins can be denatured thermally or in acid solution (pH 4.6) 
[47, 51], the aggregated particles are then sieved by subsequent filtration. Starting with whey 
protein phospholipid concentrate, ethanol at 60 – 80 °C denatures proteins, resulting in 
phospholipid concentration of ca. 45.8% in the filtrates [47]. Proteolysis is also a viable way 
to remove proteins, in which whey and casein break into peptides and amino acids. Then the 
small molecules enter permeate after ultrafiltration (UF) or microfiltration (MF) operation 
[49, 52]. Alcalase (E.E. 3.4.21.62), a serine type endoprotease with esterase activity, catalysed 
amino esters at pH 7.5 and 35 – 60˚C [49], while tryptic and peptic hydrolysis may be carried 
out at 42˚C for 2 – 16 h, with pH at 7.7 and 2.0, respectively [52]. Lactose is a smaller 
molecule than lipid ant it also goes into permeate [53].  
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The process flow diagrams of industrial milk phospholipid manufacturing are not available 
due to commercial confidence. However, according to previous research reports, a block 
diagram was constructed to illustrate the principle of typical industrial production processes 
of milk phospholipids (Figure 2-1). Starting from butter serum or buttermilk, milk 
phospholipid concentrate can be refined by sequential unit operations of delactosing, 
deproteinising, and defatting [35, 36, 41]. 
Apart from the combined methods of solvents, filtration and centrifugation, milk 
phospholipids can be synthesized using lecithin phosphatidylcholine and milk L-serine 
(WO2005027822A2). First, the choline group of soy PC is cleaved with Phospholipase D, and 
replaced with an L-serine group in the presence of calcium salt. The synthesized PS 20/60 (21 
and 62% PS, respectively) can acquire an unpleasant taste and may become undrinkable. 
Thus, oil capsules have been formulated to alter the flavour of PS. PS20/60 are physically 
unstable, and as they come from impure origin, these PS products (PS 20/60) were restricted 
by the public health authorities as described in WO2006128465A1.  
Table 2-1: Phospholipid composition of three typical dairy products. 
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0.1 1.84 25.4 0.99 84.7 [43] 
Notes: phospholipid (PL); dry matter (DM); anhydrous milk fats (AMF). 
 
Figure 2-1: PFD to illustrate a typical routine of MPL isolation and purification.  
Cream (> 40% fat) 







Milk lipids defatting 
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2.3.2 Available commercial products and related patents 
Among the milk phospholipid portfolio of Fonterra Co-operative Group Ltd, Phospholac 600 
comprises of approximately 75% phospholipid, representing one of the most concentrated 
milk phospholipids in large-scale commercial products [31]. Its Phospholac 500/600/700 and 
Gangolac 600 have a phospholipid content of 34, 70, 62, and 15%, respectively [31, 55]. 
Additionally, Arla Foods amba have commercialized a series of phospholipid rich dairy milk 
concentrated (PRDMC) products, including Lacprodan® MFGM 10 and Lacprodan® PL 
20/75. Lacprodan® MFGM 10 has been claimed to support physiological development of 
infant gut and provide infants with similar phospholipid benefits as breastfed infants because 
the fatty acid profile of Lacprodan® is similar to that of human milk [56]. In addition, PL 20 
is made out of serum phase of butter oil product (AMF) with membrane filtration, yielding 
over 20% phospholipids in total solids, which is a pure-natural nutraceutical with properties 
that has not been discovered in conventional phospholipid sources including soy. PL 75 is a 
further ethanolic extract from PL 20, with 75% of phospholipids and protein-free. PL 20 and 
75 targets infant milk formula and skin care, respectively [57].  
As illustrated in Table 2-2, ethanol has frequently been used to extract milk lipids during 
industrial processes of manufacturing milk phospholipids. To further purify phospholipids, 
acetone (or dimethyl ether) is a common solvent to dissolve triacylglycerols. Most industrial 
milk products are generated from buttermilk (BM) and butter serum powder (BSP), except for 
some other origins such as whey protein concentrate (WPC) by Morinaga Milk Industrial Co 
Ltd. Tatua Co-operative Dairy Company produces a milk phospholipid concentrate from β-
serum powder, an aqueous dairy ingredient separated from dairy streams comprising more 
than 60% lipids which has been made by phase inversion from an oil-in-water to a water-in-
oil dispersion [58]. For instance, Lipidex, a derivative from β-serum powder by Synlait Milk 
Limited, contains 5 – 7% phospholipids and 26.6% fat in total [59]. Bovine milk SM 
(#860063, 25 – 200 mg) by Avanti has a purity of 99% [38]. Lecico Lipamine M20 comprises 
20% of phospholipids including sphingomyelin, ceramides and ganglioside. This product has 
been produced with a special membrane technology, which used only water without using 





Table 2-2: Industrial manufacturing of milk phospholipids with 100 – 1000 kg input. 
Patent Assignee Feed Lipid extract 
Defat DM Purity  
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Notes: aButter serum powder, buttermilk; bUltrafiltration and dia-filtration; cDimethyl ether.  
2.3.3 Analysis: Sample preparation, fractionation and chromatography 
For analysis proposes, milk lipid samples are usually prepared with solvent extraction. The 
Folch and Bligh extraction method using both chloroform and methanol, is a common 
formula to dissolve milk lipids. Though dichloromethane (DCM, less toxic than chloroform) 
has recently been introduced to replace chloroform [61], the principal methods of lipid 
extraction remain to be the Folch extraction [62], the Bligh method 
(chloroform/methanol/water, 1:2:0.8, v/v/v) [63], or the Röse-Gottlieb extraction of 
ammoniacal ethanolic solution of milk samples with diethyl ether and light petroleum [51, 
64]. Total lipids of samples may be measured using gravimetric determination, Gerber-van 
Gulik butyrometer, infrared spectral method specified in International Dairy Federation (IDF) 
[51], or gas chromatograph equipped with a flame ionization detector (FID) [65].  
Milk phospholipid fractions are usually further purified by a solid-phase extraction (SPE) 
before a determination assay of phospholipids and their subclasses, as illustrated in Table 2-3. 
Silica gel bonded cartridge is the most used SPE column to fractionate phospholipids from 
neutral lipids. First, the column is conditioned with hexane, then it is eluted by a mixture of 
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hexane (C6) and diethyl-ether (DEE) to separate triacylglycerols. After that, another elution 
with chloroform, methanol and water will recover the phospholipids from the SPE column, 
which will be collected for solvent evaporation by using rotary evaporation. The final product 
(phospholipids) after solvent drying is stored at -20˚C before using [66]. In addition, 
chloroform and methanol have been used as SPE conditioning and elution solvents [67]. 
Some SPE was performed with silica gel plate instead of silica gel bonded cartridges [35]. 
Total phospholipids in milk samples can be determined by IDF molybdate assay [68], Fourier 
transform infrared (FTIR) spectroscopy [69] or enzymatic method measuring the choline 
content [70]. 
Nuclear magnetic resonance (NMR) using 31P is a standard assay to quantify milk 
phospholipids and their subclasses [71, 72]. However, chromatography is the more common 
assay to determine milk phospholipids. Thin layer chromatography (TLC) is a convenient 
assay without sophisticated instruments. A formula of TLC elution solvent mixture containing 
hexane, diethyl ether and acetic acid (80:20:1, v/v/v) has often been applied on a silica gel 
plate. The fractionated subclasses are then visualized on the plate with iodine vapour [35, 73].  
High-performance liquid chromatography (HPLC) remains the most commonly used method, 
because it can more accurately quantify the total phospholipids and each of their subclasses 
than TLC. For each HPLC assay, 5 – 10 µL sample (approximately 5 – 100 μg/mL) is the 
necessary amount to perform chromatographic analysis [63]. As shown in Table 2-3, HPLC 
has been usually coupled with such detectors as ultraviolet (UV) absorbance, evaporative 
light-scattering detector (ELSD) and mass spectroscopy (MS). Due to the polarity of milk 
phospholipid, silica column has often been used to separate the subclasses of milk 
phospholipids. To further fractionate the species of specified milk phospholipid subclasses, 
reverse phase (RP) HPLC with a C18 column can be employed [74]. The binary solvents of 
chloroform and methanol or acetonitrile and ammonium acetate are frequently used as an 
elution medium. The change of formula of elution solvents leads to the different detection 
order of phospholipid subclasses in the chromatogram, as illustrate in Table 2-3. In some 
cases, pH of mobile phase was modulated by trimethylamine or ammonia hydroxide (pH 3 
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aQuadrupole time of flight mass spectrometry; bevaporative light-scattering detector, low 
temperature; ccharged aerosol detector; dlysophosphatidylcholine; elactosylceramide; 
facetonitrile and ammonium acetate; gchloroform and methanol; hacetic acid, methanol; 
ihexane, iso-propanol, di-chloromethane, formic acid; jhuman being milk; khexane, diethyl 
ether; lmethanol, phosphoric acid, and acetonitrile (32, 0.6, 67.4% in volume, respectively). 
2.4 Vesicle properties 
2.4.1 Liposomes  
Milk phospholipid concentrate has sufficient emulsification properties due to its amphiphilic 
molecular structure. Milk phospholipids can also be used to deliver nutraceuticals and 
bioactive compounds in food and bio-pharmaceutical industries, increasing stability, solubility 
and bioavailability of the encapsulate [87]. In a recent report, the vesicle properties of milk 
phospholipids was thoroughly reviewed [39]. 
Milk phospholipid-based liposomes have been proven to deliver lipophilic or hydrophilic 
components to improve the bioavailability of encapsulates, in either pharmaceutical or food 
industries. In the cosmetic area, liposomes have been used to facilitate dermal absorption of 
active compounds. Milk phospholipid-based liposomes have been applied to co-deliver β-
carotene within the membrane and ascorbic acid in the inner phase [88]. The complexing 
index increased to 26 ± 0.5% from ca. 14% when the milk phospholipid concentration was 
improved from 5 to 10%, then plateaued at 26 ± 0.5% when the milk phospholipid 
concentration was 10 – 15%. The size of carriers was 120 ± 2 nm using micro-fluidization 
unit. The samples aggregated during storage at pH 3, whereas the colloid remained stable 
after 7 weeks storage at pH 7 [3]. The liposome carriers based on milk phospholipids are 
shown in Table 2-4. 
2.4.2 Phytosomes 
As illustrated in Table 2-4, the phytosome carrier can also deliver bioactive compounds, both 
lipophilic and hydrophilic, to enhance oral bioavailability [89]. Phytosomes are physically-
stable complexes, with a simple manufacturing process [90]. Complexing reaction of milk 
phospholipids and encapsulate (molecular ratio 1 – 5) was realized in either ethanolic or 
methanolic solution of 55°C. As a result phytosomal conjugation, the bioavailability of 
encapsulate was enhanced by 3 – 5-fold y compared with crude samples [91, 92], and 
whereas, the solubility of 36-fold increase was evidenced [93].  
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Both milk phytosomes and liposomes are derived from milk phospholipids. Liposomes 
encapsulate bioactive compounds in either the core of phospholipid globule or in the 
phospholipid bilayer, whereas phytosomes are different from liposomes because 
phospholipids conjugate with encapsulates. Therefore, they are more durable and efficient 
than liposomes [94]. Currently, milk phospholipid-based phytosomes are not yet explored, 
and it should provide a prospective area to study.  
2.4.3 Gastrointestinal digestion and absorption of phospholipids 
Milk phospholipids do not hydrolyse in the mouth and gastric tract, thereby they can be 
carriers of bioactive compounds [12]. Their digestion occurs in the lumen, the upper part of 
intestinal gut. Phospholipase A, B, C or D acts on either sn-1 or 2 acyl (A), both sn-1 and 2 
acryl (B), sn-3 phosphoric base (C) and sn-3 polar head (D), respectively [95]). In human 
being, pancreatic phospholipase A2 (EC 3.1.1.4 [96]) can act upon sn-2 position of 
phospholipids, resulting in lysophospholipids and fatty acids. The fatty acid group of 
lysphopholipids can be further cleaved by lysophospholiase (EC 3.1.1.5) [97]. Furthermore, 
the pancreatic lysophospholipase of human beings is most likely a non-specific 
phospholipase, but carboxyl ester hydrolase (EC 3.1.1.1) [98]. In addition, sphingomyelinase 
(alk-SMase, EC 3.1.4.12) acts on phosphoric di-ester bond of sphingomyelin, generating 
ceramide and phosphocholine [99]. Ceramide will be further split by mucosal ceramidase (N-
CDase EC 3.5.1.23) [100]. The lipolysis products then cross the border of epithelial cells 
(mucosa) and enter the enterocyte to synthesize new phospholipids, which are then 
incorporated into chylomicrons (CM). After that, approximately five hours postprandial, CM 
will enter into the lymph and blood circulation. Apart from absorption of hydrolysate of 
phospholipids (lyso-PLs and fatty acids), approximately 20% of phospholipids are passively 
absorbed in the intestinal lumen [12]. In addition, indigenous phospholipid excretion into bile 
is 10 – 20 g per day [101], which was much higher than endogenous phospholipids (2 – 8 g 








Table 2-4: Milk phytosomes and liposomes as bioactive compound carriers. 
Encapsulate Phospholipid Vesicle Bioavailability Reference 
Celastrol (CST) Soy PC Phytosomes 4 – 5-fold increase [92] 
Apigenin Soy PC Phytosomes Up to 82%  [93] 
Berberine (BER)  Soy PC Phytosomes 3-fold increase [91] 
18β-glycyrrhetinic 
acid 
Soy lecithin Phytosomes Extended storage to 
30 – 90 days 
[103] 
Curcumin Milk PL Liposomes: 
Sonication  
More efficient and 
stable than soy 
lecithin 
[9] 
Lactoferrin (LF) Milk PL Liposomes: 
Ethanol injection 




Tea phenolic Milk PL Liposomes: 
Micro-fluidization 





Milk PL Liposomes Micro-
fluidization 
Poor physical 
stability upon storage 
[88] 
Silybin Milk PL Reverse phase 
evaporation (RPE)  
10-fold increase [104] 
2.5 Health impacts 
The nutraceutical value of milk polar lipids has been reviewed, including the efficacy for 
modification of the trajectory recession of cerebral structure in old age [105], the roles in the 
growth of infant brain and gut [13], the effects of immune-mediated anti-carcinogenic effects 
and anti-inflammatory activity [14], and the relevance to hepatoprotection and cardiovascular 
diseases [12]. Furthermore, milk phospholipids have been shown to reduce the waist 
circumference of the participants, compared with soy lecithin in a clinical trial, although the 
blood lipid concentrations of the attendants in the trial was not altered [106]. In addition, the 
effects of Lacprodan® PL-20 in supporting infant intestinal maturation [107] and a healthy 
microbiota [108] have been demonstrated clinically. Research has also illustrated that 
buttermilk and krill oil phospholipids may be associated with the improvement of synaptic 
signalling in aged rats [109].  
2.5.1 Neurocognitive effects 
The nutritional value of milk polar lipids includes gut development (SM), neurocognitive 
development (SM), liver protection (PC), bacteria inhabitation (lyso-phospholipids), 
maintaining homeostasis (PE), cell signalling (PI) and memory restoration (PS), as reviewed 
in previous reports [28, 110, 111]. It has been documented that milk phospholipids can 
enhance neurocognitive development. For example, research has shown that sphingolipid 
supplementation improved the myelination of central nervous system and was responsible for 
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the normal brain weight of rat infants [12]. L-serine is essential for the synthesis of 
sphingolipids and phosphatidylserine (PS) in particular types of central nervous system 
neurons [112]. Additionally, the cognitive performance benefits of dietary milk phospholipid 
have been evidenced with the clinical trial [113], the rats model [114], and the piglet model as 
well [115].  
Table 2-5 illustrates the present results appertaining the cognitive functions of milk 
phospholipids, from either ex vivo models or in vivo models. Most tests conferred the benefits 
of milk phospholipids on brain function, however one examination showed that it might be 
due to the combined effects of membrane proteins and polar lipids [116]. In terms of 
commercial application, milk phospholipids are well-recognized ingredients for infant milk 
formula (IMF), which represent the world’s fastest growing functional food in recent years 
[36]. 
2.5.2 Skin care 
Skin parameter enhancement examination has been performed in either in vivo or ex vivo, 
yielding positive results except for a non-effectiveness report under the set conditions [117], 
as illustrated in Table 2-5. Some of these benefits appear to be related to phospholipids, 
altering the hydration of skin and therefore increasing elasticity and resilience.  
2.5.3 Anti-inflammatory in gastrointestinal development 
Milk phospholipids have proven to be able to modulate inflammatory reaction and to protect 
against gastrointestinal leakiness, as illustrated in Table 2-5. Animal models and cell models 
have shown that the polar lipids fraction from MFGM affects infant gastrointestinal 
development. Milk phospholipids diet decreased gut permeability [118], altered distal gut 
microbiota and reduced serum lipopolysaccharide (LPS) [119], inhibited infectivity of 
rotavirus [73], and regulated the neonatal gut microbiome and promote intestinal development 
[120]. 
2.5.4 Antioxidant activity 
Milk phospholipids act as both antioxidants and a pro-oxidants and sometimes are used to 
alleviate food oxidation. Anti-oxidative activity of phospholipids might be due to such 
mechanisms as metal-chelation, alteration of the location of other antioxidants, and 
regeneration of other primary antioxidants. However, phospholipids can also act as primary 
antioxidants and pose significant antioxidant activity to biological membranes (i.e. meats), 
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owning to their unsaturated fatty acids and negative charge [121]. Phospholipid 
supplementation to soybean oil significantly retarded the oxidative process, extending 
oxidative stability index (OSI) from 7.62 to 12.96 h. However, phosphatidylcholine addition 
caused trimethylamine (TMA, fishy off-door) generation [122]. Marine lecithin (i.e. krill oil) 
consists of a natural antioxidant (astaxanthin) and phospholipids bound LC-PUFA, which 
inhibits oil peroxidation during its shelf life [123]. α-tocopherol enhanced the oxidative 
stability of marine phospholipid emulsions [124].  





Model Result Reference 
Cognitive PL PUFA In vivo: Healthy 
elderly 
Cognitive function was enhanced [125] 
Cognitive Lacprodan® PL-
20 
In vivo: Healthy 
elderly 
Set protocols to assess Lacprodan® PL-20 [126] 
Cognitive MFGM Ex vivo: Rats MFGM altered brain lipid [127] 
Cognitive Lacprodan® PL-
20 
Ex vivo: Neonatal 
piglet 
Spatial ability was enhanced [115] 
Cognitive MFGM Ex vivo: Suckling 
rat pups 
Increased expression of brain gene BDNF and GLP-
1R 
[128] 
Cognitive Milk SM In vivo: Low birth 
weight infants 
SM activated prefrontal cortex of the brain, increasing 
score on visual evoked potential, attention, and 
memory 
[129] 
Cognitive Ganglioside In vivo: 6-months 
infants 
Cognitive score increased [130] 
Cognitive MFGM In vivo: Infant and 
Toddler 
The diet led to similar cognitive score to breastfed 
infants but showed higher score to pure polar lipids 
fed infants 
[116] 
Cognitive Milk PL In vivo: 54 
healthy, non-
obese adult men  
Cognitive performance was improved under 
conditions of psychosocial stress but failed to 
moderate cortisol response 
[113] 
Cognitive Milk PL coated 
dietary lipid 
Ex vivo: Healthy 
male mice 
T-maze test: Increased to 87% from 74% in short-term 
memory tests; while same in long-term memory 
[114] 
Skincare Milk PL Ex vivo: Dog with 
allergic skin 
disorders 
Enteric improvement and enhancement of skin 
conditions 
[131] 
Skincare Milk PL In vivo: Healthy 
adults aged 20 to 
39 year 
Skin elasticity in the region below the eye increased [30] 
Skincare Milk PL In vivo: Atopic 
dermatitis patients 
Not effective [117] 
Skincare Milk PL Ex vivo: Mice Modulated epidermal covalently bound ceramides 
associated with formation of lamellar structures and 





MFGM rich diet Ex vivo: Mice Attenuated the inflammatory response to a systemic 





Milk SM diet Ex vivo: high-fat-
fed mice 




Milk SM diet Ex vivo: high-fat-
diet-induced mice 




Milk PL extract In vitro: MA-104 
cells of embryonic 
African green 
monkey kidney 
Polar lipids displayed effects of anti-rotavirus activity 





MFGM Ex vivo: Rat pups Protective and replenishing effects on neonatal 
intestinal epithelium caused by clostridium difficile 




2.6 Structure, composition and occurrence of milk fats 
2.6.1 Molecular structure, composition and occurrence  
Bovine milk lipids are comprised of 97.5% TAG, 0.36% DAG, 0.027% MAG, 0.027% FFA, 
and 0.6% phospholipids [134]. There are also some minor lipid classes present in milk, for 
instance, sterols, carotenoids, lipophilic vitamins, and flavour compounds [18]. 
The triacylglycerol molecule consists of a glycerol backbone and three fatty acids esterified at 
the positions of sn-1, sn-2, and sn-3. Two subclasses of phospholipids are 
glycerophospholipids and sphingolipids. Glycerophospholipids consist of a glycerol moiety 
with two fatty acids esterified at the positions of sn-1 and sn-2 and a hydroxyl group at sn-3 
position, linked to a phosphate group and a hydrophilic residue. The structural details of the 
hydrophilic residue determine the types of glycerophospholipids, namely phosphatidylcholine 
(PC), phosphatidylserine (PS), phosphatidylethanolamine (PE), phosphatidylinositol (PI), 
phosphatidyl-glycerol (PG), and phosphatidic acid (PA) [19]. Sphingolipid consists of 
sphingosine backbone (ceramide, 2-amino-4-octadecene-1,3-diol), linked to a fatty acid 
through an amide bond and a polar head. Sphingomyelin (SM) is the predominant subclass of 
sphingolipids, having a phosphocholine head group. A minor constituent of sphingolipids in 
milk is glycosphingolipid, of which the polar group is comprised of carbohydrate groups 
(glucose, galactcose, and lactose) [13]. 
In intact raw bovine milk, lipids (3.3 – 4.6% [18]) are present in the form of milk fat globules 
(MFG), with an average diameter of 0.1 – 20 μm and are enveloped by a tri-layered 
phospholipid membrane [39]. The triple-layer membrane consists of a surface-active inner 
monolayer enveloping TAG in the centre and an outer bilayer in contact with the aqueous 
phase of the milk. The milk fat globule membrane (MFGM) is composed of polar lipids, 
proteins, glycoproteins, enzymes and minor neutral lipids [40].  
2.6.2 Fatty acid profile  
The most abundant milk fatty acids are palmitic (26.3 – 30.4%), oleic (28.7 – 29.8%), stearic 
(10.1 – 14.6%), and myristic (8.7 – 7.9%) acids [134]. Anhydrous milk fats (AMF), known by 
the US Department of Agriculture (USDA) as 1003, consist of palmitic acid (27.7%), oleic 
acid (26.5%), stearic acid (12.8%), and myristic acid (10.6%) [18]. Due to a high content of 
stearic and palmitic fatty acids (melting points at 69.3 °C and 62.9 °C, respectively), milk fats 
are solid at ambient temperature. Conjugated linoleic acids (CLAs) are isomers of linoleic 
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acids (0.8 – 2.5%) with the predominant CLAs being cis-9 and trans-11 CLAs (73 – 94%) 
[134].  
SFA and monounsaturated fatty acids account for 62.2% and 28.9% (w/w) of the total fatty 
acids (FA) in the anhydrous butter oil of USDA 1003, respectively, whereas long-chain FAs 
(LCFAs, C13 – C21) accounts for 83.9% of the total FA, compared with medium-chain FA 
(MCFAs, C6 – C12, 8.8%) and short-chain FA (SCFAs, C2 – C5, 3.4%) [18]. Unlike LCFAs, 
SCFAs and MCFAs are absorbed intact as non-esterified fatty acids into the portal 
bloodstream and metabolized rapidly in the liver [135]. Via gastrointestinal digestion, 
medium-chain TAG is decomposed into glycerol and MCFAs, which reduces total cholesterol 
in serum by boosting hepatic synthesis of bile acid [136]. The SFA degrees of main 
shortening lipids are shown in Table 2-6 [18]. Lipids of dairy products can be separated by the 
Folch extraction [62], the Bligh method [63], the Röse-Gottlieb extraction [51], or 
dichloromethane method [61]. Total lipid (TL) content of samples may be measured using 
gravimetric determination, a Gerber-van Gulik butyrometer, infrared spectrometry in a 
Milkoscan FT2 apparatus [51], or gas chromatography [65].  
Table 2-6: Composition of shortening lipids. 
Code Shortenings TL (g) SFA (g)  MUFA (g)  
PUFA 
(g) TFA (g) 
SFA: 
UFA 
4582 Canola oil 100.00 7.37 63.28 28.14 0.40 0.08 
4506 Sunflower oil 100.00 10.30 19.50 65.70 - 0.12 
4669 Soybean oil 100.00 15.25 22.73 57.33 0.68 0.19 
4585 Margarine 80.32 14.20 30.29 24.17 14.95 0.26 
4037 Rice bran oil 100.00 19.70 39.30 35.00 - 0.27 
4615 Composite shortening 99.97 24.98 41.19 28.10 13.16 0.36 
4002 Lard 100.00 39.20 45.10 11.20 - 0.70 
1056 Cultured sour cream 19.35 10.14 4.59 0.80 0.80 1.88 
1145 Butter 81.11 50.49 23.43 3.01 - 1.91 
1003 Anhydrous butter oil 99.48 61.92 28.73 3.69 - 1.91 
1017 Cheese cream 34.44 20.21 8.91 1.48 1.17 1.95 
4513 Palm kernel oil 100.00  81.50  11.40  1.60  - 6.27  
4663 
Hydrogenated palm 
kernel oil (filling fat) 100.00  88.21  5.71  - 4.66  15.46  
4701 
Fully-hydrogenated soy 
oil 100.00  93.97  1.34  0.38  1.15  54.50  
Notes: Saturated fatty acids (SFA), mono-, poly-unsaturated fatty acids (MUFA/PUFA), and 
trans-fatty acids (TFA) of shortening lipids per 100 g adapted from US Department of 
Agriculture (USDA) Database v.3.9.5.3 [18]; total lipids (TL) 
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2.6.3 Melting properties and solid fat index 
Solid fat index (SFI) is a critical physical parameter of bakery shortening, determining the 
plastic behaviour of bakery fats and dependent on temperature. The SFI profile of milk fat 
crystal powder can be measured by pulsed nuclear magnetic resonance (p-NMR) with 
thermostatic incubation, and differential scanning calorimetry (DSC) can be used to determine 
the fat melting point [137]. The SFIs of major lipids in bakery products are illustrated in 
Figure 2-2: Solid fat index profile of typical shortenings for baked goods. [138]. The SFI 
profile of milk butter is very similar to that of general use margarine, all-purpose shortening, 
and cake lipids, and thus, milk butter is interchangeable with other shortenings. Cocoa butter 
can be used for coating bakery products, whereas milk fats are too soft for coating. Even as a 
cookie filler, milk fats are not firm enough and need to be formulated with other lipids. To 
achieve optimum bakery activity, bakery lipids should have 20% SFI at 25 °C and a minimum 
of 5% SFI at 40 °C [139]. For instance, a blend of stearin fraction of palm-based DAG and 
palm mid-fraction (50:50 w/w; SFI at 30% and 10% for 25°C and 40°C, respectively; 
polymorphic form β’ + β; slip melting point 55.4 ± 0.12°C) makes a more effective bakery 
shortening than sunflower oil and palm oil [139]. An SFI profile of less than 15 – 20% at the 
dough temperature is too soft to make a shortening. However, fats that are too hard produce 
adverse effects, for instance, shortening with an SFI of ca. 47.5% at 20 °C produces less 
acceptable biscuits than shortening with an SFI of ca. 22.5% at 20 °C [140]. 
 
Figure 2-2: Solid fat index profile of typical shortenings for baked goods. 










Milk butter Cocoa butter
Lightly-hydrogenated oil All-purpose shortening
Cake lipids Cookie filler
Coating fat General margarine
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2.6.4 Crystalline polymorphism 
In addition to SFI, polymorphic forms of milk fat crystals are also a factor in controlling the 
bakery activity of lipids [137] Lipids exist in three major polymorphic forms, α, β’, and β, and 
their thermodynamic stability increases in the order of α < β’ < β. Lipid crystal α is usually 
undesirable due to its instability. The β crystal (large plate-like) is stable, but coarse and 
sandy, whereas β’ form is desired in baked goods since it is fine, needle-shaped, and stable. 
Enzymatic inter-esterification can rearrange fatty acids on the TAG backbone, creating tightly 
packed, small β' crystals, which produce more desirable bakery activity than composite blends 
[141]. Milk fats, together with other natural edible lipids such as tallow, palm oil, cottonseed 
oil, and high erucic acid rapeseed oil possess the β’ polymorph, whereas crystals of soybean 
oil, sunflower oil, coconut oil, palm kernel oil, and lard are usually present in the β 
polymorph. Crystalline forms may transform into a more stable form as time and temperature 
change [142]. The crystalline polymorphism can be determined by using an x-ray 
diffractometer (XRD) [143]. Characteristic peaks of the acylglycerol emulsifier-shortening 
blend at 4.15 Å and 4.6 Å are from α and β forms, respectively, whereas the β’ form 
demonstrates three signals at 3.8 Å, 4.2 Å and 4.3 Å. In addition, sub-β and sub-β’ forms may 
cause peaks at 4.5 Å and 4.0 Å, respectively [144]. 
2.7 Milk fats in baked goods 
2.7.1 Milk fats and related dairy products 
Milk fats and related dairy products include butter, anhydrous milk fat, ghee, and cheese 
(combination of milk lipids and proteins) [145]. Butter is the predominant milk fat product 
used in the bakery industry, comprised of 81.11% milk lipids and 16.17% moisture, 
approximately (USDA 1145 in Table 2 [18]). In native milk, the enveloped fat globules are 
dispersed in the serum [54]. During churning, the membrane is disrupted and those milk fat 
globules aggregate to form butter, separating out from serum (buttermilk) [146]. Cultured 
lactic butter is more popular in Europe than in the USA, whereas sweet cream butter is more 
prevalent in the UK and USA than in other countries [147]. Salted butter (1.6 – 1.7% salt) has 
a 4-fold shelf life in refrigeration than unsalted butter due to reduced water activity [145]. 
Ghee is clarified milk fats from butter or cream, with an enriched flavour [148]. A milk butter 
blend with vegetable oil (e.g. corn oil, canola oil) reduces the overall SFA. Being 
hydrogenated from vegetable oils (e.g. soybean and palm oil) or animal fats (e.g. beef tallow) 
to raise the SFI and melting point, margarine is a cheaper substitute for milk butter in the 
bakery industry [149]. To avoid TFAs resulting from hydrogenation, inter-esterification of 
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vegetable oils (soybean oil, palm stearin, coconut stearin; 20:50:30, w/w/w) by Lipozyme RM 
IM, an immobilized Rhizomucor miehei lipase, produce SFI and crystals of β’ polymorphic 
form, which are equally as effective as commercial margarines [150]. 
AMF contains 99.48% lipids and 0.24% moisture, respectively (Table 2-2 [18]). AMF and 
butter oil are comprised of no less than 99.8% and 99.6% lipids, respectively, without 
additives [145]. The AMF is produced by vacuum drying and removal of non-fat solids from 
pasteurized cream. First, cream (40% lipids) is concentrated to 70 – 80% milk fats, and after 
phase inversion, the milk fats are further dried to no more than 0.1% moisture [145]. The 
AMF can be produced from both butter and cream [54], and butter oil is made out of butter 
[145]. For cost-saving, substitution of 30% AMF by hydrogenated vegetable oils (e.g. soya or 
coconut oil) has been formulated into the shortening of bakery products in Asian countries 
such as Japan [138]. AMF has a broad melting and crystallization range, fully crystalizing at 
−40 °C and completely melting at 38 – 40 °C. Thus AMF can be fractionated into low (<10 
°C), middle (10 – 20 °C), high (>20 °C), and very high (>50 °C for confectionery) melting 
fractions [151]. 
Cheese is produced from milk by inoculation with bacteria and separation of the resulting 
semi-solid curd (33 – 55% lipids for origin cream cheese, 0.5 – 16.5% lipids for reduced-fat 
cheese) from the liquid whey, leading to less-perishable products than milk [152]. Among the 
most commonly used bakery flavours, cheddar and parmesan cheeses have been used to 
impart flavour in biscuits or crackers [153]. In addition to flavour enrichment, cheese can also 
be used as a bakery coating or filling lipids [154]. A typical cheddar cheese contains 33.31% 
lipids (Table 2-2 [18]). Gas chromatography analysis of enzymatically-modified white cheese 
for bakery flavour revealed 58 volatile compounds of seven chemical classes including 
alcohols (12), aldehydes (8), ketones (10), esters (8), acids (11) and hydrocarbons (9), among 
which most compounds were produced by metabolism of carbohydrates, milk fats and amino 
acids [154]. Kefir cheese culture fermentation yielded volatile compounds, for instance, 
diacetyl (i.e. major buttery aroma), acetaldehyde, ethanol, and acetone by probiotic bacteria 
like Lactobacillus spp. and yeasts (e.g. Saccharomyces spp. and Kluyveromyces spp.) [155]. 
Bacterial metabolism produces diacetyl, for instance, by Lactococcus lactis subsp. [156]. 
Sour cream, a critical bakery flavour improver, is produced by the moderate-temperature 
fermentation of cream, and it can also be made by the treatment of acid-producing bacterial 
cultures on pasteurized cream. Compared to cream, sour cream (typical lipid content 19.35% 
in Table 2-7 [18]) is thicker and more acidic, with a longer shelf-life [157]. 
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Furthermore, milk fats are often consumed together with biscuits and breads (e.g. as fillers) 
[158]. Milk fat products such as butter and AMF are sometimes manufactured as flaked or 
powdered forms by spray chilling or spray drying, which are easy to disperse [142]. The 
typical composition of milk fats and related dairy products are illustrated in Table 2-7 [18].  
Table 2-7: Proximate nutritional information of main milk lipid products. 
Code 














1017 Cheese 52.62 1,466 6.15 34.44 1.27 5.52 
1005 Cheese 41.11 1,553 23.24 29.68 1.85 2.79 
1009 Cheddar cheese 36.37 1,684 22.87 33.31 3.71 3.37 
1053 Cream 57.71 1,424 2.84 36.08 0.53 2.84 
1056 Cultured sour cream 73.07 830 2.44 19.35 0.51 4.63 
1145 Butter 16.17 2,999 0.85 81.11 0.09 0.06 
1003 Anhydrous butter oil 0.24 3,665 0.28 99.48 - - 
Notes: The nutritional data was adapted from US Department of Agriculture (USDA) 
Database v.3.9.5.3 [18]. 
2.7.2 Functionalities of milk fats in baked goods: baking activity 
Milk fats have been used to perform multifunctional roles in bakery products, for instance, as 
mouthfeel and flavour improvers, texture improvers, dough conditioners, and anti-staling 
agents [142]. In addition, milk fats can fulfil a wide variety of functions such as laminating 
and filling fats, coating or topping lipids, spray oil, and imparting flavour [147]. The functions 
of milk fats are dependent on the dose and the type of baked products. For instance, they play 
more strengthening roles in yeast-leavened bread dough than in cookie/biscuit dough or cake 
batter, whereas cake fats are highly recommended for aeration and whipping in batter 
agitation [159], and biscuit or cookie laminating fats are mainly responsible for crisping and 
puffy effects by textural improvement [159]. Almost half of the lipids in coconut oil (USDA 
4047) are comprised of lauric acid (41.84%, Tm = 43.2 °C), but bovine milk fats (USDA 
1003) contain only 2.79% lauric acid in comparison [18]. Therefore, milk butter is soft for 
bakery coating, and its SFI need to be changed by blending with composite. 
Bakery shortening is defined as the ability of a fat to lubricate, weaken, or shorten the 
structure of bakery products, thereby providing tenderization effects and other desirable 
textural properties to bakery products [160]. During the mixing process of dough or batter, 
lipids interact with gluten and starch particles to strengthen their network, thus improve the 
gas retention of dough. Hence, bakery products become softened, resulting in consistent grain, 
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lubricated mouthfeel, enhanced heat transfer, and extended shelf life [23]. Shortening lipids 
are made from milk butter, animal fats (e.g. tallow, lard), or hydrogenated plant oils (e.g. 
palm oil) [159]. In contrast to standard shortening, lipids such as hydrogenated vegetable fats 
may be used to replace milk fats for bakery products, such as biscuits [161]. 
Laminated dough shortening has an SFI of 10 – 40% for the temperature range of 33 °C to 10 
°C, causing a puffy texture for croissants, danishes, and pastries. Milk butter is a benchmark 
laminated dough preparation agent for appropriate SFI profile and β’-form crystal. Cheap 
alternatives include hydrogenated shortenings and inter-esterified fats, which lead to a trans-
fatty acids (TFA) issue or less acceptable sensory quality [137].  
Bakery lipids have their characteristic SFI profile, plasticity (processability), and antioxidant 
stability [162]. For instance, a coconut oil cookie filler is designed as a 59% SFI at 10˚C, 29% 
at 21.1˚C, and 0% at 26.7˚C onwards, with a melting point of 24.5˚C. In contrast, croissant 
shortening melts at 39 °C, with an SFI profile of 39% at 10 °C, 27% at 21.1 °C, 22% at 26.7 
°C, 19% at 33.3 °C, and 18% at 43.3 °C [159]. Milk fat flavours have been attributed to 
volatile molecules, including branched-chain fatty acids, lactones, methyl ketones, aldehydes, 
and other minor compounds, which are originated from milk fats or produced during 
fermentation, lipolysis, or processing. Milk fat products, such as cheese (e.g. cheddar and 
feta), cream, sour cream, and butter are all used to improve the sensory properties of bakery 
products [155]. 
2.7.3 Interactions of milk Fats with other bakery ingredients 
Lipid-protein and lipid-starch interactions 
Lipid-protein binding interactions can increase gluten polymerization. However, the ionic 
amphiphilic binding will cause interface aggregation due to charge neutralization, and 
therefore, these interactions may also decrease surface activity as the lipid concentration at the 
aqueous – oil interface increases to a certain level, which leads to the disruption of protein – 
protein interactions in the interfacial film [163]. The gluten – lipid interactions yield a 
dynamic balance of surface activity, altering the surface activity and aeration ability. This 
mechanism is critical for dough rheological characteristics and product textural properties. 
Horra et al. [164] compared refined milk fats (SFI 38% at 25 °C) and margarine shortening 
(SFI 5 – 25% at 25 °C) and found, through confocal microscopy, that the gluten network with 
milk fats is less developed and more orderly structured (with isolated starch particles) than the 
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network formed with margarine shortening, thereby producing greater elastic and viscous 
moduli, and higher puff pastry.  
During dough mixing, milk fats coat the gluten network and starch particles, reducing the 
water hydration capacity of the dough [20]. With the formation of an extensible gluten film by 
hybrid hydration and lipid coating, the lipid crystals decrease the surface tension of the gluten 
film (lubrication effects), promoting aeration of the dough [23]. The crystals align their 
orientation along the air cells and stabilize them. Milk fats (β’ polymorph) aerate more 
effectively than soybean oil (β polymorph) by forming fine and consistent gas bubbles [165]. 
During dough fermentation and proofing, the fat crystals further melt and become absorbed at 
the gas-liquid interface with increased temperatures. They re-orientate along the interface 
plane and hold the yeast-leavened carbon dioxide in the gas cells [166]. Low melting fats or 
oils have been found to be much less effective in gas retention at this stage [167].  
During baking, starch particles become gelatinized and the gluten film turns into a permanent 
cross-linked thin film together with lipids, with the crust drying and browning (the Maillard 
reaction) taking place concomitantly [168]. Without lipids, the bubbles tend to coalesce or 
collapse and produce coarse crumb grain, whereas shortening fats lead to fine crumb grain 
and consistent porosity [169]. Hydrogenated fats produce a stronger dough and more tender 
cookies than sunflower oil [170].  
When baked products cool down, amylose and amylopectin crystallize and retrograde in the 
early stages of storage and over the course of shelf life, respectively [168]. Using low-
frequency NMR, it has been found that water migrates from crumb to crust or to amylopectin 
during storage, and immobilization of moisture will reduce water activity and decrease 
crystallization of amylopectin, thereby inhibiting the staling rate [171]. Most bread staling 
mechanisms have been explained by water migration. Reducing its water activity can slow 
down the staling rate of bread crumb. During bread storage, starch polymer retrogrades 
concomitantly with fat re-crystallization [172]. This concurrent polymorphic conversion from 
β’ to β has been evidenced by powder XRD analysis for croissant samples [173]. 
In brief, shortenings such as milk fats have effects on the lubrication/stabilization (mixing), 
gas retention (proofing), textural tenderization (baking), and anti-staling (storage) properties 
of bakery products. The addition of emulsifiers can consolidate the above effects, thus 
reducing the amount of shortening lipids required. The interactions of lipids with other 
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ingredients is different among breads, cookies, biscuits and cakes, such as with the additional 
interactions of lipids with egg components.  
Starch-lipid complexes 
Starch can form complexes effectively with MAG, as it can with fatty acids, but TAG does 
not form complexes with starch [174]. A previous report has shown that four kinds of lipids: 
monopalmitate glycerol (96.3%), (palmitic acid (41.8%), dipalmitate glycerol (DPG, 1.1%), 
and tripalmitate glycerol (8.3%) have reduced complexing ability [174]. The starch-lipid 
complexes have been found to lower the glycaemic load of bakery products and impact on 
their staling processing. Using confocal laser scanning microscope (CLSM) and scanning 
electron microscopy (SEM), both non-inclusion and inclusion lotus seed starch-lipid 
complexes have been identified, causing slow digestibility of starch [175]. The complexing 
index of debranched starch-stearic acid complexes reached 89.31% [176], while that of the 
native starch (yam)-palmitic acid complexes (2%, w/w, starch base) was maximized as 
26.39% [177]. In addition to the reduction of the starch glycaemic index, high amylose corn 
starch-lipid complexes inhibited the staling process of baked goods [178], as also evidenced 
by a recent report, where the firmness of wheat bread during storage was significantly reduced 
by resistant starch [179].  
Emulsification lipids during dough or batter forming 
Emulsifiers can be used to disperse milk fats, enhance their baking activity, assist ingredient 
mixing and emulsification during dough or batter formation, and promote aeration and air 
distribution, especially for cake batter [142]. Commonly used emulsifiers for baked goods 
include MAG and DAG (E471), lecithin (E322), sodium stearoyl lactylate (SSL, E481), and 
diacetyl tartaric acid ester of mono- and diacylglycerols (DATEM, E472e) [25]. For instance, 
in a high-ratio layer cake, 5% MAG was formulated into the shortening [144].  
Similar to the baking activity of shortening, anionic emulsifiers such as DATEM, SSL, and 
calcium stearoyl-2-lactylate (CSL) are useful in both dough strengthening and bread 
softening, as are the nonionic emulsifiers (sucrose esters of fatty acids (SE), polysorbate-60 
(poly-60)). Lecithin and distilled MAG have no strengthening effects [26]. Fu et al. [144] 
compared distilled MAG and four acylglycerols (40%) of octanoic acid (8:0), palmitic acid 
(16:0), stearic acid (18:0), and linoleic acid (18:2) and found that monopalmitate glycerol and 
monostearin glycerol led to a higher SFI and finer crystals (β’ form), thus increasing aeration 
ability in batter formation and tenderizing the crumb of layer cakes. In contrast, monooctanoic 
glycerol and linoleic acid glycerol produced adverse effects to the SFI and β’ form crystals, 
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thereby reducing cake size and increasing its firmness. In addition, lecithin and distilled 
monostearate stabilized the shortening crystals and increased the air-absorbing ability on both 
beef tallow and hydrogenated palm oil [180]. Using digital imaging of crumb micro-structure, 
the emulsifier functionality in assisting air aeration was recognized. At the same level of 
dough hydration, five emulsifiers (DATEM, SSL, distilled MAG, lecithin, and polyglycerol 
esters of fatty acids (PGEF)) increased the bread dough permeability and gas retention ability, 
resulting in increased gas bubble number and homogeneity [181]. 
2.8 Milk fats in baked goods 
Breads use less fats and sugar than biscuits and cakes, and biscuit recipes use less water than 
breads and cakes. For instance, breads (AACC 10.10 recipe, flour based) are comprised of 
wheat flour, 6% sugar, 5% milk butter, 1.5% salt, 1.5% yeast, and 60% water; biscuits 
(AACC 10.54) consist of wheat flour; 42% sugar, 40% shortening, 1% skim milk powder, 
1.25% salt, 1% sodium bicarbonate, 0.5% ammonium bicarbonate, 1.5% high fructose corn 
syrup, 22% water; and high-ratio cakes (AACC 10.90) are made out of wheat flour, 140% 
sugar, 50% shortening, 2% emulsifier, 12% dry skimmed milk powder, 5.5% baking powder, 
9% egg white powder, 3% salt, and ca. 135% water [182].  
2.8.1 Bread fats 
Milk fats account for 3 – 4% of a bread recipe [182]. During dough mixing, both starch 
particles and gluten become hydrated, and the gluten proteins polymerize through reactions 
between the sulfhydryl ( – SH) groups and disulphide ( – SS – ) bonds, forming an extensive, 
interlinked dough skeleton [183]. Milk fats mainly perform three kinds of functions in bread 
dough. First, lipid crystals brace the developed gluten network as a plasticizer. In this 
instance, shortening oil (e.g. sunflower oil) exhibits far less effect on the developing strong 
gluten network than shortening fats and milk butter due to less SFI [170]. Secondly, lipid 
crystals align themselves with the gas-liquid interface of bubbles during dough mixing, 
exerting lubricating effects [184]. Lastly, lipid crystals enhance the stability index of bread 
dough [185], and β’ crystal-stabilized bubbles are larger than that of β crystals [186]. β’ 
crystal lipids aerate dough more effectively than β crystal lipids [187]. 
During dough fermentation at 40˚C, yeasts produce carbon dioxide and ethanol. Newly 
produced carbon dioxide diffuses into gas bubbles and leavens dough to 1–1.5-fold in height 
[188]. Milk fats will then melt and form an extensible thin film, further stabilizing the gas 
bubbles [189], whereas doughs with insufficient lipids will leak gas via the gluten network 
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due to the penetration or rupturing of the cell wall [189]. However, a high concentration of 
lipids will inhibit dough rising, as aggregated gluten and solid lipid crystals exert low 
elasticity, thereby hindering the expansion of bubbles [174]. 
Upon heating, the cells expand with carbon dioxide diffusion and moisture/ethanol 
evaporation. With the moisture mobilization and heat transfer, gluten and gelatinized starch 
become solidified and form a fine crumb texture, and at the same time, the bread crust dries 
and turns brown due to the Maillard reaction [184]. Shortening fats melt fully and form an 
elastic thin film together with gluten along cell walls, again stabilizing gas cells [166]. Solid 
fat-incorporated breads exhibit increased porosity, loaf volume, and softness [190]. During 
baking, with the melting and gelatinization of starch particles, fat globules melt and form gas 
cells. The dough moisture migrates towards the edges of gas bubbles to evaporate. Eventually, 
the bread forms an interlinked porous texture [191]. 
During the staling process, the bread crust becomes leathery and the crumb turns rigid and 
unresilient, in parallel to the losses of aroma and eating quality [192]. The migration of 
moisture across the crumb and crust leads to increased bread rigidity. In addition, amylose 
and amylopectin retrograde successively over shelf life [193]. Milk fats have sufficient SFI at 
ambient temperature, and thus, they are able to act as plasticizers to increase storage stability, 
as well as change the thermoplastic properties. 
2.8.2 Biscuit fats  
Biscuits are among the most consumed bakery products worldwide, and they are formulated 
with flour, fat, sugar, milk, water, egg (optional), and salt into a viscous dough, and are baked 
on a flat surface [182]. In addition to lubrication and aeration in dough forming, biscuit fats 
perform roles including filling, laminating, coating, surface spray, nutritional value, sensory, 
and tenderization. Fats (Tm ca. 33 °C to give smooth mouthfeel, SFI 53% at 20˚C and 3% at 
35 °C) constitute around half of the biscuit filler, in which inappropriate melting points will 
cause brittleness or filling collapse. Coating fats are usually cocoa butter equivalents (Tm ca. 
36.6 °C), whereas typical spray lipids approximately possess SFI profiles of 22% at 20 °C and 
0.5% at 35 °C [142]. Milk fats can be formulated compositely to fulfil these roles. Milk butter 
(no less than 7%, flour based) and cheese have been used to make premium butter biscuits 
(USDA 18214 [18]) and cheese crackers (USDA 45080543 [18]). Furthermore, cookies also 
utilize milk butter powder to laminate the dough sheets into several discrete layers, creating a 
puffy effect on the end product [142]. Enzymatically hydrolysed or cultured milk fats have 
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been used as flavour agents [154, 156]. In addition to the above functionalities, milk butter 
also serves as a nutritional ingredient. For instance, AMF and butter is comprised of 
polyunsaturated fats and lipophilic compounds such as vitamin E and β-carotene [147]. In 
addition, milk fats are natural lipids, without the trans-fatty acid issues such as hydrogenated 
shortenings [194]. 
Crackers are usually salty biscuits, based on layered dough, whereas cookies are normally 
made out of high fat and sugar recipes (short-dough [195], more cake-like). To 
counterbalance gluten development with syrup, comparable fats are added to confine starch 
granule swelling and limit dough forming [142]. Cookie dough is short-formed, and therefore 
a chemical leavening agent is used to increase its volume. The lipid content of leavened 
cookies and crackers is 7 – 20%, whereas unleavened cookies can have a lipid content as high 
as 16 – 33% (dough-based, Table 2-8). A typical cracker recipe incorporates 23.1% of milk 
butter (flour-based) [147]. In contrast to breads (35 – 45% moisture), the moisture content of 
cookies and biscuits are comparably low. For instance, crackers and cookies in Table 2-9 
contain 2.75% and 5.9% moisture, respectively [140], and thus they can sustain a long shelf 
life. Compared with cookies, cracker recipes have no sugar (Table 2-8).  
Table 2-8: Biscuit recipes based on 100 g flour. 
Ingredients (g) Cracker 1 Biscuit 1 Biscuit 2 Biscuit 3 Biscuit 4 
Wheat flour  100.00 100.00 100.00 100.00 100.00 
Water  27.50 35.71 13.33 20.00 20.00 
Shortening  10.50 13.84 44.89 39.90 66.00 
Baking Powder  0.80 0.98 1.11 0.50 - 
Salt  1.00 0.66 0.93 0.71 2.40 
Emulsifier  2.75 0.59 5.00 0.51 1.00 
Sugar  - 26.79 60.00 40.40 33.00 
Shortening Dough Base 7% 8% 20% 20% 33% 
Reference [196] [197] [198] [195] [199] 
Table 2-9: Nutritional information and fatty acid profile of baked goods. 
Baked 
Products 









USDA code 18064 21142 3213 18133 45209528 18232 45262644 45174254 
Water (g) 35.25 27.88 5.90 29.70 26.25 2.75 24.69 18.83 
Energy (kJ) 1145 1547 1812 1213 1516 1903 1654 1725 
Protein (g) 10.67 7.08 11.80 5.4 3.75 7.3 2.47 2.35 
TL (g) 4.53 18.92 13.20 2.7 15.00 16.4 18.52 16.47 
Ash (g) 2.01 3.31 2.00 1.2 - 2.83 - - 
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Carbohydrate (g) 47.54 42.82 67.10 61 55.00 70.73 54.32 62.35 
Sugar (g) 5.73 3.88 24.2 36.66 40.00 6.9 - - 
TDF (g) 4.00 2.50 0.20 0.5 - 15.48 43.21 49.41 
SFA (g) 0.70 11.80 2.35 0.80 3.75 3.21 7.41 8.24 
MUFA (g) 0.61 2.49 5.99 0.95 0.00 3.47 - - 
PUFA (g) 1.62 2.20 2.88 0.45 0.00 8.474 - - 
TFA (g) 0.03 0.21 0.02 - 3.75 0.034 - - 
Notes: data retrieved from US Department of Agriculture (USDA) [18]; total lipids (TL); total 
dietary fibre (TDF); saturated fatty acids (SFA); monounsaturated fatty acids (MUFA); 
polyunsaturated fatty acids (PUFA); trans fatty acids (TFA). 
2.8.3 Milk fats in cakes  
Cake batter is an emulsion of flour, sugar, shortening, egg, and other minor ingredients [200], 
and cakes contain more lipids and sugar than breads. In contrast, milk fats, especially butter, 
play a greater role in cakes than in biscuits. Yellow cakes (Table 2-10) use butter and whole 
egg, resulting in a rich colour, tender grain, and milky flavour. White cakes, on the other 
hand, usually use egg white and shortening instead of milk butter (Table 2-10). Pound cakes 
require equal amounts of flour, whole egg, milk butter, and sugar (Table 2-10), leavened by 
baking powder. Distinctly, butter may be absent in sponge cake recipes, where egg performs 
the aeration function in batters, creating foam and an airy grain.  
In a layer cake formula ([201], Table 2-10), the amount of sugar is not greater than the 
quantity of wheat flour (both 100 g), and the egg amount (49.1 g) is equal or comparable to 
the amount of shortening (40.91 g). The amount of liquid in the recipe (114.89 g, Table 2-10) 
may be equal to or greater than the amount of sugar in the recipe (100 g, Table 2-10) [202]. 
Conversely, high-ratio cakes use more sugar than wheat flour (Table 2-10). To counterbalance 
the inhibitory effect of excess sugar on starch gelatinization [202], an extra egg is added to 
strengthen the formula (60 g egg vs. 40 g shortening [144] in Table 2-10). 
Cake fats perform similar functions to bread lipids, for example, air incorporation, air cell 
stabilization, structure tenderization, and elevation of oven spring [203]. Propylene glycol 
monostearate (PGMS, 1.8% w/w), glycerol monostearate (GMS, 1% w/w), and lecithin (0.8% 
w/w) blended with soy bean oil are equally as effective as commercial liquid shortenings in 
increasing cake size and softness. However, liquid shortening cakes exhibit a reduced firming 
rate compared with cakes containing plastic shortening, seen over the course of three-weeks 
in storage [203].  
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Wheat Flour 100 100 100 100 100 100 
Granulated Sugar 136 100 120 100 81.82 100 
Water 106 65.79 75.00 16.33 - - 
Fresh Egg 60 49.10 60 100 127.27 100 
Butter or 
Equivalent 25 40.91 40 83.55 86.36 100 
Emulsifier 0.30 - 2 0.12 - - 
Skimmed Milk 
Powder 9 8.18 7 - 6.05 6.66 
Vanilla Flavor - 2.03 - - - - 
Salt 3 2.03 3 1.63 - - 
Baking Powder 6 0.55 5.5 6.53 9.09 - 
Fats in Batter 6% 11% 10% 20% 19% 25% 
References [147] [201] [144] [204] [205] [206] 
Notes: * White cakes use egg white (not yolk) and shortening, instead of butter. 
2.9 The replacers of bakery milk fats 
To make cost effective bakery products, milk fats need to be replaced with more economic 
sources. In addition, milk fats are high-calorie (3665 kJ/100 g for AMF in Table 2-7), highly-
saturated lipids (ca. 66% in Table 2-6). With a high content of shortenings in biscuits and 
cakes, the total lipid content in some bakery products (1812 kJ/100 g in Table 2-9) catalogues 
them as high-calorie foods (>1675 kJ/100 g [207]), as shown in Table 2-9. To produce bakery 
goods that are low in calories and saturated lipids, milk fats need to be substituted. There has 
been interest in using resistant starch (RS) emulsions to substitute bakery fats by 25 – 50%. In 
this regard, four forms of starch (2.6 – 46% RS) exhibited great potential in improving 
cookie/cake size and symmetry due to the extra hydration capacity of the added starches, 
while maintaining colour and sensory score [208]. Specialty fats (e.g. hydrogenated fats) in 
the bakery industry have been used to improve texture, shelf life and sensory acceptance. 
However, they are associated with high serum levels of low density lipoprotein and 
cholesterol, and the subsequent development of atherosclerosis [143]. Oleogels are recent 
alternatives to reduce SFA, as illustrated in  
 
Table 2-11. It has been found that fat replacement has less impact on the acceptability of 




Table 2-11: Fat replacer in bakery products. 
Replacer  Baked goods  Replacement%  Result Reference 
Beeswax-sunflower oil 
oleogels 
AACC 10.90 cake 100% SFA 58%→15.5%  [210] 
Candelilla wax-canola oil 
oleogels 
AACC 10.54 cookie 30 – 40% SFA 63.4%→32.3% [162] 
Carnauba wax-canola oil 
oleogels 
AACC 10.90 cake 25% SFA 74.2%→
64.24% 
[211] 
Candelilla wax-canola oil 
oleogels 
AACC 10.52 cookie 100% SFA 52.8%→8.5% [212] 
Inulin from chicory roots. Sponge cake: 100% 
sugar, 46% sunflower 
oil 
70% Reduced fat and 
fortified fiber 
[213] 
Inulin Short dough biscuit: 
74.1% margarine; 37% 
sugar  




Inulin Short dough biscuit: 
30% shortening; 15% 
sugar 
20% Weakened 
lubrication of biscuit 
dough 
[215] 
Acetylated rice starch Cookie: 60% sugar, 
30% shortening 
20% Native and modified 
rice starch equally 
effective 
[216] 
Inulin  Biscuit: 45% 
margarine, 26.7% 
sugar 
20% Biscuit energy 




maltodextrin or lupine 
extract 
Short dough biscuit: 
132% margarine, 66% 
sugar 
30% 28.6% fat reduction 
and 23 g/kg fiber 
fortification 
[218] 
Carnauba wax (5% cotton 
oil oleogels) 
AACC 10.90 cake 50% SFI similar to 
shortening fats 
[219] 
Chia seeds mucilage 
(80.16% carbohydrate, 
10.63–10.76% protein) 
AACC 10.90 cake and 
AACC 10.10 bread 
50% and 75% 51.6 – 56.6% fat 
reduction and protein 
fortification 
[184] 
High-oleic sunflower oil 
and inulin/β-
glucan/lecithin 
Biscuit: 34% sugar, 
46% shortening 





Chia mucilage gel Pound cake: 75% 
sugar, 30% shortening 
25% Higher replacement 
led to adverse effect 
to color and texture 
[221] 
Puree of canned green 
peas 
full-fat chocolate bar 
cookies: 324% sugar, 
134% shortening 
75% By sensory 
assessment 
[222] 
High oleic sunflower oil + 
wheat bran (1.9:1) 
Cookie: 52% sugar, 
33% shortening, 40% 
egg 
100% SFA: 54.624.5% [223] 
77.3:34:12.4:1.3 olive oil: 
water: inulin: lecithin 
Cake: milk fats 35%, 
sugar 33%, egg 40% 
50% SFA: <39% 
TL: <19% 
[224] 
Notes: Solid fat index (SFI); saturated fatty acids (SFA); total lipids (TL); base: 100 g flour. 
In contrast to the moisture-retention and staling-retardation effects of carbohydrate-based 
replacers, protein-based replacers perform functions as texturizers. For instance, milk whey 
protein concentrate has been compositely used to substitute fats [225]. In addition, enzymes 
can also reduce shortening use, by targeting the endogenous flour lipids. Fugal lipase, e.g. 
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Lipopan F, has been successfully developed to hydrolyse flour lipids to replace milk fats [190, 
226, 227]. In another report, amylase-hydrolysed starch was used to replace shortening, and 
achieved a comparable loaf size and consistency, but lower springiness and softness [228]. In 
general, reduced-fat bakery products have shown poorer performance in regards to mouthfeel, 
flavour, and texture properties than standard bakery products [229]. 
2.9.1 Carbohydrate-based milk fat mimetics 
Carbohydrate-based fat mimetics are the most common milk fat replacers, including plant 
polysaccharides, dietary fibre, and starch [230]. These fat mimetics have been initially 
designed to generate sufficient baking activity, such as moisture retention, texturizing, and 
mouthfeel, whereas yielding only half to a quarter of the total calories of fats. However, in 
terms of flavour, palatability, crumb consistency, appearance, and customer acceptances, 
these replacers are less effective than milk fats. Recently, dietary fibre (e.g. inulin [231] and 
pectin [232]) and other resistant starches (e.g. Emjel) have been added to cookie and cake 
recipes [208], and they achieved similar textural properties to full-fat bakery products. Pectin 
(Yuja pomace) gel substitution (10%, w/w) led to the same level of volume and textural 
properties as shortening cake (AACC 10.90), with increased softness and whiteness [232]. 
Inulin (e.g. Agave angustifolia fructans) replacement (20%) led to similar sensory properties 
and enhanced prebiotic activity [233]. Light microscopy images showed that, with the 
replacement of shortening fats with β-glucans from an edible mushroom in the batter recipe, 
the population of gas bubbles became decreased, with broader size distribution, which 
indicated the loss of stabilization by forming an interfacial lipid film along bubbles during 
batter forming [234]. 
2.9.2 Lipid-based milk fat mimetics 
Unsaturated lipids or low-calorie lipids have been used to replace milk fats. For instance, 
replacement of butter in breads by rapeseeds caused a 91% reduction of low-density-
lipoprotein-cholesterol in plasma [235]. Margarine is a cheap alternative to milk fats. 
However, the high water content of margarine limits its use in biscuit manufacturing. Animal 
fats have been used to inter-esterify with plant oils (e.g. canola oil) to prepare bread 
shortenings [236], and cookies prepared with oils were firmer than full-fat cookies [237], 
whereas shortening (palm oil) and emulsifiers together have produced cakes with a similar 
firmness to cakes prepared with fats [203]. Inter-esterified beef tallow caused slower 
crystallization than tallow, and brought about an SFI increment of approximately 11% and 5% 
at 25 °C and 40 °C, respectively, thus increasing cake size and textural consistency. Inter-
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esterification of the beef tallow-palm medium fraction produced similar plasticity and 
operability of shortening to beef tallow [238]. The addition of MAG and tripalmitin induced 
the formation of a polymorphic β-form, accelerating the processing of crystal formation and 
reducing the size of crystals [239].  
2.9.3 Emulsion-based milk fat mimetics 
Oleogels have been prepared to structure vegetable oils for bakery products, to reduce SFA 
and trans-fatty acids from the diet, as illustrated in  
 
Table 2-11. Oleogels were prepared by thermal dispersion of sunflower oil into SSL (7–13%, 
w/w) at 75 °C [143]. Candelilla wax-canola oil oleogels reduced cookie SFA to ca. 8%, 
without damaging eating quality [212]. In another study, beeswax-sunflower oil oleogels 
reduced SFA in cakes to 14 – 17% from 58% in full-fat cakes [210]. In a previous report, 
monoacylglycerol organogels and sunflower oil-loaded hydrogels were used to replace 
shortening fats (palm oil), by 81% [240]. MAG-sunflower/palm oil (0.5%/7%, flour based) 
water gels have been formulated into bread recipes (4.7% MAG, 55.8% oil, and 39.5% water, 
w/w/w) [241]. Edible oleogels enhanced nutritional profiles and healthy benefits [242], and 
showed important features, such as thermo-reversibility and thixotropy [243]. SSL (7%) has 
been used as a gelling agent to structure sunflower oil oleogels, creating a crystal network 
similar to that of TAG [143]. 
Gels of hydroxypropyl methylcellulose (HPMC)/sunflower oil produced more acceptable 
biscuits than milk fat, vegetable shortening, sunflower oil/xanthan gum, olive oil/HPMC, and 
olive oil/xanthan gum [244]. A 15% replacement of HMPC/inulin made crisper biscuits than 
full-fat shortening [245]. Biscuit dough formulated with an HPMC emulsion showed similar 
rheological properties to dough made out of shortening fats [246]. 
2.9.4 Whole foods or combined ingredients to replace bakery lipids 
Whole foods, such as avocado, chia, and banana, have been used to replace bakery lipids. For 
instance, chia (Salvia hispanica L. oil content 30 – 40%, protein content 15 – 25%) is 
comprised of rich polyunsaturated fatty acids, such as ω-3 fatty acids (linolenic acid, 54 – 
67%) and ω-6 (linoleic acid, 12 – 21%). A chia mucilage gel (25%) has been shown to be a 
feasible alternative for pound cake shortening [221]. The use of oatrim (100% ), bean puree 
(75%) or green pea puree (75%) as fat replacers in biscuits have proven to be equally 
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effective, and avocado puree can replace half of the shortening in both cakes and biscuits [21]. 
Okra gum from an edible green fruit (flowing plant of the mallow family) has been identified 
as a fat replacer for reduced-calorie bakery products, improving the nutritional quality of 
baked goods [247]. Avocado purée as a full replacement of shortening fats has brought about 
an increase in MUFA by 16.51%. Substitution by half demonstrated comparable acceptability, 
whereas further fortification with avocado purée caused undesirable flavour and aftertaste, 
according to the tested panelists in the study [248]. 
2.10 Conclusion 
2.10.1 Milk phospholipid vesicle properties and health benefits 
In this review, milk vesicle properties and health impacts were addressed. As an emerging 
material in nutraceutical and bio-pharmaceutical, milk phospholipids show advantages over 
lecithin of soy and egg yolk in encapsulation efficiency. Recently, various kinds of liposomes 
have been prepared for enhancing the solubility and bioavailability of encapsulates. 
Phytosomes, more stable carriers than liposomes, should provide a further area to study. For 
instance, milk phospholipids have been proven to support cognitive development owning to 
their balanced distribution in phosphatidylserine and sphingomyelin, which was almost absent 
in soy and egg yolk lecithin. Apart from brain function, milk phospholipids have a role in skin 
care, due to their more saturated fatty acids, which lead to milky-white colour and stability.  
In summary, milk phospholipids have prospective applications in nutritional delivery, infant 
formula and cosmetic for their vesicle properties and biological functionalities. As potential 
alternatives to traditional polar lipids from egg yolk and soy, milk phospholipids need to be 
efficiently produced in large-scale. Ethanolic extraction remains the most used lipid extraction 
process in dairy industry. Defatting with supercritical carbon dioxide or acetone are frequently 
used to further refine phospholipids from lipids.  
2.10.2 Bovine milk fats in baked goods and their replacers  
This review verifies the relevance and significance of milk fats in bakery products. Their roles 
include altering structural, rheological, nutritional, and sensory characteristics. The milk fats 
can be used for dough strengthening in bread making, texture softeners in cakes, and sensory 
improvers in butter biscuits. In addition, they can be used as cookie fillers, laminating fats, 
topping and coating fats in bakery products. The interactions of milk fats with flour gluten 
and starch particles provide dough strengthening and texture improving effects to bakery 
products. Appropriate fat substitution with the design of new matrices such as oleogels and 
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inulin gels can improve the nutritional value of bakery products by reducing the saturated 
fatty acid content and energy density, and by increasing the nutrient quality, without adversely 
affecting the textural and sensory properties. In addition, lipase treatment of flour lipids or 
milk fats can generate emulsifiers including monoacylglycerols, which may enhance the 
shortening effect of milk fats and thereby reduce shortening use. Milk fatty acid-wheat starch 
complexes may also be facilitated so as to reduce glycaemic response and increase the shelf-
life of baked goods.  
In the end, milk fats have performed multi-functions in both technological importance and 
nutritional value, especially for high-end, valued-added baked goods. With partial 
replacement of milk fats in bakery products to balance their saturated lipids, both nutritional 
quality and customer acceptability can be further improved. 
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Chapter 3: Materials and methods 
3.1 Materials for phytsomes 
Milk phospholipid concentrate (20.81% and 51.3% (w/w) for lipids and proteins, 
respectively) was donated by Tatua Co-operative Dairy Company Ltd. Lipase (L3126, porcine 
pancreas, type II, EC232-619-9), phospholipid assay kit (MAK122), α-tocopherol 
(SKU258024, 95.5%), L-ascorbic acid (A92902, 99%), bovine bile extract, and 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were procured from Sigma-
Aldrich. IEC-6 cells were seeded from Tianjin Key Laboratory of Food and Biotechnology, 
Tianjin, China. All other reagents including ethylenediamine tetraacetic acid (EDTA) were of 
analytical grade.  
3.2 Phospholipid isolation and determination 
3.2.1 Extraction of milk phospholipids 
Milk phospholipids were extracted using a modified Folch method. Milk lipids (20 g) were 
first dissolved in 450 mL methanolic chloroform (1:2, v/v) for laboratory propose. After 20 
min of agitation, 0.74% saline solution (160 mL) was added to precipitate casein protein. 
Following another 20 min of agitating, the mixture was centrifuged at 4000 g for 30 min at 
4˚C. Subsequently, the aqueous supernatant was withdrawn with a 5 mL pipette, and the solid 
layer was removed with a scraper. Milk lipids in the chloroform layer (denser bottom layer) 
were dried under vacuum. The lipids were defatted three times with acetone. The acetone-
insoluble precipitate was lyophilized to obtain purified phospholipids [249]. 
3.2.2 Proximate chemical compositional analysis 
Total lipid content of milk samples was analysed gravimetrically, while the contents of 
proteins, triacylglycerols (TAG), and phospholipids of each fraction were determined by the 
Bradford assay, a TAG enzymatic colorimetric kit (glycerine phosphate oxidase peroxidase 
(GPO-PAP)), and the phospholipid assay kit MAK122 (Sigma-Aldrich China). 
3.3 Preparation of liposomes and phytosomes 
3.3.1 Preparation of liposomes  
Liposomes were prepared using thermal method [250], with minor supplementation—
sonication. The mixture of milk phospholipids and encapsulates (i.e. ascorbic acid and α-
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tocopherol) was agitated in aqueous phase at 80 ℃ for 60 min. Subsequently, the liposomal 
suspension was further treated with sonication for 10 min to gain fine droplets (Sonics and 
Materials, Inc., 240 W, 20 kHz). The samples were analysed immediately following 
preparation.  
3.3.2 Preparation of phytosomes  
Phytosomes were prepared using ethanol evaporation method [92, 251]. Phospholipids and 
ascorbic acid (10 mg) were mixed at five molar ratios (0.33:1 – 3:1) and dissolved in 10 mL 
of ethanol. The mixture was then agitated with a magnetic stir bar at 300 rpm and 45 °C for 3 
h. Finally, the formulated complexes were obtained by evaporating the solvent under vacuum. 
The precipitated phytosomes were stored at 4 °C before use. Vitamin E phytosomes were 
made using the same procedure.  
3.3.3 Complexing index of phytosomes 
The complexing index (CI) of associated vitamins C/E (ascorbic acid or α-tocopherol) in 
phytosomes was indirectly determined from the equation of 𝐶𝐼 = 1 − 𝑉𝑢𝑛𝑐𝑜𝑚𝑝𝑙𝑒𝑥 𝑉𝑡𝑜𝑡𝑎𝑙⁄ , 
where 𝑉𝑢𝑛𝑐𝑜𝑚𝑝𝑙𝑒𝑥 is the amount of uncomplexed ascorbic acid or α-tocopherol, and 𝑉𝑡𝑜𝑡𝑎𝑙 is 
the total quantity of the antioxidants. The uncomplexed antioxidant was precipitated using a 
α-tocopherol and ascorbic acid-insoluble solvent (chloroform, available at laboratory) to 
dissolve the phytosomes and phospholipids. Subsequently, the remaining antioxidant 
precipitate was separated by centrifugation at 8,000 g for 45 min at 4˚C. The contents of 
ascorbic acid and α-tocopherol were quantified with the SolarBio Life Sciences assay kits 
BC1235 and BC1423, respectively.  
3.3.4 Encapsulate efficiency of liposomes 
The ascorbic acid added into the liposomes was measured indirectly. The liposomal 
dispersion (2 mL) was centrifuged at 8,000 g for 45 min at 4˚C. The unincorporated ascorbic 
acid in the supernatant was determined using the assay kit BC1235 (SolarBio Life Sciences). 
The encapsulation efficiency (EE) of ascorbic acid liposomes was calculated by Eq. 3-1: 
𝐸𝐸 = 1 − 𝐴𝐴𝑢𝑛𝑒𝑛𝑐𝑎𝑠𝑢𝑙𝑎𝑡𝑒𝑑 𝐴𝐴𝑡𝑜𝑡𝑎𝑙⁄ ,                 (3-1) 
where 𝐴𝐴𝑢𝑛𝑒𝑛𝑐𝑎𝑝𝑠𝑢𝑙𝑎𝑡𝑒𝑑 is the amount of non-encapsulated ascorbic acid, and 𝐴𝐴𝑡𝑜𝑡𝑎𝑙  is the 
total quantity of ascorbic acid. 
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3.4  Verification of phytosomal complexing 
3.4.1 Fourier-transform infrared spectroscopy 
The molecular interactions of phytosomes was investigated by Fourier-transform infrared 
(FTIR) spectroscopy. Phytosomes (1 mg pellet) and KBr powder (100 mg) were finely ground 
together in a mortar. The fine powder was then pressurized to 10 MPa with a hydraulic unit to 
form a thin layer crystal. A Varian 3100 FTIR spectrophotometer (Varian Inc., USA) was 
used to scan the spectrum of the crystal from 400 to 4000 cm–1 at a resolution of 2 cm–1 [252].  
3.4.2 Ultraviolet spectrum analysis  
Characteristic ultraviolet (UV) absorbance of phytosomes will change after phytosomal 
complexation. Therefore, UV absorption spectrometry has been used to verify the 
conformation of phytosomes [253, 254]. The UV spectrums of the phytosomes, their 
constituents, and the mixture in ethanolic dispersion were measured with a UV 
spectrophotometer (Thermofisher Evolution 201 model) over the wavelength of 190 – 400 nm 
at room temperature [254].  
3.4.3 Differential scanning calorimetry analysis 
The differential scanning calorimetry (DSC) thermograms of pallet samples (e.g. phytosomes 
lyophilisation powder) were obtained using a Q1000 DSC unit (TA Instruments, USA) [255]. 
The samples (3 – 5 mg) were first placed and sealed in aluminium crimp cells, and then each 
cell was heated from 30 to 300 °C at a rate of 10 °C min–1 under a constant nitrogen flow (60 
mL min–1). An empty pan was used as the reference. The acquired temperature-enthalpy data 
for samples was analysed using the TA Instruments Universal Analysis 2000 software 
(Version 5.5.24).  
3.5  In vitro digestion 
3.5.1 Simulated intestinal digestion 
The milk phospholipid dispersion (10 mL, phytosomes or liposomes) was diluted with 30 mL 
of distilled water. The simulated intestinal fluid (SIF) was composed of KH2PO4 (0.68%, w/v; 
as specified in the US Pharmacopeial (USP) Convention), porcine lipase (1280 lipase unit per 
pot), and bile extract (200 mg per pot), and was adjusted to pH 7.0 using 0.1 M NaOH prior to 
its addition to each pot to initiate the hydrolysis reaction. Aliquots of the digesta were taken at 
0, 20, 40, 60, 90 and 120 min for compositional analysis [7].  
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3.5.2 Analysis of ascorbic acid and free fatty acids  
The ascorbic acid released during intestinal digestion was separated by centrifugation at 8,000 
g for 30 min at 4˚C, and was quantified using the assay kit BC1235 (SolarBio Life Sciences). 
The lipase and lipids were incubated with constant stirring at 95 rpm for 2 h at 37 ºC. The 
milk lipids were extracted with ethanolic diethyl ether (1:1, v/v). Subsequently, FFA 
concentration was determined titrimetrically with 0.05 mol/L of ethanolic potassium 
hydroxide [256], using the equation of 𝐹𝐹𝐴 = (VKOH) × (MKOH) × (MWML) 2⁄ , where VKOH 
and MKOH were the volume (μL) and molarity of potassium hydroxide titrant (μM), 
respectively, and MWML was the molecular weight of milk lipids (triacylglycerols and 
phospholipids, 794 g/mol) [257]. 
The experimental data of lipids was fitted using a linear regression model (−ln(1 −
𝑥𝑙𝑖𝑝𝑖𝑑𝑠) 𝑣𝑠 𝑡, k as the slope of trend-line) with the initial concentration of fatty acids being 
zero. The reaction rate constant k was described by the equation: 𝑘𝑡 = −ln(1 − 𝑥𝑙𝑖𝑝𝑖𝑑𝑠), 
where 𝑥𝑙𝑖𝑝𝑖𝑑𝑠 was the conversion rate of the substrates (phytosomes and liposomes) to fatty 
acids [258]. 
3.6  In vitro absorption and cytotoxicity  
3.6.1 Cell culture  
The IEC-6 cells, from small intestinal epithelial cell line, were grown in Dulbecco's modified 
Eagle's medium (DMEM), which comprised of 10% (v/v) fetal bovine serum (FBS) and 0.5% 
(v/v) penicillin and streptomycin (both 100 U mL–1). The cells were first incubated at 37˚C 
and 5% CO2 until their confluence. The confluent cells were then washed twice with 
phosphate buffered saline (PBS) after a removal of culture medium. EDTA solution (1 mL, 
1%, w/v) was used to detach the cells from the wall (1 min, 37˚C), followed by the addition of 
1 mL of culture medium to neutralize the EDTA. The detached cells were then suspended 
with a pipette and transferred to a tube for centrifugation at 240 g for 3 min at 4˚C. The 
supernatant was discarded, and the cells at the bottom of tube were again dispersed with 1 mL 
of culture medium. The amount of the cells was determined with a cell counting plate. 
DMEM medium was replaced every three days. 
3.6.2 The cellular uptake of ascorbic acid 
The method of cellular uptake of ascorbic acid was adapted from a previous report [254]. The 
confluent IEC-6 cells (passage of 15 – 35) were seeded in culture dishes (50 mm in diameter) 
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at a density of 0.2 million cells per petri dish. After 24 h of treatment of phytosomal or 
liposomal dispersion (5 mL per petri dish, 1 mg/mL), ice-cold phosphate-buffered saline 
(PBS) was used to wash the IEC-6 cell monolayer twice, and then trypsin-EDTA solution (1 
mL, 1%, w/v) was added to suspend the cells. Following incubation (1 min), the EDTA was 
neutralized by addition of 1 mL of the growth medium. The suspension was centrifuged at 
240 g for 3 min to precipitate the IEC-6 cells. Pelleted cells were gently washed with ice-cold 
PBS and then re-suspended using a further 1 mL of ice-cold PBS. The cell suspension was 
sonicated at 20 kHz for 10 min at 4˚C (by ice-cooling). The solid cellular debris was separated 
from the aqueous solution by centrifugation at 8,000 g for 10 min at 4˚C, and the ascorbic 
acid content in the supernatant was quantified with the assay kit BC1235 (SolarBio Life 
Sciences).  
3.6.3 Cytotoxicity 
Phytosomal and liposomal toxicity was colorimetrically analysed using the MTT assay [91]. 
IEC-6 cells were seeded in 96-well, flat-bottom microplates at a density of 5,000 cells per 
well. The cells were incubated for 24 h (37˚C and 5% CO2) to become confluent. The cells 
were then treated for 3 h in a dispersion of phytosomes or liposomes (2 μL per well, 0.025 – 
0.2 mg/mL) supplemented with 20 μM MTT. Following incubation, the dispersion was gently 
removed with a 200 μL pipette, and the cells were carefully washed twice with cold PBS. 
Dimethyl sulfoxide (DMSO, 100 μL) was then added to each well to dissolve the formazan 
crystals inside the cells. The absorbance of each well at 490 nm was measured in a microplate 
reader. The relative cell viability (CV) was obtained by normalizing the absorbance of the 
treated cells (𝐴𝑡) with that of the controls samples (𝐴𝑐), using Eq. 3-2.  
                                                                 CV = (Ac − At) Ac⁄                                  
(3-2) 
3.7 Materials of milk phospholipids 
Milk phospholipid concentrate (20.81% and 51.3% (w/w) lipids and proteins, respectively) 
was donated by Tatua Co-Operative Dairy Company (Morrinsville, New Zealand). Lipase 
L3126, porcine pancreas type II (EC232-619-9, CAS 9001-62-1), bovine bile (B3883), and 
phospholipid assay kits (MAK122), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid 
(ABTS), 1,1-diphenyl-2-picrylhydrazyl (DPPH), dichlorodihydrofluorescein diacetate 
(DCFH-DA), thiobarbituric acid (TBA), and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) were obtained from Sigma-Aldrich China. A 
triacylglycerol assay kit was purchased from Nanjing Jiancheng Bioengineering Institute, 
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Nanjing China. Finally, HT-29 cells (human colorectal adenocarcinoma cells with epithelial 
morphology) were seeded in Tianjin Key Laboratory of Food and Biotechnology, Tianjin, 
China. The other chemicals used in this study were of analytical grade.  
3.8  Extraction and purification of milk phospholipids 
3.8.1 Milk phospholipids extraction 
Milk phospholipids were extracted using the methods in section 3.2.1. 
3.8.2 Solid phase extrraction 
The milk phospholipid fractionate was further purified from neutral lipids by solid phase 
extraction (SPE) [78]. The lipid solution (100 mg phospholipids in 1 mL of n-hexane) was 
first loaded on a silica gel SPE cartridge (500 mg, 6 mL). After the column was washed with 
n-hexane, the non-polar lipids were eluted with 10 mL of n-hexane-diethyl ether (1:1, v/v). 
Next, the phospholipids were recovered by two steps of elution, firstly with methanol (10 mL) 
and followed by a solvent mixture of methanolic chloroform and water (5:3:2, v/v/v, 10 mL). 
The eluted phospholipids were finally dried under a gentle flow of nitrogen. 
3.9  Chemical analysis 
3.9.1 Proximate chemical compositional analysis 
Total lipid content of milk phospholipids was gravimetrically analysed, and whereas the 
contents of proteins, triacylglycerols (TG), and phospholipids of each fraction were 
determined by the Bradford assay [249], the TG enzymatic colorimetric kit (glycerine 
phosphate oxidase peroxidase (GPO-PAP) [259]), and the phospholipid assay kit MAK122 
(Sigma-Aldrich China) [70], respectively. 
3.9.2 Thin layer chromatography 
Milk phospholipids in chloroform solution (2 μL, 100 mg/mL) were pipetted to the bottom 
edge of a silica gel plate for thin layer chromatography (TLC). The subclasses of milk 
phospholipids were separated with a solvent mixture (chloroform, methanol, and water, 
65:25:4, v/v/v). Each band of polar lipids was oxidized in iodine vapour to visualize as 
coloured spot [260]. Standard phosphatidylcholine (PC) by Sigma-Aldrich was used as 
reference phospholipid subclasses.  
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3.10  In vitro digestion 
3.10.1 In vitro digestion by pancreatic lipase and fungal lipase 
Milk lipid dispersion (10 mL, phospholipids or triacylglycerol) was diluted with 30 mL of 
distilled water. The simulated intestinal fluid (SIF) was composed of dipotassium phosphate 
(0.68%, w/v), 150 mM sodium chloride and 30 mM calcium chloride [7], and the fluid was 
adjusted to pH 7.0 using 0.1 M NaOH. Lipase (0.4%, w/v) and bile extract (0.5%, w/v) were 
added to each pot to initiate the hydrolysis reaction. Aliquots of the digestion were taken at 0, 
20, 40, 60, 90 and 120 min for compositional analysis. The free fatty acids (FFA) were 
extracted with ethanolic diethyl ether, and then quantified titrimetrically with 0.1 M ethanolic 
potassium hydroxide [256]. 
3.10.2 Release kinetics of FFA from milk phospholipids 
The experimental data were fitted using the model mentioned in the section of 3.5.2. 
3.10.3 Choline cleavage from milk phospholipids 
The phosphatidyl groups in milk phospholipids were cleaved by phospholipases D and A2, 
and pancreatic lipases in 96-well, flat-bottom microplates. The free choline was quantified at 
570 nm using the colorimetric assay kit MAK122 (Sigma-Aldrich China). The reaction rate 
constant was obtained using the same model used for fatty acid release, as described in 2.4.2.  
3.11  Absorption and cytotoxicity  
3.11.1 Cell culture  
The HT-29 cells were grown as described in the section of 3.6.1. 
3.11.2 Cellular uptake of phospholipids 
The method of determining the cellular uptake of ascorbic acid was adapted from a previous 
report [91]. The confluent HT-29 cells (passage of 15 – 35) were seeded in culture dishes (50 
mm in diameter) at a density of 0.2 million cells per petri dish. After 24 h of treatment of milk 
phospholipids dispersion (5 mL per petri dish, 1 mg/mL), ice-cold PBS was used to wash the 
HT-29 cell monolayer twice, and then trypsin-EDTA solution (1 mL, 1%, w/v) was added to 
suspend the cells. Following incubation (1 min), the EDTA was neutralized by addition of the 
growth medium (1 mL). The suspension was centrifuged at 240 g for 3 min to pellet the HT-
29 cells. The supernatant was aliquoted to determine the milk phospholipid concentration 
(𝐶𝑓), and the cellular uptake (CU) of milk phospholipids was then calculated by Eq. 3-3: 
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𝐶𝑈 = (𝐶𝑖 − 𝐶𝑓) 𝐶𝑖⁄ ,       (3-3) 
where 𝐶𝑖 and 𝐶𝑓 are the initial and final concentrations of milk phospholipids, respectively.  
3.11.3 Anti-proliferation activity 
Milk phospholipid toxicity was analysed colorimetrically using the MTT assay [91], as 
descripted in section 3.6.3. The relative cell viability (CV) was obtained by normalizing the 
absorbance of the treated cells (𝐴𝑡) with that of the control samples (𝐴𝑐), using Eq. 3-4: 
𝐶𝑉 = (𝐴𝑐 − 𝐴𝑡) 𝐴𝑐⁄ .       (3-4) 
3.12  Antioxidant activity 
3.12.1 DPPH radical scavenging activity 
The free radical, 2, 2-Diphenyl-1- picrylhydrazyl (DPPH) radical scavenging activity was 
measured as previously described [261]. Samples (0.25 mL of the various concentration) and 
freshly-prepared DPPH (1 mM methanolic solution, 0.18 mL) were added to methanol (2.57 
mL), and were then incubated in dark for 30 min to measure the absorbance at 515 nm 
(DPPH) with a spectrophotometer. The DPPH radical scavenging rate (SR) was calculated 
against reagent blanks with Eq. 3-5: 
𝑆𝑅(%) = (1 − (𝐴𝑡 𝐴𝑐⁄ )) × 100,    (3-5) 
where 𝐴𝑡 and 𝐴𝑐 were the absorbance value of the samples and controls at 30 min, 
respectively [262]. Ascorbic acid was selected as the reference antioxidant.  
3.12.2 ABTS radical scavenging activity 
A colorimetric assay was used to quantify the ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid)) radical scavenging activity of milk phospholipids [263], in comparison to 
ascorbic acid. The mixture (1:1, v/v) of ABTS solution (7 mM) and potassium persulfate 
(K2S2O8, 2.45 mM) was kept for 16 h in the dark to form the radical cation (ABTS•+) at 
ambient temperature. Subsequently, the optical density of the solution was adjusted to 0.70 at 
734 nm with ethanol. The mixture of the ABTS working solution (1 mL, 0.7 in absorbance) 
and samples (100 μL) was then incubated for 20 min and then the absorbance (A20) was 
measured at 734 nm. The ABTS radical scavenging rate (SR) was calculated using Eq. 3-6, 
where 𝐴𝑏𝑙𝑎𝑛𝑘 is the absorbance of the reagent blanks: 
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𝑆𝑅(%) = ((𝐴𝑏𝑙𝑎𝑛𝑘 − 𝐴20) 𝐴𝑏𝑙𝑎𝑛𝑘⁄ ) × 100.   (3-6) 
3.12.3 Hydroxyl radical scavenging activity 
The hydroxyl radical scavenging activity of the milk phospholipids was measured with a 
spectrophotometric protocol as described by Zhu et al. [264]. PBS (1mL, 0.4 M, pH 7.4), 
1,10-phenanthroline (1 mL, 2.5 mM, Sigma-Aldrich), FeSO4 (1 mL, 2.5 mM), and H2O2 (0.5 
mL, 0.01%, w/v) were added to the milk phospholipid dispersion (1 mL of various 
concentration). After 1 h of incubation at 37˚C, the absorbance of the samples was measured 
at 536 nm (1,10-phenanthroline-Fe2+ complex). The scavenging rate (SR) of hydroxyl radicals 
was calculated as follows: 𝑆𝑅(%) = [(𝐴 − 𝐴𝑏) (𝐴𝑐 − 𝐴𝑏)⁄ ] × 100, where Ac was the 
absorbance of the controls (the samples and H2O2 were replaced with 1.5 mL of distilled 
water), Ab was the absorbance of the reagent blanks (the samples were replaced with 1 mL of 
distilled water), and A was the absorbance of milk phospholipid samples.  
3.12.4 TBARS formation inhibition method 
Thiobarbituric acid reactive substance (TBARS) assay on milk phospholipids was determined 
by the description of Murdifin et al. [265], in comparison with both ascorbic acid (0.1 
mg/mL) and butylated hydroxytoluene (BHT, 0.1 mg/mL). The mixture of 4 mL milk 
phospholipid dispersion (1 mg/mL) and 1 mL linoleic acid (13%, w/v) were dispersed with 
sonication for 10 min at 20˚C. Following encapsulation of the oil droplets, the samples were 
incubated in darkness at 50˚C for 2 days. An aliquot (1 mL) was added to 2.5 mL TBA 
solution (0.375% TBA (w/v), 15% trichloroacetic acid (w/v), and 0.25 M HCl), and was then 
boiled for 10 min. The thiobarbituric reactive substance, malondialdehyde (MDA), from the 
oxidation of linoleic acid, became pink. The supernatant after centrifugation (5,000 g, 25˚C, 
and 10 min) was then determined spectrophotometrically at 532 nm. Lipid peroxidation 
inhibition percentage (IR) was calculated by Eq. 3-7: 
𝐼𝑅(%) = [(𝐴𝑐 − 𝐴𝑠) 𝐴𝑐⁄ ] × 100,     (3-7) 
where 𝐴𝑐 and 𝐴𝑠 were the absorbance values of controls and samples, respectively.  
3.12.5 Cellular antioxidant activity 
The cellular antioxidant activity (CAA) of milk phospholipids was assayed on HT-29 cells 
[266]. The cells were seeded on a 96-well microplate, with a density of 5×104/well. After one 
day’s incubation at 37˚C, the growth medium was removed and the cells were washed twice 
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using PBS. Subsequently, the cells were treated with milk phospholipid dispersion (0.05 – 1 
mg/mL) and DCFH-DA (25 μM) for 60 min. Following the removal of growth medium and 
washing twice with PBS, 600 µM 2,2′-azobis (2-amidinopropane) dihydrochloride (ABAP, 
Sigma-Aldrich) was applied to the cells in 100 µL of growth medium. The emission at 538 
nm was measured with excitation at 485 nm in one hour, using a microplate reader. The CAA 
value was calculated by Wolf et al. [266]. 
3.13 Dough preparation and bread making 
3.13.1 Ingredients and reagents 
Whole wheat flour, comprising 1.2% of lipids and 11.5% of gluten, was purchased from 
Champion Flour Milling Ltd, Christchurch, New Zealand. Bakery yeast was procured from 
Edmonds Yeast Company, Christchurch, New Zealand. Milk butter from bovine pasteurized 
milk consists of 82.9% and <1% for total lipids and proteins, respectively, and was supplied 
by Mainland Baking Company, Christchurch, New Zealand. Lipopan F (25 – 50 kLU g–1, 
active at pH 5 – 7) was supplied by Novozyme Company, Australia. Pepsin (P1700 0.8 – 2.5 
kU mL–1) and pancreatin (P75458, USP specification) were procured from Sigma-Aldrich 
Australia. Amyloglucosidase was procured from Megazyme Australia, with enzymatic 
activity of 3.3 kU mL–1 on soluble starch. 
3.13.2 Bread making 
The bread samples including controls were prepared according to AACC 10.10 straight dough 
and yeasted formula [182], consisting of 150 g of whole wheat flour, 90 mL of water, 2.25 g 
of instant yeast, 2.25 g of salt, 9 g of sugar, and 7.5 g of milk butter. In lipase-treated milk 
lipid samples (LML4.5), the level of Lipopan F supplementation was 4.5 mg for 150 g flour. 
Whereas the doses for LML9 and LML18 were double and quadruple to that for LML4.5 
samples, respectively. Whereas, for LFL2.3 samples, Lipopan F lipase concentration was as 
2.3 mg per 150 g flour. With regard to lipase-treated milk lipid (LML) samples, microwave-
melted butter was mixed with lipase in aqueous dispersion and incubated with constant 
rotation at 95 rpm for 20 min at 37˚C, and the lipolysate was added to other ingredients for 
dough mixing. Whereas, for lipase-treated flour lipid (LFL) samples, lipase in aqueous 
dispersion was added to wheat flour to digest its lipids during dough mixing and maturation at 
ambient temperature. After the dough was formed, it was removed from the mixer and 
kneaded to release the air trapped during dough mixing. The matured dough was either tested 
immediately or it was divided into 50 g portions and moulded in 110 mL baking pans. The 
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3.14.3 Dough firmness 
Dough firmness was measured by penetrating with a cylinder probe of 6 mm in diameter into 
each dough pot. Prior to measurement, an aeration plunger followed by a flat plunger were 
applied to remove any air pockets and flatten the dough sample, respectively. 
3.14.4 Dough pH 
The dough pH was measured according to a method by the International Association for 
Cereal Chemists (ICC). Matured dough (5 g) was dissolved in 100 mL of 5% acetone aqueous 
solution (v/v) for 30 min before pH measurement [268].  
3.15  Bread analysis 
3.15.1 Physical properties  
The loaf volume was determined on intact loaves according to AACC method 10.05.01 [182]. 
The specific loaf volume was obtained from the ratio of volume and weight. The porosity was 
calculated by the equation of ε = 1 − ρtotal ρsolid⁄ , where ε was crumb porosity; ρtotal 
represented the crumb density; and ρsolid was the density (1.111 g/mL) of compact crumb 
without gas cells for wheat flour bread baked at 180˚C [269].  
3.15.2 Crust colour  
A CR210 colorimeter unit equipped with a 50 mm diameter was used to measure the colour 
parameters (CIELAB colour space: L*, a*, and b*). The whiteness index (WI, [270]) and 
brownness index (BI for evaluation of the Maillard reaction, [271]) were calculated with Eq. 
3-8 and Eq. 3-9, respectively.  
WI = 100 − √(100 − L∗)2+a∗2 + b∗2,                (3-8) 
BI = 100(x − 0.31) 0.17⁄ , where x = (a∗ + 1.75L∗) (5.645L∗ + a∗ − 3.01b∗)⁄ .       (3-9) 
3.15.3 Texture profile analysis 
A texture profile analysis (TPA) unit (Texture Technologies Corp., Scarsdale, NY) was used 
to analyse bread texture profile according to AACC method 74.09 [182]. A 6 mm diameter 
cylindrical probe and a load cell of 5 kg, and TA.XT2 kit (Stable Micro System Ltd., UK) 
were equipped to the unit. The bread macro software provided by the TPA unit was used to 
collect the data. Bread samples were cut into slices of 2.5 cm thickness. The crust was 
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removed to restrict the limit to TPA analysis. TPA analysis was measured in triplicate from 
three different slices. The probe speed was set at 1 cm/s.  
3.16  Bread in vitro digestion and glycaemic glucose equivalent 
A dinitrosalicylic acid (DNS) colorimetric assay was used to determine the glycaemic glucose 
equivalent (GGE) of reducing sugar generated from starch in vitro hydrolysis [272]. 
Glucosidase enzymatic digestion was carried out in 70 mL plastic containers on a multi-
magnetic stirrer. A GOPOD starch kit TSTA-100A (Megazyme Int. Ltd, Co. Wicklow, 
Ireland) was used to determine the total starch content of bread, according to AACC method 
76.13.01 [182].  
The potential glycaemic response of milk lipid-complexed starch gels was determined by 
simulated gastrointestinal digestion [272]. Starch gel (2.5 g) was added to 30 mL of distilled 
water to conduct in vitro digestion (37 °C with constant stirring). HCl (0.8 mL, 0.05 M) and 1 
mL of pepsin (10%, w/w, Acros Organics, New Jersey, USA CAS: 901-75-6) was added to 
each digest to simulate gastric fluid. After 30 min of simulated gastric digestion, 1 M 
NaHCO3 (2 mL) solution was added to neutralize the gastric acid, and 0.1 mL 
amyloglucosidase was added to prevent end product inhibition. This was followed by the 
addition of 5 mL pancreatin (2.5%, w/w, (EC: 232-468-9, CAS: 8049-47-6, activity: 42.36 
FIP-kU/g, Applichem GmbH, Darmstadt, Germany) in 0.1 M sodium maleate buffer to 
simulate intestinal fluid and the digestion was continued for 2 hrs. During the intestinal 
digestion phase, aliquots of 1 mL were taken at 0, 20, 60, 120 min and added to 4 mL of 
ethanol for subsequent reducing sugar analysis by a dinitrosalicylic acid (DNS) colorimetric 
assay.  
3.17  Complex index 
Iodine solution was used to spectrophotometrically determine the CI value of starch-lipid by 
the equation of 𝐶𝐼 = 1 − 𝐴𝑡 𝐴𝑐⁄ , where 𝐴𝑡 and 𝐴𝑐 were the absorbance (at 620 nm) of lipase-
treated samples and controls, respectively [174].  
3.18  Anti-staling performance 
3.18.1 Water activity and bread staling during shelf life 
The crumb water activity was measured with an AquaLAB CX2 unit (Decagon Devices, Inc., 
WA, USA), using the moisture diffusion method. The firmness of intact breads during storage 
was tested according to Giannone et al. [273]. 
 75 
3.19  Lipolysis and free fatty acid determination 
The mixture of fungal lipase Lipopan F and milk butter dispersion was incubated with 
constant stirring at 95 rpm for 2 h at 37 ºC. The milk lipids were extracted with ethanolic 
diethyl ether (1:1, v/v). Subsequently, FFA concentration was determined as mentioned in the 
section of 3.5.2. 
3.20 Materials and reagents for amylose-fatty acid complexes 
Wheat starch (WS, S5127), corn starch (CS, S4126), waxy corn starch (WCS, S9679), rice 
starch (RS, S7260), and stearic acid were procured from Sigma-Aldrich, while high amylose 
corn starch (HACS) was obtained from Megazyme Australia. Milk lipids (bovine pasteurized 
milk butter, total lipids 82.9%) were supplied by Mainland Baking Company, Christchurch, 
New Zealand. Lipopan F fungal lipase was procured from Novozyme Australia. All other 
reagents were of analytical grade. The total content of proteins and lipids of milk butter were 
52.51 ± 4.45 mg/kg and 0.86 ± 0.03 g/g, respectively. The amylose contents were 67.0 ± 
0.2%, 29.74 ± 0.24%, 23.70 ± 0.96%, and 26.75 ± 0.33% for HACS, CS, WS, and RS, 
respectively. WCS was composed of pure amylopectin.  
3.21  Preparation of starch-milk fatty acid complexes 
Milk lipids (butter) were first hydrolysed by fungal lipase Lipopan F. The hydrolysates were 
lyophilized to make milk fatty acid dry pellets. Milk fatty acids at fortification concentration 
of 0 (control), 4, 12, and 20% (w/w, starch based) were mixed with 3 g of starch (WS, CS, 
RS, WCS, and HACS) in 25 mL of distilled water. The mixture was gelatinised using a RVA-
4, 23-min standard-2 procedure, in which the mixture was heated from ambient to 95˚C at a 
rate of 5˚C/min and held at 95˚C for 7 min before cooling down to ambient temperature again. 
Stearic acid supplementation (12%, w/w, starch based) was used to compare with milk fatty 
acids.  
3.22  Light microscopy analysis and particle size distribution 
One gram of fine starch powder was dispersed in 30 mL distilled water and stained with 0.2% 
iodine solution (w/w) before observation and imaging with a Nikon H55S computerised 
microscope (bright field, phase contrast mode) [274]. The starch gels with entrapped milk 
fatty acids were dyed with Sudan black ethanolic solution (0.7 g in 100 mL ethanol) and 
analysed with the same microscope to starch particle analysis. PSDs of starch granules 
solutions were measured at approximately 10% laser obscuration using the laser diffraction 
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particle size analyser MasterSizer 3000 (Malvern Instruments Ltd., Malvern, Worcestershire, 
UK) equipped with a wet sample dispersion unit (Malvern Hydro MV, UK). The refractive 
indexes of starch and dispersant (water) were set 1.54 and 1.33, respectively. The surface-
area-based mean diameter (𝑑3,2) and volume-based mean diameter (𝑑4,3) were also obtained 
together with PSD profile [275].  
3.23  Gel rheological properties and CI measurement 
The rheological properties of both untreated and fatty acid-complexed starch gels were 
determined with a Perten rapid viscosity analysis unit (RVA-4, FF Instrumentation Ltd., New 
Zealand), according to AACC 76.22 method [182]. The firmness of fresh gels was measured 
using a TA-XT2i texture analyser with a probe of 6 mm diameter, which penetrated 4 mm 
into the gel at a speed of 0.2 mm/s. The peak force at 4 mm compression cycle was defined as 
the gel firmness [276]. The CI value were spectrophotometrically determined as described in 
the section of 3.17.  
3.24  In vitro digestion of starch-milk lipids and starch hydrolysis kinetics 
The potential glycaemic response of milk lipid-complexed starch gels was determined by 
simulated gastrointestinal digestion [272]. The logarithmic slope (LOS) plotting of reaction 
curve was performed to determine lipolysis reaction rate constant [277]. The experimental 
data was fitted using a model described in the section of 3.5.2.  
3.25  Spectroscopy analysis and thermography for starch-lipid complexes 
A Varian 3100 FTIR spectrophotometer (Varian Inc., USA) was used to scan the spectrum of 
the milk fatty acid-complexed wheat starch crystal from 400 to 4000 cm–1 at a resolution of 2 
cm–1 [252]. DSC was used to assess the thermal properties of starch-lipid complexes. Wheat 
starch-fatty acid mixtures (3 mg) were weighed accurately into aluminium pans of 40 μL, and 
9 μL of distilled water was then added. After that, the pans were sealed and equilibrated for 
30 min at room temperature. The enthalpy-temperature curve were recorded during the 
heating from 20 to 120 °C at a rate of 10 °C/min. An empty pan was used as the reference. 
The acquired data were analysed using the TA Instruments Universal Analysis 2000 Software 
[174]. 
3.26  Lipolysis and determination of free fatty acids 
Free fatty acids (FFA) concentration was determined titrimetrically with 0.05 M of ethanolic 
potassium hydroxide [256]. FFA content (μg) was calculated as a previous method [257]. In 
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addition to FFA determination, the fatty acid profile of lipid was chromatographically 
analysed using fatty acid methyl esters (FAME) method, with a gas chromatograph unit 
equipped with a flame ionization detector (FID) [54].  
3.27  Materials for milk lipid lipolysis 
Corn starch (S4126), wheat starch (S5127), and rice starch (S7260) were procured from 
Sigma-Aldrich. Porcine pancreatic lipase (L3126, EC232-619-9, CAS 9001-62-1) was 
supplied by Sigma-Aldrich. Bovine bile (B3883) and amyloglucosidase were provided by 
Sigma-Aldrich USA. Milk butter (from pasteurised cream milk, proteins 0.6%, lipids 81.4%, 
carbohydrate 0.6%, sodium 0.6%, 30.3 MJ/kg) was procured from Pams, New Zealand. All 
chemicals used were of analytical grade. Total protein content of milk butter was 52.51 ± 4.45 
mg per kg, as determined according to the Bradford assay [249], and whereas, milk butter was 
extracted using Folch method and the total lipid content was gravimetrically analysed [80]. 
After being dissolved in methanolic chloroform solution (10 mL, 1:2, v/v) with constant 
stirring at 120 rpm for 30 min, milk fat dispersion was then washed with saline solution (4 
mL, 0.74%, w/v). Next, the mixture was centrifuged at 700 g for 10 min at 4˚C. Following the 
removal of supernatant, the chloroform layer at the bottom was then evaporated overnight 
with a gentle nitrogen stream. The dry precipitate was stored at –20˚C before its use as milk 
fat samples. 
3.28  Proximate nutritional analysis 
Total protein content of milk butter was determined by the Bradford assay [249], while total 
lipids of milk butter were analysed gravimetrically. The lipids (1 g) were dissolved in 
methanolic chloroform solution (10 mL, 1:2, v/v) with constant stirring for 30 min at 120 
rpm. The lipid solution was then washed with saline solution (4 mL, 0.74%, w/v). Next, the 
mixture was centrifuged at 700 g for 10 min at 4˚C. Following the removal of supernatant, the 
chloroform layer at the bottom was then evaporated overnight with a gentle nitrogen stream. 
The dry precipitate was weighed to determine the amount of total lipids [278].  
3.29  Preparation of milk lipid dispersion and its turbidity analysis  
Sonication-assisted high shearing homogenisation was used to prepare the emulsion. Milk 
lipids (2.5 g milk butter) were dispersed in 30 mL of distilled water with constant stirring for 
30 min at 50 ℃, followed by 5 min homogenisation at 16,500 rpm and subsequent 15 min 
ultra-sound treatment at 37 kHz [279]. The emulsion turbidity (𝑇, m–1) was calculated using 
equation of 𝑇 = 2.303 × 𝐴 × 𝐷 𝐿⁄ , where 𝐴, D, and L were the absorbance at 500 nm, 
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dilution factor, and light path length, respectively [280, 281]. The emulsion stability index 
(ESI) of the milk lipid dispersion was calculated with the equation of 𝐸𝑆𝐼 = 𝑡 ×
𝐴0 (𝐴0 − 𝐴𝑡)⁄ , where t is the time interval (i.e. 10 min), and 𝐴0 and 𝐴𝑡 were the absorbance at 
500 nm of lipid emulsion at 0 and 10 min, respectively [282].  
3.30 Preparation of starch gels to entrap milk fats and rheological analysis 
Starch fat-filled starch gels were prepared with starch (2, 2.5 or 3 g; rice, corn or wheat starch, 
respectively), 1 g milk fat, and 25 mL distilled water [283]. The milk fat-loaded rice, corn or 
wheat starch gels (testing samples) were defined as RF-, CF- and WF-gel, respectively, and 
whereas, MFG (control samples) represented the naked milk fat emulsion. For side control 
samples, R-, C- and W-gels were denoted as rice, corn and wheat gel, respectively, without 
filling milk fat. Milk fat-contained mixture was homogenized using a high shear homogenizer 
at 16,500 rpm, followed with an AACC 76.21.01 Standard 2 heating program (23 min heating 
including 7 min holding at 95 °C) in the cartridge container of a rapid viscosity analysis unit 
with constant bladed-agitation at 160 rpm [284]. The milk fat-filled starch gels were instantly 
analysed for lipolysis reaction rate and degree. A crude oil-in-water (O/W) emulsion, as the 
control sample, was prepared from milk fat, water and 0.5% SDS emulsifier by 16,500 rpm 
homogenization at 55 °C, and the coarse emulsion was fine-tuned and stabilized with a 37 
kHZ ultra-sonication unit for 10 min [279, 285].  
3.31  Optical, confocal laser scanner microscopy 
The starch gel light microscopy analysis and PSD analysis methods were as in the section of 
3.22. Confocal laser scanner microscopy (CLSM) protocol was adapted from a recent report 
[215], and Sudan Black was used to stain milk fats at emission wavelength 488 nm and 
absorbance wavelength 515 nm. Fat droplet particle size distribution was analysed using both 
microscopy techniques [incl. light microscopy and confocal laser scanning microscopy 
(CLSM)] and laser diffraction technique. The microscopic images were processed to find out 
surface-area-based diameter (𝑑3,2) using the software ImageJ (Version 1.48, Wayne Rasband, 
National Institute of Health, Bethesda, Maryland, USA) [161]. One gram of fine starch 
powder was dispersed in 25 mL distilled water at 60 °C. Starch granule solution (40 µL) was 
pipetted onto a microscopic glass slide, followed by 20 µL iodine solution (0.2 g iodine in 100 
mL aqueous solution) and a cover slide [286]. The slide was observed and imaged with Nikon 
H55S computerised microscope (bright field, phase contrast mode, a magnification of 10×100 
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times) [287]. Sudan black, a fluorescent dye, was used to stain milk lipids, and the CLSM 
images were viewed at 488 nm (excitation) and 515 nm (emission) [215]. 
3.32  PSD analysis 
The particle size distribution (PSD) of starch granules in 60 °C aqueous dispersion was 
measured at 10% laser obscuration using the laser diffraction particle size analyser 
MasterSizer 3000 (Malvern Instruments Ltd., Malvern, Worcestershire, UK) equipped with a 
wet sample dispersion unit (Malvern Hydro MV, UK). The refractive indexes of starch and 
dispersant (water) were set as 1.54 and 1.33, respectively. The surface-area-based mean 
diameter (𝑑3,2) and volume-based mean diameter (𝑑4,3) were obtained in addition to particle 
size distributions [275]. The PSD of Milk fat globules in emulsion was also measured with 
MasterSizer 3000. The circulation motor was set at 2000 rpm, using ethanol as dispersant 
(10% laser obscuration.  
3.33 Pancreatic-lipase-catalysed digestion of milk fats in dispersion or in 
starch gel 
Simulated intestinal fluid (SIF) was composed of dipotassium phosphate (0.68 g in 100 mL 
aqueous solution), 150 mM sodium chloride, and 30 mM calcium chloride, which was 
maintained at 37ºC with continuous agitation at 95 rpm during digestion in a temperature-
controlled multi-well stirrer platform [7]. The SIF was adjusted to pH 7.0 using 0.1 M NaOH 
prior to intestinal digestion. 
An in vitro intestinal digestion model [288] was adapted to hydrolyse milk fat in both control 
and testing samples. A sample dispersion of 30 mL (containing 1 g milk fat), 10 mL SIF, 
pancreatic lipase (32 mg or 8,000 Lipase Unit), amyloglucosidase (Megazyme Australia, 
enzymatic activity 3.3 kU mL–1, 100 μL or 330 U), and 200 mg bile extract were added to 
each pot to initiate the hydrolysis reaction. The reaction was carried out by constant agitation 
at 95 rpm and 37˚C. Aliquots of the digestion were taken at 0, 20, 40, 60, 90 and 120 min for 
free fatty acid content analysis.  
3.34 Lipolysis and free fatty acid determination 
The free fatty acid (FFA) content was assayed as the method in section 3.5.2.  
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3.35 Fatty acid methylation and gas chromatograph 
In addition to FFA quantification, the free fatty acid profile was chromatographically analysed 
using the fatty acid methyl esters (FAME) method, with a gas chromatograph (GC) unit 
equipped with a flame ionization detector (FID) [54]. Milk lipid hydrolysates were 
lyophilized for two days and then resultant lipid powder (80 mg) was transferred to test tubes. 
Internal standard (C21:0 ester 5 mg/mL, 50 µL) was added to each tube. Heptane (450 µL) 
was transferred to each tube to dissolve the milk lipids, then 2.0 mL of ethanolic sodium 
hydroxide solution (0.5 M, anhydrous) was added to esterify the fatty acids. Fatty acid 
methylated esters were produced with a 15-min incubation in a 50˚C tube incubator. The 
produced esters were washed with heptane (1 mL) and distilled water (1 mL) by vortex (1 
min). Subsequently, the mixture was centrifuged at 1500 g for 5 min. The esters in the 
supernatant were analysed by gas chromatography (GC) [289].  
3.36  Kinetic analysis of lipolysis 
The experimental data were fitted using a model described in the section of 3.5.2. 
3.37  Statistical methods 
The average of all results obtained were determined from triplicate measurements. Statistical 
analysis of results was carried out by one-way analysis of variance (ANOVA) with a Tukey 
test using Minitab 18 software (Minitab Inc., Chicago, USA). Significance was determined by 
a confidence level of 95%. 
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Chapter 4: Preparation and assessment of milk phospholipid-
complexed antioxidant phytosomes with vitamin C and E: A 
comparison with liposomes 
Chapter 4 has been submitted for publishing:  
o Zhiguang Huang, Hui Zhao, Wenqiang Guan Jianfu Liu, Charles Brennan, Maneesha S. 
Mohan, Letitia Stipkovits, Haotian Zheng, Don Kulasiri. Preparation and assessment of 
milk phospholipid-complexed antioxidant phytosomes: with vitamin C and E. Food 
chemistry, 2019 (submitted). 
Abstract: Phytosome assemblies have proved to be novel drug delivery systems. However, 
studies of phytosomes in food applications are scarce. The characteristics of milk 
phospholipid assemblies and their functionality in terms of in vitro digestibility and 
bioavailability of encapsulated nutrients (ascorbic acid and α-tocopherol) were studied. The 
phytosomes were prepared using ethanolic evaporation technique. Spectral analysis revealed 
that polar parts of phospholipids formed hydrogen bonds with ascorbic acid hydroxyl groups, 
further, incorporating ascorbic acid or α-tocopherol into the phospholipid assembly changed 
the chemical conformation of the complexes. Phospholipid-ascorbic acid phytosomes yielded 
an optimal complexing index of 98.52 ± 0.03% at a molar ratio of 1:1. Phytosomes exhibited 
good biocompatibility on intestinal epithelial cells. The cellular uptake of ascorbic acid was 
29.06 ± 1.18% for phytosomes. It was higher than that for liposomes (24.14 ± 0.60%) and for 
ascorbic acid aqueous solution (1.17 ± 0.70%).  
Keywords: Milk phospholipids; phytosome; liposome; encapsulation efficiency; in vitro 
digestion; cellular uptake 
Pubchem CID: Bile salt (PubChem CID: 439520); L-ascorbic acid (PubChem CID: 
54670067); α-tocopherol (PubChem CID: 2116); Lipase (PubChem CID: 135534490); Edetic 
acid (EDTA, Pubchem CID: 6049); Thiazolyl blue tetrazolium bromide (MTT, Pubchem 
CID: 64965) 
4.1 Introduction  
Milk contributes about one third of human dietary lipid intake. Milk phospholipids have been 
used as nutrient carriers since the early 2000s. Thompson [250] used milk phospholipids to 
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prepare three kinds of liposomes to encapsulate bioactive constituents. Since then, milk 
phospholipid-based liposomes and other encapsulated materials have been made to carry both 
lipophilic and hydrophilic components, for instance, curcumin [290], phenolic compounds 
[8], silybin [104], α-tocopherol [2], and ascorbic acid [3]. More recently, milk phospholipid 
liposomes have been manufactured as delivery systems, stabilizing the storage of tea 
polyphenols [8], solubilizing curcumin with a better efficiency than soy lecithin [9], and 
protecting lactoferrin from gastric disintegration [10]. In addition, Dynamic in vitro lipolysis 
and fatty acid titration assay have been used to understand the digestion of drug vesicles 
including phytosomes [291], and further, the vesicle property differences between lecithin and 
milk phospholipids have been made recently, and the latter was found to be more efficient in 
terms of encapsulation efficiency [9].  
    Both milk phytosomes and liposomes are derived from milk phospholipids, but they are 
distinct in several ways. Liposomes entrap bioactive compounds in either the core of 
phospholipid globule (hydrophilic encapsulates) or in the phospholipid bilayer (lipophilic 
encapsulates), forming closed vesicles (Ding et al, 2018; Lamba et al, 2018; Silva et al, 2018). 
Whereas, phytosomal complexes are constructed mainly by hydrogen bond between bioactive 
compounds and the polar heads of phospholipids. Phytosomes agglomerate into nano-size 
micelles (approximately 100 nm, slightly smaller than liposomes) when they are dispersed in 
aqueous phase. Hence they are integral conjugations, thereby more durable and efficient 
carriers than liposomes [89]. Commercial phytosomes, for instance, Silybin Phytosome™, 
Ginkgo Phytosome™, and Ginseng Phytosome™, use both synthetic and natural 
phospholipids to deliver bioactive constituents [292]. Phyto-phospholipid complexes are no 
longer limited to polyphenols either, and theoretically, the complexes can be used to deliver 
any active molecules [89].  
    Milk phospholipids are emerging biomaterials, however there are no phytosomes derived 
from them thus far. The present study aims to prepare two types of phytosomes by solvent 
evaporation, the types are: milk phospholipids-ascorbic acid phytosomes and milk 
phospholipids-α-tocopherol phytosomes. Parallel liposome based samples will be prepared as 
a control set for comparison in terms of nutrients encapsulation efficiency, assembly 
digestibility, and nutrients bioavailability using cellular uptake level as an indication. The 
formation of complexes was investigated by Fourier-transform infrared (FTIR) spectroscopy, 
ultraviolet (UV) spectroscopy, and differential scanning calorimetry (DSC).  
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4.2 Materials and methods 
The materials and methods in the section of 4.2 can be referred back to the corresponding 
sections in Chapter 3, as illustrated in Table 4-1.  
Table 4-1: Materials and methods for phytosomes. 
Section 4.2 Materials and methods 
As mentioned in 
the section of  
4.2.1. Materials 3.1 
4.2.2. Phospholipid isolation and determination 3.2 
4.2.2.1. Extraction of milk phospholipids 3.2.1 
4.2.2.2. Proximate chemical compositional analysis 3.2.2 
4.2.3. Preparation of liposomes and phytosomes 3.3 
4.2.3.1. Preparation of liposomes 3.3.1  
4.2.3.2. Preparation of phytosomes 3.3.2 
4.2.3.3. CI of phytosomes 3.3.3 
4.2.3.4. EE of liposomes 3.3.4 
4.2.4. Verification of phytosomal complexing 3.4 
4.2.4.1. FTIR 3.4.1 
4.2.4.2. UV spectrum analysis 3.4.2 
4.2.4.3. DSC analysis 3.4.2 
4.2.5. In vitro digestion 3.5 
4.2.5.1. Simulated intestinal digestion 3.5.1 
4.2.5.2. Release of ascorbic acid and free fatty acids 3.5.2 
4.2.6. In vitro absorption and cytotoxicity 3.6 
4.2.6.1. Cell culture 3.6.1 
4.2.6.2. The cellular uptake of ascorbic acid 3.6.2 
4.2.6.3. Cytotoxicity 3.6.3 
4.2.7. Statistical methods 3.37 
4.3 Results and discussion 
4.3.1  Isolation and fractionation 
The total phospholipid content of the original phospholipid enriched milk powder was 12.80 ± 
1.30% (w/w). The phospholipid content in the phospholipid extract was 91.14 ± 1.56% (w/w). 
The relative contents of proteins and triacylglycerols were 4.50 ± 1.18% and 4.35 ± 1.71% 
(w/w), respectively. The purity of phospholipid in the phospholipid extract samples obtained 
in this study was higher than those of Fonterra Phospholac 600 and Phospholac 700 [31], and 
Arla Lacprodan PL-75, which were 69.8%, 61.55%, and 75%, respectively. The increased 
purity of milk phospholipids observed in this study is likely due to the thrice defatting by 
acetone. 
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Phytosomes can be manufactured in several ways, for instance, anti-solvent precipitation or 
evaporation, and anhydrous co-solvent lyophilisation [89]. Traditionally, phytosomes were 
usually prepared in an aprotic solvent such as dioxane, acetone, methylene chloride, or ethyl 
acetate, by conjugating phospholipids with active components at molecular ratios of 1:1 – 3:1. 
More recently, protonic solvents, such as ethanol and methanol, have been successfully used 
to prepare phytosomes. For example, silybin phytosomes were successfully formed in ethanol 
[89]. In this study, the ethanolic evaporation technique was used to prepare phytosomes 
because of its food-compatibility [89, 293].  
In contrast, liposomes have been manufactured by several methods including reverse phase 
evaporation, hydration lipid film, spray drying, and lyophilisation. In the present study, 
sonication-assisted thermal hydration was adapted for liposomal manufacture due to its 
simplicity. 
4.3.2  Liposomal EE and phytosomal CI 
EE of liposomes 
The molar ratio of liposomes was optimized at 2:1 (Figure 4-1b), yielding an efficiency of 
35.88 ± 0.14%, comparable to a recent report on liposomes [253]. The encapsulation 
efficiency of liposomes is considered to be dependent on several factors, including both the 
constituents and manufacture methods. For example, in another study on supercritical fluid-
made liposomes, the encapsulation factors for olive pomace extract and linalool were 58% 
and 55%, respectively [294]. Concerning the molar ratio of phospholipids to bioactive 
molecules, two recent reports prepared phenolic compounds and conjugated with linoleic acid 
with molar proportions at 1:1 and 2:1, respectively [253, 295].  
CI of phytosomes  
As illustrated in Figure 4-1a, milk phospholipids conjugated with ascorbic acid (176.12 g 
mol–1) at different molar ratios, ranging from 0.33:1 to 3:1. The optimal CI of phytosomes 
was 98.52 ± 0.03% at molar ratio of 1:1, which was much higher than the encapsulation 
efficiency of liposomes (35.88 ± 0.14% at a molar ratio of 2:1). The complexing indexes of 
phytosomes plateaued after reaching the optimal efficiency. Whereas for α-tocopherol (430.71 
g mol–1) complexation phytosomes had their highest complexing factor at the stoichiometric 
ratio of 3:1 (Figure 4-1c), probably due to difference of molecular weight and bonding affinity 
to phospholipids.  
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In general, phytosomes are constructed of a phospholipid-bioactive compound conjugation in 
a molar proportion of 0.5 – 2.0, with an optimal index at the molar ratio of 1:1 in many cases 
[89]. In another report on phospholipid-oleanolic acid phytosomes, the molar ratio of 1:1 led 
to the best loading efficiency. However, the efficiency at molar ratios of 2:1 and 3:1 did not 
differ from those complexes (oleanolic acid phytosomes) with a molar ratio of 1:1 [296]. The 
optimal complexing molar ratio of phospholipids to bioactive constituents is dependent on 
both the carrier and the encapsulated bioactive molecules. For example, in silymarin-
phospholipid phytosomes, the optimum efficiency was achieved at a molar ratio of 5:1 [297]. 
Furthermore, in oxymatrine phytosomes, the stoichiometric ratio of 3:1 generated a higher CI 
than those at other ratios [298]. In a drug phytosome, the molar ratio was optimized at 3:1 to 
achieve the highest entrapment of berberine hydrochloride, nevertheless, there was no 
distinctive difference in the efficiency when this ratio was 4:1 [299]. In the present study, α-
tocopherol phytosomes yielded the highest efficiency at molar ratio 3:1.  
Phytosomes exhibited higher binding efficiency than liposomes, consistent with a previous 
report on rutin encapsulation, where phytosomes led to an entrapment efficiency of 24 ± 2%, 
compared with that of liposomes (17 ± 10%) [252]. In another system (egg yolk 
phosphatidylcholine therapies), the CI of phytosomes was 49 ± 3%, almost double that of 
liposomes [300]. The observed difference in the CI and EE between phytosomes and 
liposomes could be attributed to the hydrogen bonding between bioactive compounds and 
phospholipids, providing association sites at both the interior and exterior membranes of the 
lipid vesicles [301]. In contrast, liposomes can only entrap bioactive molecules either in the 
core (lipophilic) or within the lipid bilayer (hydrophilic) [89]. Thus, phytosomes frequently 
exhibit high complexing indexes, as shown in two previous studies (98.4% and 97.2%, 
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Figure 4-1: Encapsulation efficiency of MPL-derived phytosomes and liposomes. 
Notes: The complexing index (CI) of milk phospholipids (MPL)-ascorbic acid phytosomes 
(a); the encapsulation efficiency (EE) of MPL-ascorbic acid liposomes (b), and the 
complexing index of phytosomes between MPL and α-tocopherol (c). 
4.3.3  Spectroscopy study 
Fourier-transform infrared spectroscopy 
Since liposomes displayed significant lower encapsulation efficiency (𝑝 < 0.05) than 
phytosomes, FTIR spectral analysis only focused on phytosomes, their constituents, and the 
mixture, as illustrated in Figure 4-2. When the spectrums of ascorbic acid (Figure 4-2c) and 
the mixture of constituents (Figure 4-2d) were compared, it was worthy to note that the 
characteristic bands of ascorbic acid in Figure 4-2c (3525 – 3219 cm–1 and 1672 – 756 cm–1) 
were also visible in the spectrum of the mixture in Figure 4-2d, which suggests that there was 
no formation of new chemical bonds during mixing, consistent with a previous study by 
Telange et al [93]. At the same time, the aliphatic groups of phospholipids (2920 cm–1, 2850 
cm–1, and 1741 cm–1 in Figure 4-2a) were also inherited in the mixture spectrum in Figure 
4-2d, whereas others were diluted and invisible, in line with a previous report by Zhang et al 
[255].  
When the spectrums of milk phospholipids (Figure 4-2a) and phytosomes (Figure 4-2b) were 
compared, it was found that in the phytosomal conformation the peaks from the phospholipid 
bonds P=O (1236 cm–1), P–O–C (1092 cm–1), and [ – N+(CH2)3] (970 cm–1) of the choline 
residues shifted to 1207 cm–1, 1061 cm–1, and 974–1 cm, respectively. Whereas the aliphatic 
signals in Figure 4-2a including carboxyl ester bond C=O (1741 cm–1), hydroxyl bond (3390 
cm–1), and methyl and methylene groups of fatty acids (2920 cm–1, 2850 cm–1, and 1468 cm–1) 
were unchanged in both the phytosomes (Figure 4-2b) and the mixture of constituents (Figure 
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(c) Phytosomes of MPL and
α-tocopherol
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with hydroxyl groups of ascorbic acid, resulting in the replacement of the major bonds in the 
phosphatidyl residues in phospholipids, whereas the non-polar heads of fatty acids including 
methyl, methylene groups and carboxyl ester bond C=O exhibited no chemical interaction. 
In contrast to the collective effect of the mixture spectrum (Figure 4-2d) from its constituents, 
the spectrum of phytosomes (Figure 4-2b) revealed synthetic effect on the constituents. For 
instance, characteristic signals (3410 cm–1 and 1672 cm–1 for O–H and C=O groups, 
respectively) in ascorbic acid (Figure 4-2c) merged into new peaks at 3390 cm–1 and 1741 
cm–1 in Figure 4-2b, respectively. A recent study, evaluating the hydroxyl stretch (O–H, 3377 
cm–1) of lipophilic drug dihydroartemisinin (DHA), also illustrated such broadening 
complexing with phospholipids [303]. The similar change has been observed in apigenin 
phytosomes, in which a peak of phenolic O–H group moved to 3338 cm–1 from 3272 cm–1 
[93]. Further evidence in celastrol phytosomes is provided by Freaga et al [92], where 
celastrol peak at 1689 cm−1 (C=O stretching) shifted to 1738 cm−1 after formation of 
phytosomes.  
Similar observations have been reported on spectral change during formation of soy 
phosphatidylcholine phytosomes has been reported, where the P=O peak (1251 cm–1) went to 
1240 cm–1 [91]. In addition, the results of Figure 4-2c are congruous with a recent record, in 
which the P=O peak at 1237 cm–1 (from the polar head group) disappeared in the spectra of 
silymarin phytosomes [297]. Further evidence is provided by Telange et al. [93], where both 
P=O and P–O–C peaks were altered in phospholipid complexes, as a result of intermolecular 
interactions and conformation of complexes between apigenin and phospholipid molecules. In 
addition, the peak at 1645 cm–1 (C=C of milk phospholipids in Figure 4-2a) shifted to 1684 
cm–1 in phytosomes in Figure 4-2b, and one possible explanation is that, on formation of 
phytosomes, ascorbic acid interacts with the polar heads of phospholipids molecules, while 
fatty acid chains in sn-1/2 positions may rotate freely to wrap the polar heads of ascorbic acid. 
Thus their wavenumbers in FTIR spectrum were rearranged, in support of previous reports 
[304, 305]. Based on the previous evidences, and the results reported here, we conclude that 






 Figure 4-2: FTIR spectrum of MPL and their constituents. 
Notes: Milk phospholipids (MPL) (a); MPL-ascorbic acid phytosomes (b); ascorbic acid (c); 
and the mixture of MPL and ascorbic acid (d). 
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(d) FTIR spectrum of the mixture of milk phospholipids and ascorbic acid
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UV spectra 
The UV spectrums of milk phospholipids, ascorbic acid, their mixture, and phytosomes 
exhibited analogous profiles, but with significant differences in peak wavelengths (𝑝 < 0.05), 
as shown in Figure 4-3. Ascorbic acid displayed its main peak at 255.5 nm (Figure 4-3c), 
while the milk phospholipids exhibited a major peak at 209.5 nm (Figure 4-3a).  
When milk phospholipids and ascorbic acid were mixed together in ethanolic dispersion, both 
major peaks (209.5 nm for phospholipids and 255.5 nm for ascorbic acid (Figure 4-3d), 
respectively) were present in the resultant spectrum. However, when the two components 
were incorporated as phytosomes (Figure 4-3b), the major peaks shifted to 257 nm and two 
adjacent, minor peaks at 203 nm and 221 nm, indicating a change in the chemical 
conformation of the complexes. Similar spectra with multi-peaks have been reported for an 
aqueous dispersion of silybin phytosomes, in which both a principle maximum and a weak 
shoulder were identified at 285 and 325 nm, respectively. The spectral change was attributed 
to the molecular interactions between constituents in the form of hydrogen bonding [254]. 
Further, the UV spectrum of egg phosphatidylcholine-derived vesicles displayed a maximum 
peak at 254.5 nm in aqueous solution and 259.7 nm in aqueous system and carbon 
































































Notes: Milk phospholipids (MPL) (a); MPL-ascorbic acid phytosomes (b); ascorbic acid (c); 
and the mixture of MPL and ascorbic acid (d). 
DSC analysis 
The interactions between milk phospholipids and the encapsulated constituents in phytosomes 
can be investigated further using DSC, by comparing the transition temperature, appearance 
of new peaks, disappearance of original peaks, melting points, and changes in the relative 
signal of DSC spectroscopy [89]. As shown in Figure 4-4c, the DSC thermogram of ascorbic 
acid exhibited a major endothermic peak at 193.85˚C, which corresponds to its crystalline 
melting point. Phospholipids (Figure 4-4a) demonstrated an obvious sharp endothermic peak 
at 47.82˚C, two following blunt peaks at 85.64˚C and 128.15˚C, and further two successive 
peaks at 227.35˚C and 262.17˚C, similar to the DSC results on quercetin phytosomes 
documented by Zhang et al. [255] in which peaks of heat-induced polar-head motion, crystal-
liquid phase transition, and non-polar hydrocarbon tail of phospholipid melting were observed 
at 143.6˚C, 228.3˚C, and 239.4˚C, respectively. In addition, Ma et al. [305] recorded one 
exothermic peak in mangiferin phytosomes at 251.25˚C (crystal-liquid transition point). With 
regards to the mixture (Figure 4-4d), the melting points of both the phospholipids (47.82˚C) 
and ascorbic acid (193.85˚C) shifted slightly to 48.53˚C and 193.29˚C, respectively. 
Furthermore, the thermal transition at 181.16˚C in Figure 4-4d may be the crystal-liquid 
transitional point of phospholipids. In addition, there were distinct peaks at 195.67˚C 
(endothermic) and 206.02˚C (exothermic) in Figure 4-4d, which may be due to the 
disintegration of constituents (around 195.67˚C) and further reactions among the newly 
produced intermediates and the original constituents (approximately 206.02˚C). The melted 
ascorbic acid (antioxidant) and phospholipids (both antioxidant and pro-oxidant) could 
interact in several ways, consequently resulting in the multiple high-intensity endothermic 
(concave peaks for breakdown or endothermic reactions) and exothermic (convex peaks for 
exothermic reactions) peaks, as presented in Figure 4-4d. 
On the other hand, the DSC spectrum of phytosomes (Figure 4-4b) was totally different from 
that of the mixture (Figure 4-4d). The phospholipid melting point of 48.53˚C in the mixture 
(Figure 4-4d) shifted to a minor endothermic peak at 52.44˚C. Furthermore, the major 
endothermic peak in the spectra of phytosomes (180.96˚C in Figure 4-4b) may be the result of 
the phase transition of crystalline phytosomes or due to the dissociation of phospholipid-
ascorbic acid interactive forces (hydrogen bonds and van der Waals forces). This is in support 
of a previous DSC study by Tan et al. [307]. In addition, there are further endothermic peaks 
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at 244.07˚C and 281.56˚C in Figure 4-4b. It is possible these indicate a series of splitting of 
the milk phospholipids or further dissociation of the phytosome complexes, as reported by 
Zhang et al. [255]. Furthermore, those endothermic peaks could equally be due to the melting, 
isomerisation or crystal change of the phytosomes, as proposed in another study on 
phytosomes [308]. Altogether, the DSC spectra observed in this present study are in 
agreement with DSC data on phytosomes that has been published [103]. 
  
  
Figure 4-4: DSC thermograms of MPL and their constituents.  
Notes: Milk phospholipids (MPL) (a); MPL-ascorbic acid phytosomes (b); ascorbic acid (c); 
and the mixture of MPL and ascorbic acid (d). 
4.3.4  In vitro digestion and absorption 
In vitro digestion 
Gastric pH and salts can alter the size the structure of particles, which further affect the 
intestinal digestion. However, gastric digestion contributes to only a minor proportion (1.5 – 
8%) of the total phospholipid hydrolysis [293] and takes place at pH 1.5 – 3, which is 
incompatible with the present titration quantification since both gastric acid and free fatty 
acids consume titrant. Therefore, only intestinal digestion was surveyed this study, as also 
commonly performed by recent reports on lipid digestion [309-311]. As illustrated in Figure 
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different (𝑝 < 0.05). Disintegration rate is often used to determine the stability of 
encapsulation vesicles [10]. In the present study, liposomes exhibited a higher degradation 
rate than phytosomes, indicating that phytosomes are comparably more stable matrices. In 
addition, the slow disintegration of phytosomes may be due to the hydrogen bonding between 
constituents, thus it takes a comparably longer time to be detached from the carrier than those 
in complexed matrices [300]. In another study, the formation of stable H-bonding in 
phytosomes has been attributed to a better structural integrity, bioavailability, and absorption 
in phytosomes compared with liposomes [301]. Phytosomes have also been reported to not 
only increase the area under the concentration-time curve (AUC) but also prolong the half-life 
of the particles [312].  
Under the catalysis of pancreatic lipase, the fatty acid release from phytosomes and liposomes 
followed by first-order kinetics, with reaction rate constants of 0.016 ± 0.001 min–1 and 0.034 
± 0.007 min–1, respectively. The half digestion time for phytosomes and liposomes is 44.71 ± 
1.14 min (R2=0.97) and 20.15 ± 0.08 min (R2=0.93), respectively. The reaction rate constant 
of phytosomal degradation is lower than that of liposomes, thus the phytosomes disintegrated 
at a slower rate than the liposomes. This difference may be due to the particle structural 
discrepancy and related difference in interfacial properties between phytosomes and 
liposomes, as reported by Manici et al. [300]. 
As shown in Figure 4-5, the release of both ascorbic acid and fatty acids demonstrated a 
similar trend, indicating the synchronous liberation of ascorbic acid and fatty acids with the 
disintegration of the particles. 
  
Figure 4-5: FFA and ascorbic acid release during intestinal hydrolysis.  











































The cellular uptake of ascorbic acid from phytosomes (29.06 ± 1.18%) was greater than that 
from liposomes (24.14 ± 0.60%) or from ascorbic acid aqueous solution (1.17 ± 0.70%), 
consistent with a previous report where phytosomes exhibited a higher propensity across cell 
membranes and resulted in a massive cellular uptake [254]. Further, bioflavonoids in 
phytosomal complexes (US5043323A-1991) have been found to be more bioavailable than 
uncomplexed flavonoids using a mouse model. The greater degree of phytosomal cellular 
uptake is likely because the membrane permeability and oil-water partition coefficients of 
phytosomes are remarkably enhanced. Therefore, bioactive constituents in phytosomes are 
more readily absorbed than those in liposomal matrices and aqueous solution [89]. 
Phytosomes may be absorbed from the intestinal tract through enterocyte-based transport, and 
bioactive compounds then transport to the systemic circulation via the intestinal lymphatic 
system [90]. 
MTT assay 
As illustrated in Figure 4-6, both phytosomes and liposomes showed no detrimental effect on 
the viability of IEC-6 cells, which demonstrated their safety with intestinal cells. The slight 
increase (insignificant, 𝑝 < 0.05) in cell viability may be due to the antioxidant activities of 
ascorbic acid. This biocompatibility was consistent with a mice-model study on the 
cytotoxicity of phosphatidylcholine [313]. Also, phosphatidylserine exhibited no adverse 
effects via oral administration in an in vivo model [314]. Being biodegradable, liposomes in 
aqueous dispersion have been used to deliver both lipophilic and hydrophilic bioactive 
molecules since the 1960s. Therefore, both phytosomes and lipsomes can be regarded as 
biocompatible and effective to integrate into food systems. 
  
Figure 4-6: Relative cell viability in MPL dispersion.  























4.4 Conclusion  
In this study, phospholipids were isolated and refined from milk products and prepared into 
both phytosome and liposome particles. Ascorbic acid phytosomes exhibited higher 
encapsulation efficiencies (optimal complexing index 98.52 ± 0.03% at molar ratio 1:1) than 
liposomes. The spectral analyses of phytosomes suggest that ascorbic acid associates through 
hydrogen bonding at the polar heads of phospholipids, inducing the rearrangement of P=O 
and P – O – C stretches of the polar heads of milk phospholipids. In addition, in vitro 
digestion showed that the cleavage of both fatty acids and ascorbic acid from phytosomes 
were slower than those from liposomes. Cellular uptake studies displayed that phytosomes 
were more readily absorbed than liposomes. Both matrices demonstrated biocompatibility, 
without compromising on safety. In summary, these results reveal that milk phospholipid-
based phytosomes had greater in vitro digestion stability than liposomes, and thus show 
potential to be developed as nutrients for functional foods or infant formulas. 
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Chapter 5: Milk phospholipids antioxidant activity and 
digestibility: kinetics of fatty acids and choline release 
Chapter 5 has been submitted for publication:  
o Zhiguang Huang, Hui Zhao, Wenqiang Guan Jianfu Liu, Charles Brennan, Maneesha S. 
Mohan, Letitia Stipkovits, Don Kulasiri. Milk phospholipids antioxidant activity and in 
vitro digestion: kinetics of fatty acids and choline releases. Journal of Functional Foods, 
2019 (submitted). 
Abstract: Milk phospholipids have been used as functional ingredients in foods recently. 
Thus, there have been no reports on how polarity of lipids affects their digestibility. This 
study aims to isolate milk phospholipids from dairy products, characterize them 
chromatographically, and assess their digestibility and antioxidant activities in vitro. The 
results revealed that their lipolysis reaction rate constants were significantly different (𝑝 <
0.05) between milk phospholipids and triacylglycerols, and thus the degradation of both lipids 
followed first-order reaction kinetics. Furthermore, the cellular uptake of milk phospholipids 
was determined with a HT-29 cell model, and they were found not to be absorbed intact 
during intestinal digestion. Milk phospholipids exhibited significant antioxidant activity in 
vitro, while their cellular antioxidant activity (CAA) was very limited. The results of this 
study provide useful information for the design of milk phospholipid-based carrier systems.  
Keywords: In vitro phospholipid digestion; Choline phospholipid digestion; Fatty acid 
release; Cellular uptake; Antioxidant activity 
5.1 Introduction  
Phospholipids are important ingredients in milk. They serve as functional nutrients with both 
technological importance and nutritional relevance [13]. For instance, milk phospholipids 
have been used as vesicle materials since the early 2000s. Thompson [6] used milk 
phospholipids to prepare three kinds of liposomes to carry bioactive molecules. Since then, 
milk phospholipid-based liposomes have been prepared to deliver ascorbic acid [3] and 
lactoferrin [7]. More recently, milk phospholipid liposomes have been applied to improve the 
storage stability of encapsulates [8], the encapsulation efficiency [9, 10], and the delivery 
system for anticancer drugs [11], with milk phospholipids showing higher efficiency 
compared with soy lecithin [10]. Phospholipids have been used to prepare antioxidant 
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phytosomes [300] and to modulate the release of antioxidant from phospholipid vesicles 
[252]. The digestion kinetics of phospholipids control the bioavailability of encapsulated 
bioactive compounds and impact on their release [315]. Native milk phospholipids are mainly 
located in the bilayer membrane of tri-layered globules in colloidal structure, which may 
affect the release of bioactive compounds along the gastrointestinal tract [39].  
In addition to the vesicle properties, milk phospholipids have been refined as functional 
ingredients. Phospholac 500, 600, 700 and Gangolac 600 have purities of 33.9%, 69.8%, 
61.6%, and 14.5%, respectively [31, 55], while Lacprodan® MFGM 10 and Lacprodan® PL 
20 (purity 20% ) have been produced for functional food ingredients [48] and infant formulas 
[56]. Lipidex, a derivative from β-serum powder, contains 5 – 7% phospholipids and 26.6% 
fat in total [59], and bovine milk sphingomyelin has a purity of 99% [38]. In addition, 
Lipamine M20, which has been manufactured with membrane separation, comprises of 20% 
of sphingomyelin, ceramides, and ganglioside [60]. Ethanol is the most commonly used 
solvent to extract milk phospholipids, for instance, hot alcohol (70%) extraction at 70˚C 
rendered 45.8% purity, starting from whey protein phospholipid concentrate [47]. 
Supercritical carbon dioxide extraction can be used to enrich polar lipids by removal of 
neutral lipids [316]. In a laboratory up-scaling test on buttermilk powder substrate, a pilot unit 
integrated enzymatic proteolysis, ultrafiltration, and super-critical fluid extraction, yielding a 
dry-matter purity of 56.24 ± 0.07% [49, 317].  
There have been a few reports on the digestibility of highly-purified milk phospholipids. For 
example, phospholipase A2 is the enzyme responsible for phospholipid hydrolysis, but milk 
phospholipid liposomes disintegrate slower than soy lecithin liposomes [10, 39]. There have 
also been no reports on how polarity impacts lipid digestion so far. Therefore, the present 
study aims to extract and refine phospholipids from dairy products, to characterize them 
chromatographically, and to evaluate their stability in simulated intestinal fluids and cellular 
update on HT-29 cells, and in vitro antioxidant activity. 
5.2 Materials and methods 
The materials and methods in the section of 5.2 can be referred back to the corresponding 
sections in Chapter 3, as illustrated in Table 5-1.  
Table 5-1: Materials and methods for MPL digestibility and antioxidant activity  
Section 
5.2 Materials and methods of milk phospholipids (MPL) 
As mentioned in 
the section of  
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5.2.1. Materials  3.7 
5.2.2. Extraction and purification of milk phospholipids  3.8 
5.2.2.1. Milk phospholipids extraction  3.8.1 
5.2.2.2. Solid phase extraction (SPE)  3.8.2 
5.2.3. Chemical analysis  3.9 
5.2.3.1. Proximate chemical compositional analysis  3.9.1 
5.2.3.2. Thin layer chromatography (TLC)  3.9.2 
5.2.4. In vitro digestion  3.10 
5.2.4.1. Simulated intestinal digestion catalysed by pancreatic lipase  3.10.1 
5.2.4.2. Release kinetics of FFA from milk phospholipids  3.10.2 
5.2.4.3. Choline release from milk phospholipids  3.10.3 
5.2.5. Absorption and cytotoxicity  3.11 
5.2.5.1. Cell culture  3.11.1 
5.2.5.2. Cellular uptake of phospholipids  3.11.2 
5.2.5.3. Anti-proliferation activity  3.11.3 
5.2.6. Antioxidant activity  3.12 
5.2.6.1. DPPH radical scavenging activity  3.12.1 
5.2.6.2. ABTS radical scavenging activity  3.12.2 
5.2.6.3. Hydroxyl radical scavenging activity  3.12.3 
5.2.6.4. 
Thiobarbituric acid reactive substance (TBARS) inhibition 
method  3.12.4 
5.2.6.5. Cellular antioxidant activity (CAA)  3.12.5 
5.2.7. Statistical method  3.37 
5.3 Results and discussion 
5.3.1  Proximate nutritional analysis 
The total phospholipid content of milk polar-lipid extract was 91.14 ± 1.56% (w/w) and 12.80 
± 1.30% (w/w) after and before extraction, respectively. The relative protein and 
triacylglycerol contents were 4.50 ± 1.18% and 4.35 ± 1.71%, respectively. Compared to 
previous reports [31, 318], the increased purity of milk phospholipids observed in this study 
was due to the repeated defatting using solvents at laboratory. 
5.3.2  Chromatographic analysis of milk phospholipids 
The phosphatidylcholine (PC) band was first located by aligning its 𝑅𝑓 with that of standard 
PC, then the others (i.e. SM, PS, PE, PI) were be determined by their ranking of Rf. As 
illustrated in Figure 5-1, the bands appeared in an ascending order sphingomyelin (SM, 
𝑅𝑓=0.21 ± 0.00), phosphatidylserine (PS, 𝑅𝑓=0.34 ± 0.00), PC (𝑅𝑓=0.62 ± 0.02), 
phosphatidylethanolamine (PE, 𝑅𝑓=0.88 ± 0.01), and phosphatidylinositol (PI, 𝑅𝑓=0.95 ± 
0.04). The comparative area of each spot were measured with ImageJ Software (National 
Institutes of Health, Bethesda, MD, USA), resulting in a relative content of phospholipid 
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species (SM 12.5 ± 1.8%, PS 17.7 ± 0.5%, PC 36.9 ± 2.9%, PE 19.6 ± 5.3%, PI 9.5 ± 1.0%). 
The current relative content of the phospholipids which were obtained from the samples was 
comparable to a recent report using HPLC evaporative light scattering detector (ELSD) assay 
[319]. A typical, relative composition of bovine milk phospholipids was also analysed with 
P31 NMR in a previous report [320], with similar results to that of the TLC reported here 
except for the content of PE. The discrepancy may be due to the differences in both samples 
and assays. 
 
Figure 5-1: TLC image of MPL and PC.  
Notes: The chromatography of milk phospholipids (MPL) and standard phosphatidylcholine 
(PC, right), and the relative position was determined by aligning the 𝑅𝑓 value of each band 
with that of the reference. 
5.3.3  Milk phospholipid digestion and cellular uptake 
FFA from milk phospholipids and triacylglycerols 
Gastric digestion contributes only a minor proportion (1.5 – 8%) of the total phospholipid 
hydrolysis [293]. Normally, gastric digestion occurs at pH 1.5 – 3, which was incompatible 
with the present titration quantification since both gastric acid and FFA consume titrant. 
AACC 02.31.01 method [182] was used to titrimetrically quantify FFA. The titratable acidity 
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of lipophilic solution can be best detected with ethanolic potassium hydroxide in the presence 
of diethyl ether [321], as also adapted in an AOAC method [256].  
As illustrated in Figure 5-2a, both milk phospholipids and triacylglycerols were digested 
following first-order kinetics, but with different reaction velocity and degrees. In the first 20 
min, approximately 56% of fatty acids were released from milk polar lipids, much higher than 
that of neutral lipids. Following 2 h of intestinal digestion, the hydrolysis degrees were 91.60 
± 4.04% and 56.71 ± 3.51% for phospholipids and triacylglycerols, respectively. Their 
breakdown rate constants were 0.007 min–1 and 0.016 min–1, corresponding to a half-digestion 
time of 6.35 min and 43.86 min, respectively. The results are comparable to a previous report 
on lipolysis kinetics by type II lipase with L-α-phosphatidylcholine (Sigma-Aldrich, 1%, 
w/w) [322]. 
The lipolysis fits first-order kinetics (R2=0.98 and 0.99 for phospholipids and triacylglycerols, 
respectively), as also reported on hydrolysis of palm, rapeseed, and linseed oil [323] and 
caroteniod enriched olive oil in phosphatidylcholine emulsion [322]. Milk phospholipids 
exhibited a higher digestion velocity and hydrolysis degree than triacylglycerols, indicating 
the polarity influence on the reaction rate constant. The difference in the kinetics might be due 
to several factors, such as the difference in lipase catalysis and interfacial properties between 
phospholipids and triacylglycerols.  
In humans, pancreatic phospholipase A2 (EC 3.1.1.4) can act upon the sn-2 position of 
phospholipids, resulting in lysophospholipids and fatty acids [96]. The fatty acid group of 
lysophospholipids can be further cleaved by lysophospholipase (EC 3.1.1.5) [324]. 
Furthermore, the pancreatic lysophospholipase of human beings is most likely a non-specific 
phospholipase, that is, carboxyl ester hydrolase (CEH, EC 3.1.1.1, wide substrate specificity) 
[98]. In addition, CEH can also attack intact phospholipids [325], whereas, triacylglycerol 
lipase (EC 3.1.1.3) acts on triacyglycerols concomitantly with co-lipase, in the presence of 
bile salt [323]. In brief, different enzymes are involved in the hydrolysis of triacyglycerols 
and phospholipids during intestinal digestion, thereby their reaction rate constants differ from 
each other.  
Lipopan F fungal lipase (EC 3.1.1.X, wide substrate specificity) was used to break down 
phospholipids and triacylglycerols in the present study. As illustrated in Figure 5-2b, the 
lipolysis reaction rate constants under the fungal lipase catalysis were 0.002 ± 0.001 min–1 and 
0.007 ± 0.001 min–1 for phospholipids and triacylglycerols, respectively, corresponding to 
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half digestion time of 289.80 ± 21.52 min (R2=0.96) and 97.69 ± 8.88 min (R2=0.97). Since 
phospholipid hydrolysis was faster than that of triacylglycerols in both specific lipase and 
non-specific lipase (Lipopan F), there must be factors other than lipases that contributed the 
reaction rate difference of the two lipolysis reactions.  
  
Figure 5-2: Milk lipolysis by two kinds of lipases.  
Notes: Pancreatic lipase (a) and fungal lipase Lipopan F (b); MPL: milk phospholipids, TAG: 
triacylglycerols. 
Lipolysis occurs by interfacial catalysis, which involves two equilibrium processes. Firstly, 
the adsorption of the lipase to the lipo-aqueous interface, followed by the subseqent 
conformation of the acyl-lipase complex intermediate [325]. The lipase must penetrate the 
interface to act, therefore the interfacial properties of substrates (e.g. in the form of micelles, 
emulsions, liposomes, or vesicles), have a direct impact on lipolysis kinetics [326]. In additon 
to colloidal structure, the lipolysis reaction rate constant is also dependent on lipid 
composition. For instance, short chain fatty acids hydrolyse faster than long chain fatty acids, 
and whereas milk fat breaks down faster than soy and fish oil [315]. Milk phospholipids and 
triacyglycerols have similar fatty acid profiles and chain lengths, but different unsaturation 
degrees. Although higher degree of unsaturated lipid (C18:1 and C18:2) digests more 
effectively due to elevated cholecystokinin (CCK) response during in vivo digestion. 
However, the degree of unsaturation appears to be an insignificant factor on in vitro lipolysis 
[323]. The colloidal difference may be the key factor that caused the greater phospholipid 
digestion. Further, the larger surface area and cation-phospholipid association contribute to 
the quick access of the lipase to the substrate [327].  
Previously, bovine milk phospholipids have been refined for infant formulas to enhance 
cognitive benefits [126]. The intestinal secretion of pancreatic triacylglycerol lipase (PTL, EC 







































than adults. Instead PTL-related protein 2 and bile salt-stimulated lipase (BSSL, also present 
in breast milk) are the key lipases responsible for digesting both phospholipids and 
triacyglycerols in babies’ milk in conjunction with gastric digestion [328]. 
Gas chromatographic analysis of the free fatty acids after milk lipid hydrolysis revealed that 
oleic acid (C18:1 C9, 22.0 ± 4.0%) was the most abundant fatty acid, followed by myristic 
acid (C14:0, 19.2 ± 2%), stearic acid (C18:0, 12.5 ± 1.7%), lauric acid (C12:0, 7.3 ± 0.8%), 
and palmitic acid (C16:0, 4.7 ± 0.8%), which was similar to previous report [38].  
Cleavage of phospholipids to release choline  
Choline phospholipid breakdown by phospholipases D and A2, and pancreatic lipases is 
illustrated in Figure 5-3b at a constant concentration of substrates and enzymes. 
Phospholipase D (PLD, EC 3.1.4.4) cleaves the choline polar heads of the phosphoric di-ester 
bonds at the sn-3 positions, and can also catalyse transphosphatidylation reactions [329]). 
Phospholipase A2 present in pancreatic juice specifically attacks the sn-2 acyl position [96]. 
PLD is an intracellular enzyme, absent in pancreatic juice. Hence phospholipase A2 and 
pancreatic lipase had no cleavage effects on choline groups of phospholipids in the present 
study.  
 In addition to choline-cleaving phospholipase D, sphingomyelinase (alk-SMase, EC 3.1.4.12) 
acts on the phosphoric di-ester bond of sphingomyelin, generating ceramide and 
phosphocholine [99]. Ceramide will be further disintegrated by mucosal ceramidase (N-
CDase EC 3.5.1.23) [100]. 
Choline phospholipid digestion with PLD 
Choline released from milk phospholipids exhibited first-order reaction kinetics under the 
catalysis of PLD, as illustrated in Figure 5-3a. The reaction rate was proportional to the first 
power of substrate concentration. As the enzyme concentration changed, the reaction rate 
constants also changed in a range of 0.031 – 0.001 min–1, leading to half-digestion time 
ranging from 22 – 495 min, as recorded in Table 5-2. These first-order reaction kinetics have 
been documented in reports on lipolysis of carotenoid-enriched lipids [289] and on the 
lipolysis of nano-emulsion [330]. PLD plays critical roles in a wide varities of physiological 
pathways, for instance, membrane trafficking, cytoskeletal reorganisation, regulation of cell 
proliferation and transformation, and a biomarker of neurodiseases (i.e. Parkinson's and 
Alzheimer's) [331]. Two isoforms PLD1 (120 kDa) and PLD2 (106 kDa) have been 
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5.3.5  Milk phospholipid antioxidant activity 
As illustrated by the DPPH assay (a), hydroxyl radical assay (b) and ABTS assay (c) in Figure 
5-4, the antioxidant activity of milk phospholipids was concentration-dependent, in line with 
previous reports on oil oxidation inhabitation by phospholipids. For instance, phospholipids 
of egg yolk PC and ox brain PE protected n-3 polyunsaturated fatty acids (PUFAs) of salmon 
oil from peroxidation during storage [334]. Further, 0.5% phospholipid supplementation was 
found to remarkably alleviate the concentration of volatile organic compounds generated from 
both salmon and menhaden oils [335]. The primary substrates of free radical reactions include 
the PUFA moieties [336], amine groups (of PC, SM, PE, or PS) and hydroxyl groups (of 
phosphatidylglycerol (PG) or PI) in the sn-3 side chain of phospholipids [337]. Also, the 
moieties of hydroxyl and nitrogen-containing amine groups collectively act as catalysts of 
hydroperoxide decomposition [338], thereby PC, PE, and SM exhibit more antioxidant 
activity than PS, PG and PI, while phosphatidic acid (PA) was shown to have no antioxidant 
activity [336]. TBARS results Figure 5-4d further evidenced that the antioxidant activity of 
milk phospholipids can be used to delay the oxidation of PUFAs.  
The CAA assay was developed recently to determine the attenuation effects of antioxidants on 
the cellular oxidation. As illustrated in Figure 5-4e, the CAA value of milk phospholipids was 
very low, indicating a poor bioavailability of the antioxidants. The intracellular DCFA was 
oxidized to fluorescent DCF, which can be reduced with intracellular antioxidants [339]. 
Milk phospholipids are increasingly regarded as important nutritional ingredients for infant 
milk formulas to boost cognitive performance of infants [56] as claimed by manufactures, 
which have been evidenced by either by ex vivo model (suckling rats pups [128] and neonatal 
piglet [115] or by in vivo models low birth weight infants [129], infants [130], toddler [116]. 
In this study, they showed a degree of in vitro antioxidant activity which, in addition to its 
nutritional benefits, may also be valuable for milk powder preservation (reducing lipid 
oxidation) during shelf life. 
5.3.6  Anti-proliferation activity 
Figure 5-4g illustrates that milk phospholipids had no significant effect on HT-29 cell 
viability. This demonstrates their biocompatibility to HT-29 cells, and is consistent with 
previous reports on soy lecithin and bovine brain PS. For instance, oral administration of PS 
exhibited no adverse effects on models of both in vivo [314] and ex vivo (animal model) 
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[340]. Also, long-term feeding studies of soy lecithin yielded no treatment-related histologic 
changes in mice [313] and rats [341].  
  
   
  
 
Figure 5-4: MPL antioxidant activity and MTT assay. 
Notes: by DPPH radical scavenging (a), hydroxyl radical scavenging (b), ABTS radical 



























































































































(e), milk phospholipid (MPL) concentration before and after cellular uptake (f), and relative 
cell viability to untreated HT-29 cells by MTT assay (g). 
5.4 Conclusion 
In the end, milk phospholipid lipolysis followed by first-order reaction kinetics, which were 
significantly higher (𝑝 < 0.05) than those of triacylglycerols by pancreatic lipase and fungal 
lipase. Significant antioxidant activity was evidenced by DPPH, ABTS, TBARS and hydroxyl 
radical scavenging assays, but their cellular antioxidant activity was very limited. 
Additionally, their choline groups were not cleaved by pancreatic lipase and they were not 
absorbed intact during intestinal digestion. This study elaborates on the polarity effects on 
lipid digestibility and provides useful knowledge on the design of milk phospholipid-fortified 
functional foods including infant formulas.  
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Chapter 6: The effects of fungal lipase-treated milk lipids on 
bread making 
Chapter 6 is published as:  
o Zhiguang Huang, Charles Brennan, Haotian Zheng, Maneesha S. Mohan, Letitia 
Stipkovits, Wenjun Liu, Don Kulasiri. The effects of fungal lipase-treated milk lipids on 
bread making. LWT – Food Science and Technology, 2019 (submitted). 
Abstract: Milk lipids have been functional ingredients in bread making. However, 
incorporation of enzymatically-treated milk lipids into bread recipes and their effects on bread 
properties has not been explored. This study aims to ascertain the impact of lipase-treated 
milk lipids on bread quality in comparison with untreated bread controls. As a result of lipase 
treatment, dough structure was strengthened, and loaf volume improved. In vitro digestion 
revealed that the glycaemic load of lipase-treated breads was significantly lower than that of 
control samples (𝑝 < 0.05). In addition, lipase treatment reduced the crumb water activity. 
The study provides a novel and practical method to improve bread functionalities and lower 
product glycaemic response, without detrimental effects on the quality of the final products. 
Keywords: Rheological characteristics; Texture profile analysis (TPA); Glycaemic response; 
Complexing index; Anti-staling. 
6.1 Introduction  
Bread lipids originate from endogenous (i.e. wheat flour) and exogenous (e.g. shortening and 
surfactants) sources. Although they are a minor component, approximately 2 g in 100 g flour 
[20], lipids play a critical part in bread making. For instance, they have been shown to reduce 
the crumb firmness [226] and starch digestibility [342] by their interaction with the gluten 
network and their conjugation with amylose. Filamentous fungal lipases have been isolated 
and extracted from Aspergillus spp. and Rhizopus oryzae for bakery applications [343]. In 
2005, Danisco issued a patent to hydrolyse flour lipids with fungal lipase, improving both loaf 
volume and softness [344]. Lipase treatment reduces fermentation time by virtue of the 
surfactant effects of lipolysates (mono- and diacylglycerols E471), [345], renders synthetic 
emulsifiers unnecessary [346], increases oven rise [347], attenuates staling process [226], 
extends dough durability [348], and promotes gas cell stabilization [227]. Further, lipase 
treatment of endogenous flour resulted in similar or better dough rheological properties and 
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crumb texture, by ameliorating the interaction of amylose and lipids compared with diacetyl 
tartaric acid esters of mono- and diglycerides (DATEM, E472e) and dough constituents, as 
reported by Colakoglu et al. [346].  
Enzyme mixtures can generate hybrid effects on bread quality. For example, the addition of 
both amylase and lipase to bread mixtures gives rise to appreciable improvement in crumb 
texture and loaf volume, and significant inhibition of the bread firming process [273]. 
Combining exogenous lipase implementation (25 mg per kg flour) with supplementary lipid 
(1 g monoacylglycerols per 100 g flour) led to a higher score in sensory evaluation than 
untreated samples [349].  
Milk lipids are composed of mainly TAG (ca. 98%, only 1% polar lipids), while polar lipids 
account for ca. half of the total lipid contents, with 22 – 27% galactolipids and 13 – 23% 
phospholipids [20], which hydrolyse into fatty acids and lyso-phospholipids. Despite of the 
compositional difference, both lipids have been used for baked goods. 
In respect of roles of milk fat-derived bakery lipid, first, milk lipid hydrolysates (i.e. MAG, 
fatty acids) have been proven to be dough strengtheners and bread textural improvers, via 
such mechanisms as starch-lipid complexes [174], emulsification effects of MAGs [350], and 
shortening effects of un-hydrolysed TAG [23]. Whereas, flour lipid hydrolysates (e.g. lyso-
phospholipids) can be surfactants of bread dough [190]). Therefore, milk fat performs more 
functionalities than flour lipids in bread making. Second, flour lipid alone didn’t improve loaf 
volume. Using various combination of polar lipids and neutral lipids on defatted flour, 
Schaffarczyk et al. [351] found that the hydrolysate of polar lipids of baking lipases needed 
the presence of unmodified, non-polar lipids (as shortening fat) to provide optimal functional 
effects. Further, it has been found that the major phospholipid subclass—phosphatidylcholine 
only exhibited a neglect impact on baking activity of wheat flour [352]. Third, compared to 
ca. 1 g flour lipids per 100 g flour, milk fat has more abundance in bread recipes (ca. 4.15 g 
per 100 g flour for AACC10.10 recipe).  
Given the above three reasons plus the industrial availability and nutritional value of milk fat 
[353], hence, it can be hypothesized that lipase-treated milk lipids may perform greater 
function than flour lipids. Thus far, using exogenous lipase-treated milk fat as bread 
improvers has not yet been explored. Therefore, in the present investigated by evaluating 
dough rheological characteristics and pH, bread physical and textural properties, in vitro 
digestion and predictive glycaemic response, starch-lipid complexing index (CI), and anti-
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staling performance. The starch-lipid interaction induced by lipase-treatment to milk fat was 
elaborated as well. 
6.2 Materials and methods 
The materials and methods in the section of 6.2 can be referred back to the corresponding 
sections in Chapter 3, as illustrated in Table 6-1.  
Table 6-1: Materials and methods for lipase-treated milk lipid in bread recipes.  
Section 
6.2 Materials and methods 
As mentioned in 
the section of  
6.2.1. Dough preparation and bread making  3.13 
6.2.1.1. Ingredients and reagents  3.13.1 
6.2.1.2. Bread recipe  3.13.2 
6.2.2. Dough characteristics  3.14 
6.2.2.1. Dough rheological properties  3.14.1 
6.2.2.2. Dough stickiness  3.14.2 
6.2.2.3. Dough firmness  3.14.3 
6.2.2.4. Dough pH  3.14.4 
6.2.3. Bread analysis  3.15 
6.2.3.1. Physical properties  3.15.1 
6.2.3.2. Crust colour  3.15.2 
6.2.3.3. Textural profile analysis (TPA)  3.15.3 
6.2.4. 
Bread in vitro digestion and glycaemic glucose 
equivalent (GGE)  3.16 
6.2.5. Complex index (CI)  3.17 
6.2.6. Anti-staling performance  3.18 
6.2.6.1. Water activity and bread firming during shelf life  3.18.1 
6.2.7. Lipolysis and free fatty acid (FFA) determination  3.19 
6.2.8. Statistical analysis  3.37 
6.3 Results and discussion 
6.3.1 Lipolysis  
Lipopan F, a second generation baking phospholipase (E.C. 3.1.1.X) extracted from Fusarium 
oxysporum strain by Novozymes, has lipolytic activity on both triacylglycerols [354] and 
phospholipids as reported by Gerits et al. [347]. It cleaves two fatty acids from each substrate 
molecule (i.e. both triacylglycerols and phospholipids) [288, 355]. In respect to endogenous 
flour lipids, the dose of Lipopan F has been optimized by Moayedallaie et al. [345] as 15 
mg/kg flour (563 U/kg). The degree of milk fat hydrolysis in 20 min was 7.60 ± 0.82%, 12.11 
± 1.89%, and 19 ± 2.06% for LML4.5, LML9, and LML18, respectively. The generated fatty 
acids were 0.10 g, 0.16 g, 0.26 g per 100 g dough (acceptable at level of less than 0.3 g per 
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100 g dough). The produced mono- and diacylglycerol (0.14 – 0.34 g per 100 g flour) fell into 
the surfactant supplementation level of 0.3 – 1.0 g per 100 g flour, as depicted for bread 
recipes by Pareyt et al. [20].  
Both the reaction rate constant k and hydrolysis degree of milk fat increased with the increase 
of lipase dose, as illustrated in Table 6-1 and Figure 6-1. When the lipase dose increased, the 
reaction rate constants increased accordingly, leading to the reduction of half lipolysis time 
(T1/2). Both polar lipids and non-polar lipids hydrolysis can be catalysed by Lipopan F. The 
half lipolysis time of LML9 samples was 253.43 ± 32.37 min in Table 6-1. According to the 
measured reaction rate constants, the amount of fatty acid produced can be modulated by 
changing the level of lipases and substrates (i.e. milk fat) or the time of lipolysis.  
Lipase treatment on flour lipids (1.2 g per 100 g flour), which is usually implemented in 
baking factories, appears to be easier to the treatment of milk fat. However, milk fat (4.15 g 
lipids per 100 g flour) may exhibit more potentials, and therefore, a side control (LML2.3) 
was designed to depict the effectiveness of lipase-treatment. The present lipase-treated milk 
lipids are not suitable for long fermentation baking due to free fatty acid accumulation, but 
they are suitable for the replacement of synthetic emulsifiers in industrialized bakery 
manufacturing, in which lipase treatment time can be controlled precisely. 
Table 6-2: Milk lipid lipolysis reaction rate constants and half digestion time. 
Samples 𝒌 (min–1) 𝑻𝟏/𝟐 (min) R2 
LML4.5 0.002c ± 0.001 289.80a ± 21.82 0.96 
LML9 0.003b ± 0 253.43b ± 32.37 0.95 
LML18 0.004a ± 0.001 184.39c ± 40.37 0.96 
Notes: The results are presented as means ± standard deviations (𝑛 = 3). Means in the same 
row that do not share a letter are significantly different (𝑝 < 0.05). Lipase dosage for 
LML4.5/9/18 were 4.5, 9 and 18 mg for 7.5 g of milk butter, respectively. 𝑘 is reaction rate 
constant (𝑚𝑖𝑛–1) and 𝑇1/2 is half digestion time (min).  
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Figure 6-1: Lipolysis of milk lipids.  
Notes: 𝑛 = 3; Lipase dose for LML4.5, LML9 and LML18 were 4.5, 9, and 18 mg for 7.5 g 
milk butter. 
6.3.2 Dough characteristics 
Dough resistance to extension and extensibility 
As illustrated in Table 6-3, dough rheological properties were altered as a result of lipase 
treatment. The proportion of resistance strength to extensibility (R/E) significantly (𝑝 < 0.05) 
increased in LML4.5 samples, while R/E was reduced slightly in other samples, compared to 
controls. This is consistent with a previous report on surfactant-modified dough, where the 
maximum R/E was 2.01 at a 0.3 g addition of monoacylglycerols to 100 g flour. However, 
overdose 0.4 g addition of monoacylglycerols to 100 g flour led to a weaker dough [356]. 
This is also in support of another report on DATEM-emulsified bread dough [357], where this 
ratio was increased by 28% for an addition of 0.05 g DATEM to 100 g flour, but if the 
DATEM concentration increased to 0.1%, the R/E decreased to that of the control. 
In regards to the strengthening effect of using surfactant, it has been found that, with the 
addition of surfactant, the dough rheological properties also increased in a recent report [358]. 
In a more recent study on lipase impact on dough rheological, a direct mechanism for dough 
strengthening was attributed to improved surface activity at gas-liquid interface and lipid 
surfactant stabilization of the liquid lamellae surrounding gas cells [351]. The film generated 
remarkable substantial elastic restoring forces, which resist distortion at the interfacial area of 
gas-liquid. In another emulsifier study, both distilled monostearate and lecithin stabilized the 
shortening crystals and increased the air-absorbing ability on both beef tallow and 





















hydrophobic interactions led to protein aggregates and strengthened the gluten network [356]. 
During the dough mixing, starch particles hydrate and swell, and gluten develops into 
continuous extensible gluten film by hydration and lipid coating, the lipid crystals decrease 
the surface tension of the gluten film (lubrication effects), promoting aeration of the dough 
[23]. 
Dough firmness  
The dough firmness decreased in all the lipase-treated samples by 7 – 25% (Table 6-3), 
consistent with a report by Mehta et al. [359], in which 2, 4, and 8% of lipid fortification led 
to a reduction of the dough density by 0.06 – 0.07 g/mL from 1.22 g/mL. Whereas the density 
of dough reduced by more than 5%, the dough texture became looser and less firm after lipid 
treatment. In addition, surfactants (distilled mono-acylglycerol i.e. monostearate and lecithin) 
stabilized the bakery lipid crystals and increased the index of air-absorbing ability on 
shortening oil (hydrogenated palm oil) by various degree [180]. It has been well known that, 
during dough mixing, the gluten network develops and the nucleation of gas bubbles occurs 
concomitantly. Dough will be softer as a result of elevated gas bubble entrainment capacity by 
surfactants, as also elaborated at the above section (Dough resistance to extension and 
extensibility).  
Dough stickiness  
Dough stickiness, a parameter associated with the dough machinability, was reduced in LML 
samples (Table 6-3), in agreement with a report by Colakoglu et al. [346], in which dough 
stickiness decreased by approximately 13% when Lipopan F lipase (dose: 10 mg per kg flour) 
was added to treat whole flour, while the increase of dose to 20 – 40 mg/kg (flour base) did 
not further reduce the dough stickiness. This was in accordance with a previous report in 
which soy lecithin supplementation of 0.2 – 0.5% reduced dough stickiness significantly 
[360].  
Dough pH  
The acidity levels of lipase-treated doughs were 0.3 – 0.9 lower than those of controls due to 
yielded fatty acids, but still falling in the range of pH 4.5 – 5.5, i.e. a normal range of yeasted 
dough [361], thus baking yeast activity was not affected. Further accumulation of free fatty 
acids can cause an off-flavour, as recorded by Brunstedt et al. [362]. Hence, the amount of 
free fatty acids from lipolysis should be limited by modulating the dose of lipases and milk 
lipids or treatment time.  
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Table 6-3: Dough textural characteristics and dough pH.  
Samples  Control   LFL2.3  LML4.5 LML9 LML18 
Resistance to 
extension (g) 45.43b ± 0.96 29.85d ± 0.98 70.28a ± 0.71 46.18b ± 0.39 41.74c ± 0.29 
Extensibility 
(mm) 54.83b ± 0.19 56.72b ± 2.16 23.92c ± 0.71  57.07b ± 1.10 74.89a ± 0.04 
𝑅/𝐸 (g/mm) 0.83b ± 0.02 0.53c ± 0.02 2.94 a ± 0.09 0.81b ± 0.01 0.56c ± 0.00 
Firmness (g) 301.04a ± 0.83 207.92c ± 7.81 287.68ab ± 4.47 278.64b ± 7.91 274.45b ± 3.92 
Stickiness 32.38 a ± 0.22 25.37b ± 0.30 20.35d ± 0.95 19.47d ± 0.69 22.08c ± 0.05 
pH  6.08a ± 0.07 5.81a ± 0.01 5.95a ± 0.30 5.85a ± 0.02 5.23b ± 0.08 
Notes: The results are presented as means ± standard deviations (𝑛 = 3). Means in the same 
row that do not share a letter are significantly different (𝑝 < 0.05). Lipase dosage for 
LML4.5/9/18 were 4.5, 9 and 18 mg for 7.5 g of milk butter, respectively. Lipase dosage for 
LFL2.3 were 2.3 mg for 150 g wheat flour. 𝑅/𝐸: ratio of resistance strength to extensibility.  
6.3.3  Bread analysis 
Bread physical properties 
In addition to dough-strengthening resulting from lipase-treatment, loaf volume increased due 
to the effects of gas cell stabilisation by milk lipid emulsifiers. As shown in Table 6-3, the 
enzymatic hydrolysis led to a 5 – 11% increase in bread volume except for LML18. Crumb 
porosity also increased in LFL 2.3 and LML 9 samples except for LML 18, which was in 
agreement with a study on both lipase-treated breads by Gerits et al. [190] and the breads 
from food surfactant-modified dough (sucrose ester E473, [363]). Substitution with 4 g palm 
oil per 100 g flour as shortening reduced the crumb density by 4%, by improvement of 
porosity, as reported by Chin et al. [166]. In addition, the rise of loaf volume was attributed to 
the improvement of both diameter by 10% and homogeneity of pores by at least 5%, as 
reported by Søe et al. [344]. The specific volume for the controls and lipase-treated samples 
LML9 were 3.73 ± 0.05 mL/g and 4.10 ± 0.06 mL/g, respectively, consistent with a report by 
Gerits et al. [227], where the loaf volume increased by ca. 30.8% and 21.7 ± 4.3% for lipase-
treatment of flour lipid (1 mg lipase protein/kg flour) and DATEM addition (0.5 g in 100 g 
flour), respectively. It was also in support of a lipase treatment study by Moayedallaie et al. 
[345], where loaf volumes were 4.0 ± 0.19 mL/g and 4.5 ± 0.18 mL/g for control and 
treatment, respectively. Further increase in lipase dose or treatment time (e.g. long 
fermentation) didn’t increase loaf volume (i.e. LML18), as evidenced in previous reports by 
Moayedallaie et al. [345] and Gerits et al. [227]. However, overdose (LML18) reduced loaf 
size, similar to a lipase-treated bread report, where loaf volume was optimized at 1 mg 
 113 
Lipopan F per kg flour, where 5 mg/kg dose significantly decreased the volume to 53.53 cm³ 
from the maximum (57.40 cm³) [190], probably due to the loss of gas cell stability and 
subsequent coalescence or collapse when reaching the limitation of porosity at high 
concentrations. 
Crust colour 
As shown in Table 6-4, the brownness indexes (BI) of lipase-treated breads were remarkably 
higher than those of controls, and the WI values significantly decreased in contrast to controls 
(p < 0.05). Also, similar colour results were observed in a report on 0.1 – 0.3 g surfactant-
supplementation (based on 100 g flour) to cassava-maize-wheat bread by Eduardo et al. [271], 
in which the BI value significantly increased (p < 0.05) from 80 to 88.8 – 87.9 and 84.1 – 
84.8 for DATEM and sodium stearoyl lactate (SSL, E481), respectively. Also, both DATEM 
and lipase treatment produced darker bread than the control [345]. In addition, in a study on 
surfactant treatment on bread quality, the crust colour was dependent on both the gluten 
content and the type of surfactants (DATEM, SSL, and monoacylglycerols) as reported by 
Chin et al. [364]. BI values are related to both the Maillard reaction and starch 
dextrinization/sugar caramelisation [365]. The Maillard reaction is determined by 
temperature, reaction time, pH, composition, and water activity (optimum at 0.65 – 0.75), and 
an increase of water activity to a certain level can increase the rate of Maillard reaction as 
well. However, the reaction rate will decrease when water activity increases further [366]. It is 
likely that lipase treatment in the LML samples lowered the water binding capacity of starch, 
thus enhanced the Maillard reaction and generated darker bread.  
Complexing index  
As illustrated in Table 6-4, the complexing index (CI) value was dose-dependent, and the 
value for LML9 was lower than that of LML18 and LFL2.3, higher than that of LM4.5, and 
comparable with a previous study by Lau et al. [342]. It has been well known that amylose-
lipid complexes reduce iodine-binding capacity of starch since fatty acids and 
monoacylglycerols compete with iodine to fill the helix cavities of starch molecules, while 
triacylglycerols form no complex with starch [367]. The total starch of bread samples were 
42.9 ± 1.2%, in agreement with the results of controls by Liu et al. [267].  
Texture profile analysis 
As illustrated in Table 6-4, the firmness and chewiness of bread crumb for treated samples 
were significantly reduced, compared to the control samples, hence bread became softer 
through modification of milk fat. The controls had the firmest texture, while LML9 and 
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LML18 samples were softer than other samples. Further, the softening effect in LML4.5 and 
LFL2.3 was less pronounced, in contrast to LML9 and LML18. The TPA results were also 
consistent with a previous report on lipase- or surfactant-treated breads by Gerits et al. [226], 
in which both Lipopan F and SSL led to improvement in crumb tenderness. In addition to 
firmness, crumb chewiness was impacted more than the other TPA parameters, in particular, 
springiness, cohesiveness and resilience in all lipase-treated samples. The chewiness of 
controls was higher than other samples, with a similar profile to the firmness (r = 0.99), 
consistent with a report on the positive correlation of crumb chewiness and firmness (r =
0.96) [273]. Also, the crumb resilience was found to be highly correlated to the firmness (r =
0.90). The TPA results were in agreement with a previous report on bread TPA, where larger 
loaves were softer and had a looser loaf structure (i.e. higher porosity), resulting in lower 
firmness and chewiness values as recorded by Liu et al. [267]. Apart from the gas cell 
stabilisation, the composition of free fatty acids were highly correlated (r = 0.98 and 0.91 for 
FFA in the free and the bound lipid fraction, respectively) with the loaf volume [190]. 
Surfactants like mono- diacylglycerols can form starch-lipid complexes with amylose during 
baking, and it may also have a softening effect on bread crumb [20, 226]. Rogers et al. [368] 
observed that MAG can conjugate with amylose and TAG cannot. As textural improvers, 
MAG and TAG had different mechanism. MAG can form starch-lipid complexes to soften 
texture of crumb, while TAG tenderizes crumb texture by confinement of gluten protein 
network development [20].  
During baking, starch particles become gelatinized and the gluten film turns into a permanent 
cross-linked thin film, together with shortening lipids [369]. Monoacylglycerols are typical 
crumb softeners via an inclusion complex mechanism. Amylose-monoacylglycerol inclusion 
complexes are water-insoluble, therefore the complexed amylose does not participate in 
gelatinisation. Thus upon cooling after baking, the complexed amylopectin will not 
recrystallize, and it will not contribute to the staling of the bread crumb [26]. Also, amylose-
lipid complexes have been attributed to limit starch swelling and amylose crystallization (i.e. 
gelation) and to thereby impede crumb firmness [226]. 
Table 6-4: Bread physical properties, digestibility, and firming rate during storage.  
Samples   Control   LFL2.3  LML4.5 LML9 LML18 
 Volume (mL) 167.83c ± 1.61  177.50b ± 0.50 171.33c ± 1.53 183.67a ± 1.53 162.33d ± 2.08 
 Density (g/mL) 0.27ab ± 0.00 0.25c ± 0.00 0.26b ± 0.00 0.24d ± 0.00 0.27a ± 0.00 
 SV (mL/g) 3.73cd ± 0.05 3.97b ± 0.02 3.81c ± 0.04 4.10a ± 0.06 3.65d ± 0.04 
 Porosity 0.76cd ± 0.00 0.77b ± 0.00 0.76c ± 0.00 0.78a ± 0.00 0.75d ± 0.00 
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 Height (mm) 53.91ab ± 0.81 56.50a ± 0.65 52.83bc ± 1.24 56.24a ± 1.18 50.32c ± 0.90 
 L* 73.64a ± 2.19 70.97a ± 0.62 62.30b ± 0.29 65.42b ± 0.40 64.44b ± 2.18 
 a* 2.80b ± 0.75 4.79b ± 0.28 9.22a ± 1.78 8.26a ± 0.79 7.93a ± 0.60 
 b* 24.67b ± 0.90 26.32ab ± 0.26 28.12a ± 1.86 28.71a ± 0.84 27.33ab ± 1.05 
 WI 63.77a ± 2.20 60.51a ± 0.37 52.04b ± 1.23 54.29b ± 0.42 54.42b ± 1.23 
 BI 42.75 ± 4.05b 50.27 ± 0.56b 69.47 ± 6.89a 65.65 ± 2.61a 62.98 ± 1.13a 
Firmness (g) 337.43a ± 3.38 251.78b ± 4.99 196.41cd ± 7.28 187.10d ± 2.00 206.35c ± 8.89 
Springiness 0.90ab ± 0.04 0.83bc ± 0.05 0.93a ± 0.02 0.79c ± 0.02 0.92a ± 0.02 
Cohesiveness 0.62a ± 0.01 0.57ab ± 0.02 0.56ab ± 0.02 0.60ab ± 0.02 0.54b ± 0.04 
Chewiness (g) 187.51a ± 7.61 118.51b ± 11.86 102.59b ± 5.33 89.27bc ± 1.04 103.07bc ± 4.72 
Resilience 0.28a ± 0.01 0.22b ± 0.03 0.23ab ± 0.02 0.24ab ± 0.01 0.21b ± 0.01 
CI  0.17 ab ± 0.01  0.05c ± 0.01 0.11b ± 0.03  0.19a ± 0.02  
WA 0.96a ± 0.005  0.96a ± 0.001 0.96a ± 0.004 0.94b ± 0.004 0.92c ± 0.003 
IFDF (g/day) 67.93a ± 2.04 29.74c ± 0.89 28.74c ± 0.86 14.49d ± 0.43 36.48b ± 1.09 
AUC 457.20a ± 5.73 406.42c ± 15.75 423.48b ± 5.31 422.85b ± 5.84 385.68d ± 14.75 
Notes: Means ± standard deviations (𝑛 = 3). Means in the same row that do not share a letter 
are significantly different (𝑝 < 0.05). LFL2.3 was referred to samples with flour (150 g) lipid 
treatment by 2.3 mg lipase; lipase dosage for LML4.5/9/18 represented 4.5, 9 and 18 mg for 
7.5 g of milk butter, respectively. LFL2.3: 2.3 mg lipase for 150 g wheat flour; SV: specific 
volume (mL/g); WI: whiteness index; BI: brownness index; CI: complexing index; WA: 
water activity; IFDS: increased firmness during staling. 
6.3.4  In vitro digestion and predictive glycaemic response 
As illustrated in Figure 6-2, both the area under curve (AUC, for the reducing sugar curve) 
and reducing sugar concentration of all lipase-treated samples were lower than those of the 
control (𝑝 < 0.05). The lipase-treated samples were significantly more resistant to hydrolysis 
than controls, and the complexing index was highly correlated (r = 0.94) to AUC for the 
reducing sugar curve, in agreement with the report by Lau et al. [342], where 20 g addition of 
coconut, grapeseed, and olive oil to 100 g flour yielded CI values of 30 – 50% in bread, 
thereby reducing bread glycaemic index significantly (p < 0.05). As described previously by 
Chao et al. [174], forming resistant starch using starch-lipid complexes has been a viable tool 
to lower the glycaemic response of cereal products. Lipase treatment improves both textural 
and physiological properties of bread, and whereas, α-amylase addition increases both 
glycaemic index and loaf size [370]. 
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Figure 6-2: Reduced sugar release in vitro digestion and AUC. 
Notes: Means ± standard deviations (𝑛 = 3). Means in the same column that do not share a 
letter are significantly different (𝑝 < 0.05). LFL2.3 was referred to samples with flour (150 g) 
lipid treatment by 2.3 mg lipase; lipase dosage for LML4.5, LML9, and LML18 were 4.5, 9 
and 18 mg for 7.5 g of milk butter, respectively. AUC: area under the curve of reducing sugar.  
6.3.5  Water activity and bread staling  
As illustrated in Table 6-4 and Figure 6-3, the water activity (an indicator of bread stability, 
quality, and firming rate during storage) of LML9 samples was reduced by 4% in contrast to 
that of the controls, in line with a previous study on enzymatically treated bread [273]. The 
reduction in water activity is related to lipophilicity change by surfactants [371]. Similarly, as 
a result of lipase-treatment or addition of surfactant (i.e. sodium stearoyl lactylate (SSL), 
reduction in crumb water activity was evidenced by a decrease in 1H nuclear magnetic 
resonance (NMR) population in fresh bread crumb with lipase or SSL treatment [226]. During 
storage, water migrates from crumb to crust, leading to amylopectin crystallization and 
stiffness of gluten network [372], and therefore, reducing water migration can delay the rate 
of crumb hardening.  
Along with the reduction of water activity, the staling of lipase-treated samples (recorded as 
firmness) was significantly reduced (p < 0.05) in contrast to the controls (Fig. 3). This is 
consistent with previous reports on lipase treatment by Gerits et al. [226] and Purhagen et al. 
[192], and enzyme mixture treatment [373]. Additionally, amylose-lipid complexes can hinder 
the crystallisation (i.e. gelation) of amylose (i.e. decrease of crystal populations) during the 
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retrogradation was impaired by amylose complexation with lipolysis products (e.g. free fatty 
acids, or lyso-lipids) as determined by low-field nuclear magnetic resonance [226].  
  
Figure 6-3: Bread crumb firmness during storage.  
Notes: LFL2.3 was referred to samples with flour (150 g) lipid treatment by 2.3 mg lipase; 
lipase dosage for LML4.5, LML9, LML18 were 4.5, 9 and 18 mg for 7.5 g of milk butter, 
respectively. 
6.4 Conclusions 
The current study investigated milk lipolysate effects on bread quality, digestibility, and 
staling. Lipase treatment strengthened the textures of both dough and bread. In addition to 
oven rise, amylose-lipid complexes reduced the starch digestibility. With the decrease of 
crumb water activity, the firming rate of bread crumb was reduced. The dough structure 
greatly impacted on the bread textural properties including porosity. On the whole, this study 
demonstrates the potential application of exogenous fugal lipase-treated milk lipids to 
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functionalities: Amylose-milk fatty acid complex reduces glycaemic index. Journal of 
Agricultural Food Chemistry, 2019 (submitted). 
Abstract: Fatty acids of plant oils have been used to prepare resistant starch. Only a few 
papers have been published on how milk lipid-starch complexes affect starch digestibility. 
This study used fungal lipase-treated milk lipids to prepare starch-fatty acid complexes and 
the complexes were characterized spectroscopically. An empirical equation was proposed to 
estimate the complexing index (CI), and spectroscopy analysis verified the conformation of 
the milk fatty acid-starch complexes. Rheological analysis revealed that the starch-fatty acid 
complexes had decreased peak viscosities and gel firmness, while increasing the final 
viscosities significantly (𝑝 < 0.05). As a result of complexing, the starch digestibility was 
reduced by 19% for corn starch, 17% for wheat starch, and 25% for rice starch with milk fatty 
addition (12%, w/w) in in vitro studies. The study together with its results provide a means for 
manufacturing resistant starches using milk lipids.  
Keywords: Glycaemic index, amylose-fatty acid complex, in vitro digestion, rheological 
characteristics; enzyme kinetic 
7.1 Introduction  
Starch from different origins has already been used to prepare conjugations with lipids to 
prepare resistant carbohydrate foods. For instance, brown lentil-plant fatty acid complexes 
(10%, w/w) increased the content of resistant starch of brown lentil by 3% – 6.4% [374]. 
Recently, lotus seed-fatty acids (C8 – C18, 5% w/w) resulted in complexing indexes of 11.8 – 
86.3%, corresponding to increases of 12% – 112% in resistant starch content [375]. Also, 
bambara groundnut starch-fatty acid complexation (4%, w/w) yielded resistant starch with 
complexing index of 30% – 65% with stearic acid, linoleic acid, and lysophosphatidylcholine 
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[376]. Furthermore, pea amylose extract may be complexed with fatty acids (10%, w/w) of 
various chain lengths (C10 – C18) at 30, 50 and 70˚C in potassium hydroxide solution [377]. 
In addition to pseudocereals, maize starch has been used to conjugate with lipids, yielding CI 
values of 96.3, 41.8, 8.3, and 1.1% for monopalmitate glycerol, palmitic acid, tripalmitate 
glycerol, and dipalmitate glycerol, respectively [174]. Further, rice starch-fatty acid 
complexes (20%, w/w, C4 – C18 fatty acids) were used to produce edible film, yielding CI 
value of 36.54 ± 2.5% to 15.68 ± 2.2% [378]. Wheat flour and oleic acid formed starch-lipid 
complexes at 128.3˚C by extrusion [379].  
Starch-fatty acid complexes have been used as biodegradable delivery systems for bioactive 
molecules [377], in the Preparation of edible films for food preservation [378], inhibition of 
bakery staling [380], and in the preparation of low glycaemic response foods [342].  
Middle and long chain fatty acids (e.g. palmitic acid, myristic acid, lauric acid, stearic acid, 
and linoleic acid from plant oils) have sufficient complexing capacity with starches, while tri- 
and diacylglycerol have virtually no complexing ability with starches. To our knowledge, 
thus, milk fats have not been utilized for complexing with starch because triacylglycerols do 
not conjugate with amylose and amylopectin. Milk butter (per 100 g, USDA code 1145) is 
rich in middle- and long-chain fatty acids (e.g. C12:0 2.587 g; C14:0 7.436 g; C16:0 21.697 g; 
C18:0 9.999 g; C18:1 20.4 g [18]), and it has been widely used in the food industry due to its 
cost efficiency and availability. Therefore, in the present study, milk fatty acids are produced 
from milk butter by fungal lipase hydrolysis to conjugate with rice, corn, and wheat starches 
by cooking, and their complexes were evaluated by CI determination, spectroscopy, rheology 
technique, and in vitro digestibility.  
7.2 Materials and methods 
The materials and methods in the section of 7.2 can be referred back to the corresponding 
sections in Chapter 3, as illustrated in Table 7-1. 
Table 7-1: Materials and methods for starch-milk lipid complexes. 
Section 
7.2 Materials and methods 
As mentioned in the 
section of  
7.2.1. Materials and reagents  3.20 
7.2.2. Preparation of starch-milk fatty acid complexes  3.21 
7.2.3. Light microscopy analysis  3.22 
7.2.4. Rheological properties of starch gels  3.23 
7.2.4.1. Rapid viscosity analysis (RVA)  3.23 
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7.2.4.2. Gel firmness  3.23 
7.2.5. CI measurement  3.23 
7.2.6. 
In vitro digestion of starch-milk lipids and glycaemic 
response  3.24 
7.2.7. Kinetics of starch hydrolysis  3.24 
7.2.8. 
Fourier transformation infrared (FTIR) spectroscopy 
analysis  3.25 
7.2.9. Differential scanning calorimetry (DSC)  3.25 
7.2.10. Lipolysis and free fatty acid (FFA) determination  3.26 
7.2.11. Statistical analysis  3.37 
7.3 Results and discussion  
7.3.1 Milk lipid treatment with fungal lipase 
The milk lipids were digested overnight and their hydrolysis reaction rate constants were 
measured to be 0.007 ± 0.001 min–1, corresponding to a half-digestion time 97.69 ± 8.88 min 
(R2 = 0.97). During the overnight lipolysis, the degree of hydrolysis was greater than 99%. 
The gas chromatographic analysis of free fatty acids after milk lipid hydrolysis revealed that 
oleic acid (C18:1, 28.56 ± 5.08%) was the most abundant fatty acid, followed by myristic acid 
(C14:0, 19.18 ± 2.04%), stearic acid (C18:0, 12.50 ± 1.69%), palmitic acid (C16:0, 7.82 ± 
1.39%), and lauric acid (C12:0, 7.30 ± 0.81%). Thus the mid-chain fatty acids dominated the 
profile of fatty acids, consistent with USDA data (#1003) [18].  
7.3.2 Light microscopy analysis and particle size distribution 
As illustrated in Figure 7-1(f – h), in all three kinds of starch-milk fatty acid complexes 
(MFA12, 12% milk fatty acids, starch based), most starch particles fully gelatinized during 
hydration and heating with some particles still gelatinizing, and furthermore, Sudan black-
stained milk lipids were distributed densely and evenly in the starch gel matrices, as also 
observed in reports on corn starch [381] and wheat starch [382]. When starch dispersions 
were heated to 95˚C, the starch particles swelled irreversibly, and amylose leached into 
aqueous phase concomitantly. Losing crystalline structures, the starch particles became 
amorphous, which was reflected by the disappearance of birefringence and Maltese cross in 
the optical microscopic images of corn (Figure 7-1f) and rice (Figure 7-1g) starch gels. 
Finally, the starch dispersions turned into viscoelastic gels, in which amylose and water were 
bound by hydrogen bonding in three-dimension networks. As can be seen in the corn starch 
gel of Figure 7-1a. Upon cooling and gelation, amylose and amylopectin recrystallized 
successively [383]. Minor un-gelatinized particles with vague Maltese crosses (3 – 8 μm in 
diameter for rice starch in Figure 7-1g and approximately 20 μm in diameter for corn starch in 
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Figure 7-1f, consistent with the average particle size (𝑑3,2) of rice starch 5.46 ± 0.02e μm in 
Table 7-2 suggested that rice starch gelatinized slower than wheat and corn starches, likely 
due to their weaker swelling power than those of the latter. The average particle sizes (𝑑3,2) of 
high amylose corn starch and waxy corn starch were 12.70 ± 0.36d μm and 17.93 ± 0.06b μm 
(Table 7-2), respectively, compatible with a recent report [275]. The particle of corn starch is 
bigger than rice starch, and finer than wheat starch, consistent with the present optical 
observations in Figure 7-1(a – e).  
 
 
Figure 7-1: Light microscopy of starch-milk fatty acid complexes. 
Notes: (a – e) were viewed at 1000-fold magnification, bright field optical microscopy for five 
kinds of iodine-stained starches, including (a) corn starch, (b) rice starch, (c) wheat starch, (d) 
waxy corn starch, and (e) high amylose corn starch; (f – h) were viewed at 400-fold 
magnification, bright field phase contrast II optical microscopy for three kinds of starch-
stabilized milk fatty acids (MFA 12%, w/w, starch based, stained by Sudan black dye), such 
as (e) corn starch, (f) rice starch, and (g) wheat starch.  
(a) (b) (c) 
(d) (e)   
(f) (g) (h) 
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Table 7-2: The specific surface area and sizes of starch particles. 
Starch 
Specific Surface Area 
(m²/kg) 𝑑3,2 (μm) 𝑑4,3 (μm) 
RS  1,100.67a ± 3.06 5.46e ± 0.02 8.45e ± 0.06 
HACS 681.93b ± 1.95 8.80d ± 0.03 12.70d ± 0.36 
CS 520.67c ± 0.15 11.50c ± 0.00 15.60c ± 0.00 
WCS 492.17d ± 0.91 12.20b ± 0.00 17.93b ± 0.06 
WS 407.80e ± 0.50 14.70a ± 0.00 22.13a ± 0.06  
Notes: Results are expressed as means ± SD, the superscripts following each figure in the 
same column indicate significant difference (𝑝 < 0.05, 𝑛 = 3). WCS: waxy corn starch; CS: 
corn starch; WS: wheat starch; RS: rice starch; HACS: high amylose corn starch; 𝑑3,2: 
surface-area-based mean diameter; 𝑑4,3: volume-based mean diameter. 
7.3.3 Complexing index measurement 
The complexing index (CI) value of wheat starch-milk fatty acid complexes increased when 
the concentrations of fatty acids increased, as shown in Figure 7-2. Normal wheat, corn, and 
rice starches all complexed with milk fatty acids and stearic acid, in agreement with previous 
studies [381, 384, 385]. High amylose corn starch displayed remarkable CI value, which is in 
line with a previous study on amylose-stearic acid [386]. Whereas waxy corn starch exhibited 
a comparable CI value to corn starch, demonstrating the complexing ability of pure 
amylopectin, consistent with a previous report on waxy wheat starch-fatty acid complexes 
[385].  
It needs three helix pitches (6 – 8 glucose per pitch, 180.156 g/mol) to entrap a milk fatty acid 
(225 g/mol) molecule [387]. Assuming 6 – 8 glucose molecules per helical pitch form an 
inclusion complex with a single milk fatty acid, thus 225 g of lipids and 3.243 – 4.324 kg 
starch are able to make a mole of milk fatty acid-starch complexes, equal to a starch-lipids 
ratio (w/w) of 14.4 – 19.2, or 5.2 – 6.9% of lipid (starch base) for complete complexation. For 
full complexation, fatty acids (FA) to starch mass ratio would be: 𝐶𝐼(100%) =
𝑀𝑊𝐹𝐴 (3 × 7 × 180.156⁄ ) = 5.95%. Therefore, the CI of milk fatty acid-starch complexes 
can be calculated with the equation of w 𝐶𝐼(100%) = 16.82𝑥, where 𝑥 is the mass ratio of 
milk fatty acids to starch, and 𝑀𝑊𝐹𝐴 is the average molecular weight of milk fatty acids. The 
equation could be used to estimate the CI value of wheat starch-milk fatty acids, as illustrated 
in the midpoint estimate line of Figure 7-2a. Per this equation, it takes 17 starch units (w/w, 
lipid based) or 5.95% milk fatty acids (w/w, starch based) to make 100% CI. For instance, the 
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estimated CI value at 5% fatty acids was 84%, approximately close the measured value (72.58 
± 0.28%, Figure 7-2a). 
The CI value of starch-fatty acid complexes is dependent on both the constituent species and 
the manufacturing complexation process. For example, the CI value exhibit an inverse 
relationship to the chain length of fatty acids-shorter fatty acids can more effectively disperse 
in gelatinized gels, thereby facilitating the interactions of starch with fatty acids and 
enhancing complexing indexes [378]. However, the equation can still be used to estimate the 
necessary amount (usually 5-10%) of lipids needed to form complete complexes with starch. 
For instance, 5% stearic acid has been used to complex with debranched starch (ca. 70% 
amylose) [176, 386], whereas the mass ratios of stearic acid-brown lentil starch and corn oil-
corn starch were 10% and 5%, respectively [374, 381]. In this study, three mass ratios of 4%, 
12%, and 20% were designed to represent partly complexed, fully complexed, and fatty acid 
surplus.  
  
Figure 7-2: CI of starch-milk fatty acids.  
Notes: The different superscripts on each bar of the same starch indicate significant difference 
(𝑝 < 0.05, 𝑛 = 3); CS: corn starch; RS: rice starch; WS: wheat starch; WCS: waxy corn 
starch; HACS: high amylose corn starch; MFA: milk fatty acids; SA: stearic acids; MFA0 
(control), MFA4, MFA12, and MFA20 represented that the milk fatty acid concentrations in 
starches were 0%, 4%, 12%, 20%, respectively; SA 12 (side control): stearic acids 
supplementation at 12% (w/w, starch based). 
7.3.4 Rheological analysis and gel firmness 
As illustrated in Table 7-3, the formation of milk fatty acid-amylose complexes resulted in a 
concomitant significant decrease in peak viscosities except for corn starch gels (rapid 
gelatinisation), most likely due to the lubrication effects of milk lipids. There were increases 





































[276]. With respect to the mechanism of rheological change in corn starch, at the beginning, 
the granule swelling was restricted by the added milk lipids and the formed complexes, 
leading to the lower viscosity value than those of controls [388]. The increase in the final 
viscosities (FV) with the increase in percentage of milk lipids was related to the milk lipids 
re-solidification during the final, cooling stage of rapid viscosity analysis (RVA) standard-2 
procedure [374].  
In addition to pasting properties, the gel firmness decreased with the increase in milk fatty 
acid concentration, as shown in Table 7-3. As a consequence of stearic acid addition, the gel 
strength of SA12 samples became less than those of MFA0 (controls), similar to the trend 
with milk fatty acid addition (MFA4, 12 and 20). The complex-induced gel softening was 
more pronounced in wheat and corn gels than rice gels. As a consequence of lipid addition, 
the gels became softer than those of the controls, in agreement with a previous report on corn 
starch-palmitic acid (10%, w/w) complexes [276]. Furthermore, the gel firmness results were 
supported by previous reports on potato- and Bambara starch-linoleic acid, stearic acid, and 
lysophosphatidylcholine complexes [376] and on corn starch-stearic acid complexes [389]. 
The conformation of starch-fatty acid complexes (lamellar crystallites) reduces the water-
binding and gel-forming ability of starch particles, thereby weakening the gel structure.  
Table 7-3: Gel rheological characteristics and starch digestibility.  
Samples 
MFA0 
(control) MFA4 MFA12 MFA20 SA12 
WS 
PV (cp) 532a ± 13.5 429ab ± 75.5 233b ± 194.0 442ab ± 37.5 459ab ± 9.0 
FV (cp) 3,911c ± 64.3 4,779b ± 302.4 6,435a ± 209.1 5,964a ± 451.5 6,086a ± 161.0 
PT (℃) 81.10a ± 0.05 82.30a ± 1.10 81.55a ± 0.30 82.13a ± 0.63 81.38a ± 0.08 
GF (g) 117.52a ± 0.06 66.64b ± 0.20 22.71d ± 0.13 21.61e ± 0.07 51.48c ± 0.41 
𝑇1/2 (min) 39.2b ± 1.50 39.1b ± 4.15 55.4b ± 10.24  61.5ab ± 16.59  83.6a ± 12.07  
𝑘 (×10–2, 
min–1) 1.77a ± 0.07  1.79a ± 0.18  1.28ab ± 0.27  1.18b ± 0.28  0.84b ± 0.12  
R2 0.96  0.99  0.98  0.96  0.93  
AUC 85.63a ± 2.70  73.44b ± 0.67  71.37b ± 4.59  71.44b ± 0.66  62.47c ± 2.54  
CI (%) - 56d ± 0.5 88b ± 0 99a ± 0.2 81c ± 0.2 
CS 
PV (cp) 1,998c ± 8.1 2,321b ± 62.7 2,272ab ± 70.0 2,428a ± 17.7 1,985c ± 11.0 
FV (cp) 3,324c ± 34.0 3,479c ± 95.4 4,094b ± 154.0 4,885a ± 385.4 4,563ab ± 177.4 
PT (℃) 74a ± 0.2 73.50a ± 0.5 73.65a ± 0.26 73.67a ± 0.28 74.07a ± 0.25 
GF (g) 176.82a ± 2.58 120.83b ± 0.29 87.56c ± 0.30 19.31e ± 0.18 28.75d ± 0.35 
𝑇1/2 (min) 17.3b ± 0.27  25.0b ± 2.87  34.5b ± 9.27 70.0a ± 23.11 82.1a ± 8.15  
𝑘 (×10–2, 
min–1) 4.02a ± 0.06  2.80 ± 0.33b  2.12b ± 0.61  1.08c ± 0.41  0.85c ± 0.09  
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R2 0.96  0.97  0.97  0.95  0.98  
AUC 143.15a ± 2.04  123.72b ± 1.98  115.39b ± 2.12  95.15c ± 11.34  79.45d ± 1.41  
CI (%) - 5d ± 1.9 14c ± 1.5 63a ± 2.8 36b ± 1.1 
RS 
PV (cp) 753a ± 7.1 302c ± 46.0 343c ± 5.1 332c ± 14.3 458b ± 2.5 
FV (cp) 2,537d ± 15.5 3,684b ± 96.2 4,046a ± 64.1 4,138a ± 25.4 2,858c ± 50.5 
PT (℃) 74.75 ± 0.35 - - - - 
GF (g) 18.99a ± 0.08 8.43bc ± 0.37 8.91b ± 0.24 6.11d ± 0.07 8.20c ± 0.17 
𝑇1/2 (min) 19.35b ± 4.96  57.45a ± 1.36  60.18a ± 5.06  69.98a ± 9.46  63.00a ± 6.11  
𝑘 (×10–2, 
min–1) 3.78a ± 1.14  1.21b ± 0.03  1.16b ± 0.09  1.00b ± 0.15  1.11b ± 0.10  
R2 0.96 0.94  0.95  0.94  0.94  
AUC  134.59a ± 4.16  92.74c ± 1.00  101.36b ± 7.75  108.59b ± 0.71  92.29c ± 2.92  
CI (%) - 80b ± 0.7 93a ± 0.8 93a ± 0.3 54c ± 0.7 
WCS 
PV (cp) 2,666ab ± 4.7 2,757a ± 68.6 2,485cd ± 82.1 2,383d ± 24.3 2,549bc ± 22.5 
FV (cp) 3,298d ± 139.1 3,072d ± 153.4 5,145b ± 242.8 5,778a ± 52.5 3,748c ± 153.2 
PT (℃) 74.28a ± 0.73 73.53a ± 0.03 73.95a ± 0.00  74.65a ± 1.13 74.13a ± 0.23 
𝑇1/2 (min) 28.4 c ± 1.51 41.0c ± 2.45  55.8b ± 2.90  58.1b ± 11.05  80.6a ± 2.44  
𝑘 (×10–2, 
min–1) 2.45 ± 0.13a  1.69 ± 0.10b  1.24 ± 0.07c  1.22 ± 0.21c  0.86 ± 0.03d  
R2 0.92 0.94 0.92 0.92 0.95 
AUC 126.93 ± 4.13a  118.84 ± 2.10a  109.55 ± 2.91b  107.60 ± 2.73b  80.01 ± 3.81c  
CI (%) - 56±0.3d 62±0.2c 89±0.2a 65±0.4b 
HACS 
𝑇1/2 (min) 94.1 ± 1.96a - 94.1 ± 1.96a 60.5 ± 1.09b - 
𝑘 (×10–2, 
min–1) 0.74 ± 0.02b  - 0.74 ± 0.02b  1.15 ± 0.02a  - 
R2 0.96  - 0.96  0.95  - 
AUC 56.34 ± 0.82b - 60.78 ± 2.17b  72.45 ± 4.12a  - 
CI (%) - 4±0.5c 43±0.6a 42±0.8a 30±0.6b 
Notes: Results are expressed as means ± SD, the different superscripts following each figure 
in the same row indicate significant difference (𝑝 < 0.05, 𝑛 = 3). CS: corn starch; RS: rice 
starch; WS: wheat starch; WCS: waxy corn starch; HACS: high amylose corn starch; PV: 
peak viscosity; FV: final viscosity; PT: pasting temperature; GF: gel firmness; AUC: area 
under the curve of predictive reducing sugar; 𝑇1/2 : half digestion time (min); k: the reaction 
rate constant (×10–2, min–1); CI: complexing index; MFA0 (control), MFA4, MFA12, and 
MFA20 represented that the milk fatty acid concentrations in starches were 0%, 4%, 12%, 
20%, respectively; SA 12 (side control): stearic acids supplementation at 12% (w/w, starch 
based). 
 126 
7.3.5 Fourier-transform infrared spectroscopy 
Fourier-transform infrared (FTIR) spectroscopic analysis has been used to quantify the 
complexed molecules of amylose-fatty acid by characteristic groups, such as carbonyl group 
[286]. For instance, the wavenumbers 3437, 2922, and 993 cm–1 correspond to groups of 
hydroxyl (OH), C-H bond, and ether C – O – C, respectively. As shown in Figure 7-3, the 
characteristic signals at 3437 and 993 cm–1 from wheat starch were observed in the spectra of 
mixture of wheat starch and milk fatty acids, and the peak at 2922 cm–1 from milk fatty acids 
also appeared in the spectra of mixture. However, the spectrum of the complex displayed two 
new peaks at 3398 and 1024 cm–1 (repositioning by 39 and 31 cm–1, respectively) from wheat 
starch, due to the reordering of starch helices when fatty acids were complexed inside the 
cavities of starch helices.  
This shift of the carbonyl peaks was also observed in a previous study on high amylose maize 
starch-fatty acid ester complexes [390]. The shift of carboxyl bond peaks in the spectrum of 
starch-oleic acid complexes was also observed previously [377]. In addition, another study 
has demonstrated that the peak at 1662 cm–1 of p-Aminobenzoic acid (PA) was relocated to 
1672 cm–1 in the spectra of PA-linear amylose complexes [391], indicating the formation of 
inclusion complexes with starch. Further, it has been shown that the molecular state of 
salicylic acid analogues changed from a crystalline state to an amylose inclusion complex by 
breakage of the hydrogen bond between carboxyl groups, causing a band shift from 1679 cm–1 
(carbonyl symmetric stretching) and 1531 cm–1 (nitro asymmetric stretching) to 1728 cm–1 
and 1537 cm–1, respectively [392]. 
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Figure 7-3: FTIR spectrums of WS-milk fatty acid complexes and their constituents.  
Notes: a: FTIR spectrums of wheat starch (WS); b: milk fatty acids (MFA), c: mixture of milk 
fatty acids and wheat starch; d: milk fatty acid-wheat starch complex. 
7.3.6 Thermography analysis 
Previously, thermal analysis had been used to verify the formation of complexes [374]. As 
illustrated in Figure 7-4, the wheat starch spectra Figure 7-4b displayed an endothermic peak 
at 68.2˚C, indicating the pasting and gelatinisation of starch granules. Again, this peak was 
conserved in the DSC spectrum of milk fatty acid-wheat starch complexes, slightly shifting to 
72.4˚C (Figure 7-4a). However, a new endothermic peak was observed at 109.6˚C, indicating 
the disassociation of complexes, in line with a previous report [374], where the unfolding 
temperatures of helical complexes were observed at 109.8 ± 2.12˚C and 107.1 ± 0.53˚C for 
brown lentil starch-stearic acid and brown lentil starch-palmitic acid complexes, respectively. 
In another study, the two transition endotherms for 3.75% (w/w) lauric acid-complexed wheat 
starch were at 63.8 ± 0.3˚C and 98.0 ± 0.5˚C, respectively, whereas only one gelatinization 
endothermic peak at ca. 62˚C was observed for native wheat starch [385]. The temperature 
differences of complex dissociation between Wang et al. [385] and the present observation on 
WS-MFA complexes are likely due to the affinity difference between the different 
constituents or the different types of fatty acids. The DSC thermogram of gelatinisation was 
for starch or starch-fatty acid mixture, and it was not applicable for fatty acids.  
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Figure 7-4: DSC thermogram of milk fatty acid-wheat starch complexes. 
Notes: a: wheat starch-milk fatty acid complexes; b: wheat starch. 
7.3.7  Starch hydrolysis kinetics  
The starch hydrolysis followed by first-order kinetics (R2 = 0.95), and the complexes of 
starch-milk fatty acids decreased the reaction rate constant of starches (wheat, corn, and rice), 
consistent with a previous report on rice flour digestion (𝑘 = 2.04 ± 0.11 × 10–2 min–1) [393]. 
The results were also in agreement with another report on fatty acid-starch complexes, where 
lotus seed starch had a reaction rate constant of 5.5 ± 0.1 × 10–2 min–1, while the complexed 
starches had lower reaction rate constants than those of controls, ranging from 1.9 ± 0.1 × 10–2 
min (C8), 2.2 ± 0.1 × 10–2 min–1 (C10), 2.1 ± 0.1 × 10–2 min–1 (C12), 2.9 ± 0.2 × 10–2 min–1 
(C14), 5.3 ± 0.2 × 10–2 min–1 (C16), and 5.5 ± 0.2 × 10–2 min–1 (C18) [375]. One possible 
explanation for this decrease of reaction rate constants on complexation is that fatty acid-
starch complexes restrict the swelling of starch granules and reduce the susceptibility of starch 
molecules to degradation by lipases, thereby attenuating the lipolysis reaction.  
7.3.8 Reducing sugar release  
As shown in Table 7-3 and Figure 7-5, with the increase of milk fatty acid addition, the CI 
value of MFA samples decreased, causing reduction of the AUC of reducing sugar release and 
the reaction rate constant (k) concomitantly except for HACS samples. The complexation with 
fatty acids decreased the AUCs of wheat, corn, rice, and waxy corn starch samples (MFA12) 
by 17%, 19%, 25%, and 14%, respectively. Whereas the AUCs of reducing sugar release of 
SA12 samples reduced 27%, 44%, 31%, and 37% for WS, CS, RS, and WCS groups, 
respectively, compared to those of controls. The reductions in the AUCs of reducing sugar 
release due to amylose-fatty acid complexation are consistent with previous reports on two 
stearic acid-complexed starches [176, 374, 375]. The reduction in the glycaemic load has been 


































complexes [394]. In addition, the formation of complexes reduced the susceptibility of 
amylose to enzymatic hydrolysis in vitro. Wheat starch (WS), corn starch (CS), and rice 
starch (RS) showed different correlation numbers between AUC and CI. High correlation has 
been shown in WS and CS samples, c at –0.96 and –0.99 for WS and CS, respectively. 
Whereas, for RS, this number was as low as –0.89. It can be explained that starch digestibility 
is affected by both the quantity and quality of the single helix amylose-lipid complexes. For 
instance, although the complexation ability of capric acid and myristic acid complexed with 
rice starch was significantly higher than that of stearic acid, but the reduction of free sugar 
content was not significantly different. In addition, the CI value of rice starch and palmitic 
acid was relatively low, whereas a significant decrease in the digestibility of rice starch was 
observed in simulated gastrointestinal digestion [384].  
The samples MPL12 (12% fatty acids, w/w) and MPL20 (20% fatty acids, w/w) displayed 
more effective resistance to amylase digestion in contrast to MPL4 (4% fatty acid, w/w) (𝑝 <
0.05), probably due to the increased complexing index. These results were consistent with a 
recent report on the digestibility of lotus starch-fatty acid complexes, where lotus starch-
caprylic acid and starch-capric acid exhibited more resistance than those of palmitic- and 
stearic acid-complexed starches because the CI value in the former were higher than the latter 
[375].  
High amylose corn starch (HACS) has a very compact physical structure, because its 
gelatinisation temperature (Tc = 109.3˚C) is high and its gel is not developed during the usual 
95˚C cooking. Therefore, the hydrolysis velocity of HACS was very low, in conformity with a 
previous report on HACS [276]. HACS can form a strong gel, and be used to make 
biodegradable film and resistant starch. However, it has limited commercial application due to 
the challenge of producing it at normal cooking temperature conditions (60 – 95˚C, need 
130˚C to fully and homogeneously gelatinize [395]). During heating at 95˚C (standard-2, 23 
min including 7 min holding), the starch particles did not disperse sufficiently, thus confined 
starch molecules in the particle matrices yielded a low hydrolysis degree for HACS samples. 
When milk fatty acids and stearic acid were complexed with starch molecules, the crystalline 
starches became partly disrupted, resulting in unfolded starch granules. Therefore, the 
amylose binding site availability in starch increased, leading to a comparably higher 
digestibility of the lipid-treated HACS samples than the untreated controls. The enhancement 
of digestibility due to complexing was also observed in another report on lotus seed starch-
fatty acid complexes, which were made by high pressure micro-fluidization [375].  
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Waxy corn starch also exhibited complexing capacity with milk fatty acids, thereby reducing 
the AUCs for reducing sugar release accordingly. These results were in line with previous 
study on waxy corn starch-lipid complexes [276, 396]. Compared to normal starch, waxy corn 
starch showed a remarkable hydrolysis resistance effect, which made it also an attractive 
source for the preparation of resistant starches.  
The difference in the digestibility among milk fatty acid-complexed corn, rice, and wheat 
starches was significant (𝑝 < 0.05), as illustrated in the Figure 7-5, which can be explained 
by the variable ratios of amylose to amylopectin, granule size, retrogradation of amylose, and 
the degree of crystallinity [374]. The AUC value for the reducing sugar release from corn 
starch and wheat starch complexes were 143.15 ± 2.04 and 85.63 ± 2.70, corresponding to 
half-digestion constants of 17.3 ± 0.27 min and 39.2 ± 1.50 min, respectively, in line with a 
previous report on plasma glucose response of corn and wheat food [397]. In general, the 
digestibility decreased with the increase of the CI value, but the reduction of the glycaemic 
index (GI) is not inversely proportional to CI. For instance, rice-palmitic acid complexes 
exhibited a low CI value of only 30.9%, but their GI value was comparable with that of rice-



















































Figure 7-5: Predictive reducing sugar release of starch-milk fatty acid complexes. 
Notes: Predictive reducing sugar release (𝑛 = 3) from: (a) waxy corn starch (WCS)-fatty acid 
complexes; (b) corn starch (CS)-fatty acid complexes; (c) wheat starch (WS)-fatty acid 
complexes; (d) high amylose corn starch (HACS)-fatty acid complexes; (e) rice starch (RS)-
milk fatty acids (MFA); MFA0 (control), MFA4, MFA12, and MFA20 represented that the 
milk fatty acid concentrations in starches were 0%, 4%, 12%, 20%, respectively; SA 12 (side 
control): stearic acids supplementation at 12% (w/w, starch based).  
7.4 Conclusion 
To summarize, milk fat-derived fatty acids were successfully incorporated into rice, corn, and 
wheat starch gels, yielding various complexing indexes. The spectroscopy study confirmed 
the conformation of fatty acid-starch complexes. The conjugation with fatty acids led to 
weaker starch gels, with higher final viscosity and hydrolysis resistance than untreated 
controls. Compared to uncomplexed starch gels, the glycaemic indexes of the complexed 
starches were reduced by 19% in corn starch (CS), 17% in wheat starch (WS), and 25% in 
rice starch (RS), respectively. The half digestion time of milk fatty acid-complexed starches 
(MFA12, 12%, w/w) increased from 17.3 ± 0.27 min to 34.5 ± 9.27 min for corn starch, from 
39.2 ± 1.50 min to 55.4 ± 10.24 min for wheat starch, and from 19.35 ± 4.96 min to 60.18 ± 





































































resistant starches using milk lipids. These starch-milk fatty acid complexes can be further 
facilitated to produce resistant starchy foods for diabetic people.  
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Chapter 8: Milk lipid in vitro lipolysis kinetics in wheat, corn, and 
rice starch gels 
Chapter 8 is published as:  
o Zhiguang Huang, Charles Brennan, Maneesha S. Mohan, Letitia Stipkovits. Milk lipid in 
vitro lipolysis kinetics in wheat, corn, and rice starch gels. International Journal of Food 
Science and Technology, 2020 (accepted). 
Abstract: Starch-based hydrogels or nano-emulsions have been used to regulate lipid 
digestibility. However, there have been a few reports on how starch gels affect milk lipid in 
vitro digestion. This study compared the pancreatic-lipase-catalysed digestibility of milk 
lipids in two matrices: milk fat dispersion and milk fat-loaded starch gels. Optical microscopy 
analysis suggested that lipid droplets were evenly distributed in starch gels. The peak 
viscosities of lipid-containing starch gels were higher than those of samples without filled-
lipids, and whereas, final viscosities were reduced by lipid addition. Free fatty acid release 
measurement showed that milk fat embedded in three starch gels were two to three times 
more digestible than dispersed milk fat globules in aqueous phase. A multi-step hydrolysis 
reaction model was introduced to estimate lipolysis reaction rate. This study offers a feasible 
way to manipulate milk lipid digestibility by stabilization with starch gels. 
Keywords: Milk fat lipolysis; multi-step reaction model; rheological characteristics; 
lipophilic encapsulation; particle size distribution. 
8.1 Introduction  
Milk fat accounts for one third of lipid intake in the Western diet [398]. The lipid digestibility 
has caused increasing concern in regard to cardiovascular disease and the nutritional value of 
milk products [399]. Burning fats instead of carbohydrates is crucial for endurance of 
marathon athletes [400], and lipid digestion and absorption may be regulated by emulsion 
technology [401] or by dietary components such as calcium, ethanol, and caffeine [402]. 
Whey protein isolate-chitosan stabilized emulsions demonstrated more stable structure than 
lipid emulsions, and thus could impede lipolysis through electrostatic attraction [401]. 
Lipid droplets may be stabilized in starch-based hydrogels, exhibiting different digestibility 
from lipid emulsion. For instance, Mun et al. [403] used mung bean and rice starches to make 
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filled hydrogels that accommodated β-carotene-loaded oil droplets, leading to significantly 
more release of free fatty acids in 2 h digestion than lipid emulsion. As a result of starch 
gelation, lipid droplets were trapped in starch gels, and therefore, their initial digestion rate 
was slowed down, compared to lipids in emulsions. Also, seaweed polysaccharides exhibited 
stabilising properties in oil-in-water emulsion system (O/W) [404]. In a report by Park et al. 
[288], β-carotene was solubilized in lipid droplets and further entrapped by starch hydrogels, 
altering both lipid digestibility and β-carotene bio-accessibility. Further, starch particles have 
been used as surface coating material to form Pickering emulsions, limiting lipase access to 
oil droplets [405]. In addition, curcumin in oil-in-water emulsion was stabilized by starch 
granule Pickering emulsions, yielding an encapsulation efficiency of 80% and elevated 
physical stability [406]. Also, starch particles were used to increase the barrier properties of 
Pickering emulsion to oil-water interface [407]. 
Although lipid droplet-filled starch gels and their functionalities have been studied elsewhere, 
there have been a few studies on how starch gels impact on lipolysis reaction kinetics so far. It 
has been hypothesized by Marefati et al. [406] that the inner side of starch granules towards 
the oil droplets may have a less easily digestible structure than external side of the granules. 
Similarly, the inner oil droplets could have a less easily digestible structure than the lipid 
emulsions without stabilized by starch gels because the outer layer of the double-layered 
structure must first be disrupted to initiate lipolysis. Therefore, this study aimed to stabilize 
milk fat with three kinds of starch gels (rice, corn and wheat), assess their pancreatic-lipase-
catalysed digestibility, and predict the release of free fatty acids by a multiple reaction model. 
8.2 Materials and methods 
The materials and methods in the section of 8.2 can be referred back to the corresponding 
sections in Chapter 3, as illustrated in Table 8-1.  
Table 8-1: Materials and methods for milk lipolysis.  
Section 
8.2 Materials and methods 
As mentioned in the 
section of  
8.2.1. Materials 3.27 
8.2.2. Proximate nutritional analysis 3.28 
8.2.3. 
Preparation of recombined milk lipid dispersion and its 
turbidity analysis 3.29 
8.2.4. 
Preparation of starch gels to entrap milk fats and 
rheological analysis 3.30 
8.2.5. 
Light microscopy and confocal laser scanner microscopy 
(CLSM)  3.31 
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8.2.6. PSD analysis 3.32 
8.2.7. 
Pancreatic-lipase-catalysed digestion of milk fats in 
dispersion or in starch gel 3.33 
8.2.8. Lipolysis and free fatty acid determination 3.34 
8.2.9. 
Characterization of composition of released free fatty 
acids 3.35 
8.2.10. Kinetic analysis of lipolysis 3.36 
8.2.11. Statistical methods 3.37 
8.3 Results and discussion 
8.3.1 Particle size analysis and microscopy 
The average size (𝑑3,2) of milk fat globules in O/W emulsion was 16.90 ± 0.10 μm (MFG, 
control sample), consistent to microscopy image particle size in Figure 8-1d and Figure 8-1e, 
as analysed by a MasterSizer 3000 unit. The starch particle size (𝑑3,2) ranged from 5.46 to 
14.70 μm in Table 8-2, as also observed by microscopy observation in Figure 8-1a– Figure 
8-1c. 
Lipid was distributed evenly in starch gels, as shown in the green spots in the CLSM images 
of RF-gel (3:1 w/w) in Figure 8-1d and WF-gel (3:1 w/w) in Figure 8-1e, and similar to an 
observation where non-dairy cream lipids were uniformly entrapped in starch gels [408]. As 
illustrated in CLSM image Figure 8-1e, the particle size (𝑑3,2) of the milk fat globules in 
wheat starch gel was 14.85 ± 2.80 µm by ImageJ analysis, comparable to that of control 
sample (MFG) and coarser than a previous optical microscopy observation [409]. Milk fat 
globules shown in Figure 8-1d – Figure 8-1e were out of shape, probably due to distortion 
from gel stress. 
When starch dispersions were heated to 95˚C, and the hydrated starch particles swelled 
irreversibly. At the same time, amylose leached into aqueous phase, and the starch particles 
lost crystalline structures. Finally, the starch dispersions turned into viscoelastic gels [410, 
411]. Starch particles appeared to be fully gelatinized during cooking and turned into irregular 
fragments, as illustrated in non-stained spots in Figure 8-1d and Figure 8-1e, consistent with a 
previous optical microscopy analysis on rice starch gelatinization [412]. During storage, 
amylose and amylopectin recrystallized successively [413]. 
Table 8-2: The specific surface area and particle size of starches. 
Samples 






RS  1,100.67a ± 3.06 5.46c ± 0.02 8.45c ± 0.06 
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CS 520.67b ±0.15 11.50b ± 0.00 15.60b ± 0.00 
WS 407.80c ± 0.50 14.70a ± 0.00 22.13a ± 0.06 
Notes: Results are expressed as means ± SD, the superscripts following figures of starch 
samples in the same column indicate significant difference among three starches (p < 0.05, 
n = 3). CS: corn starch; WS: wheat starch; RS: rice starch; 𝑑3,2: surface-area-based mean 
diameter by laser diffraction; 𝑑4,3: volume-based mean diameter by laser diffraction. 
 
Figure 8-1: Light microscopy and CLSM images of milk fat-loaded starch gels. 
Notes: Images in Figure 1(a – c) were viewed at 400-fold magnification, bright field optical 
microscopy for iodine-stained rice (a), corn (b) and wheat (c) starch. CLSM images in Figure 
8-1(d – e) were observed at 400-fold magnification for RF- and WF-gel (3:1 w/w), 
respectively. Milk fat in green was stained by Sudan black, while starch was non-stained. 
Scale bars for images in Figure 8-1(a – c) and Figure 8-1(d – e) were 10 μm and 50 μm, 
respectively. 
8.3.2 Starch gel characterisation  
In contrast to side control samples (R-, C- or W-gels, 3:0 w/w), RF-, CF- and WF-gels (3:1 
w/w) showed different viscosity in both the peak viscosity and the final viscosity, as depicted 
in Table 8-3. With the addition milk fat, the peak viscosity of RF- and CF-gels (3:1 w/w) were 




which the increased viscosity due to the addition of milk fat was counteracted by shortening 
effect (lubrication effect, reducing gel viscosity) of milk fat on wheat starch gel. Regarding to 
final viscosity, RF-gel (3:1 w/w) was found to be less viscous than R-gel without filling milk 
fat in. This is due to the reduced gelatinisation induced by shortening lipids (i.e. milk fat). In 
addition to the concentration of milk fat, the type of starch also had an impact on rheological 
properties of milk fat-filled starch gels.  
During gelatinisation, the starch dispersions eventually turned into viscoelastic gels, in which 
amylose and water were bound by hydrogen bonding in three-dimension networks [414]. The 
viscosity of gels is associated to the degree of gelatinisation. Milk fat globules dispersed into 
starch gels and functioned as shortenings and fillers, separating and weakening the starch 
matrices [415].Therefore, the final viscosity of RF-gel (3:1 w/w) was less than that of fully 
gelatinized side-control (R-gel). Whereas, for CF- and WF-gels, no significant change in final 
viscosity was found between testing (3:1 w/w) and control (3:0) samples, due to synergistic 
effect of milk fat (i.e. both shortening effect and re-solidification). On one hand, milk fat 
restricted corn/wheat starch swelling and gelatinisation, thereby yielding less sticky gels 
[388]. On the other hand, milk fat re-crystalized and increased viscosity of gels at the cooling 
stage [374]. 
Table 8-3: Rheological properties of milk fat entrapped starch gels.  
Samples 
Side-control 
3:0 2:1 (w/w) 2.5:1 (w/w) 3:1 (w/w) 
RF-Gel PV (cp) 753b ± 7.1 119d ± 8.2 498c ± 41.1 1,352a ± 53.8 
RF-Gel FV (cp) 2,537a ± 15.5 893d ± 21.9 1,471c ± 8.2 2,068b ± 42.6 
CF-Gel PV (cp) 1,998b ± 8.1 378c ± 47.1 1,755b ± 109.1 3,824a ± 157.6 
CF-Gel FV (cp) 3,324a ± 34.0 1,120c ± 7.8 1,950bc ± 10.1 2,492ab ± 799.4 
WF-Gel PV(cp) 532a ± 13.5 16c ± 1.2 108b ± 3.2 484a ± 4.4 
WF-Gel FV (cp) 3,911a ± 64.3 726c ± 9.3 1,890b ± 21.5 3,801a ± 110.0 
Notes: Means that do not share a letter in the same row are significantly different (p < 0.05, 
n = 3). Tukey 95% simultaneous confidence intervals analysis was performed, with all 
pairwise comparison. RF-, CF- and WF-gel was denoted as the milk fat-load rice, corn and 
wheat starch gel, respectively. Side control (3:0) represented starch gel without milk fat. 
Starch gel 2, 2.5 and 3 were defined as the starch to lipid ratio (w/w) 2:1, 2.5:1 and 3:1, 
respectively. PV, peak viscosity; FV, final viscosity. 
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8.3.3 Hydrolysis degree of milk fat 
As shown in Figure 8-2, the degree of hydrolysis of milk fat varied remarkably in the three 
kinds of starch-lipid ratio. Compared to control samples, milk fat in RF-, CF- and WF-gels 
exhibited 2 – 3-fold more hydrolysis degree in 2 h. The hydrolysis degree increased in the 
order of testing gels (2:1 w/w) < gels (2.5:1 w/w) < gels (3:1 w/w), in line to the order of 
starch gel viscosity. The difference in the milk lipid hydrolysis degree among the three kinds 
of starches was less obvious in contrast to the ratio of starch to lipids, because changing milk 
fat concentration has more impact on starch gel strength (i.e. more stabilisation effects) than 
changing the type of starch. In all three starch samples, each fatty acid release curve had a 
turning point, where starch gels were fully degraded by amylase catalysis, as illustrated in 
Figure 8-2a – Figure 8-2c. 
Table 8-4: Hydrolysis degree of pancreatic-lipase-catalysed milk fat. 
Samples 0:1 (Control) 2:1 (w/w) 2.5:1 (w/w) 3:1 (w/w) 
RF-Gel 25.1c ± 1.6% 64.4b/A ± 6.0% 74.8ab/B ± 6.0% 78.3a/B ± 0.0% 
CF-Gel 25.1c ± 1.6% 13.9d/C ± 0.0% 48.8b/C ± 6.0% 78.3a/B ± 0.0% 
WF-Gel 25.1b ± 1.6% 27.8b/B ± 3.0% 93.7a/A ± 6.0% 97.1a/A ± 0.0% 
RF-Gel* 25.1c ± 1.6% 58.9b/A ± 4.7% 68.4ab/B ± 5.5% 71.6a/C± 0.0% 
CF-Gel* 25.1c ± 1.6% 15.8d/C ± 0.0% 55.3b/C ± 6.8% 88.7a/B ± 0.0% 
WF-Gel* 25.1c ± 1.6% 22.9c/B ± 4.9% 77.2b/A ± 4.9% 79.9a/A ± 0.0% 
Notes: digestion in three starch gels in 2 h intestinal digestion; Results are expressed as means 
± SD, the low-case superscripts following figures of starch samples in the same row indicate 
significant difference, and whereas the capital letter superscripts following means of data in 
the same column indicate significant difference among the different starches (p < 0.05, n =
3). RF-, CF- and WF-gel was denoted as the milk fat-load rice, corn and wheat starch gel, 
respectively. Control (0:1) sample represented milk fat emulsion without starch. Starch gel 2, 
2.5 and 3 were defined as the starch to lipid ratio (w/w) 2:1, 2.5:1 and 3:1, respectively. *The 
2-h intestinal hydrolysis degree of milk fat containing samples were normalized based on the 
same the milk fat globule area, which was assigned as 355.57 m²/kg. 
8.3.4 Kinetic analysis of lipolysis in stepwise reaction  
In addition to the experimental determination, a multi-step serial reaction model was used to 
simulate the fatty acid release [416]. The primary step was to free the encapsulated 
triacylglycerols (𝑇𝐴𝐺∗) from starch gel matrices, which was dependent on starch hydrolysis 
kinetics (𝑘1). The freed TAG was then broken down with the lipase catalysis (𝑘2). The 
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hydrolysis reaction rate of starch was assumed to follow by first-order kinetics (𝑛1 = 1) [410, 
417]. The lipolysis reaction rate of TAG was constant (zero order) at the beginning since 
enzyme concentration was much higher than that of lipidic substrates. Whereas, with the 
proceeding of lipolysis, the kinetics were first-order (𝑛2 = 1). 
𝑇𝐴𝐺∗
𝑘1(𝑛1=1)
→      𝑇𝐴𝐺 
𝑘2(𝑛2=1)𝐴𝑞𝑢𝑒𝑜𝑢𝑠
→             2𝐹𝐴 +𝑀𝐴𝐺      (8-1) 
𝑟𝑇𝐴𝐺∗ = −𝑘1𝐶𝑇𝐴𝐺∗ =
𝑑𝐶𝑇𝐴𝐺∗
𝑑𝑡
       (8-2) 
𝑟𝑇𝐴𝐺 = 𝑘1𝐶𝑇𝐴𝐺∗ − 𝑘2𝐶𝑇𝐴𝐺= 
𝑑𝐶𝑇𝐴𝐺
𝑑𝑡
       (8-3) 
𝑟𝐹𝐴 = 𝑘2𝐶𝑇𝐴𝐺 =
𝑑𝐶𝐹𝐴
𝑑𝑡
      (8-4) 
𝐶𝑇𝐴𝐺∗=𝐶𝑇𝐴𝐺0∗ exp(−𝑘1𝑡)      (8-5) 
In which, 𝐶𝐹𝐴 and 𝑟𝐹𝐴 were the fatty acid concentration and free fatty acid release rate, 
respectively. 𝐶𝐹𝐴 can be obtained by overall mass balance of TAG.  
𝐶𝐹𝐴 = 2(𝑘2(1 − exp(−𝑘1𝑡)) − 𝑘1(1 − exp(−𝑘2𝑡))) 𝐶𝑇𝐴𝐺0∗ (𝑘2 − 𝑘1)⁄            (8-6) 
The hydrolysis degree 𝑥 of milk fat can be calculated from Eq. 8-7, where 𝑡 → ∞, then 𝑥 = 1. 
𝑥 = (𝑘2(1 − exp(−𝑘1𝑡)) − 𝑘1(1 − exp(−𝑘2𝑡))) (𝑘2 − 𝑘1)⁄   (8-7)  
As illustrated in Figure 8-2, both the reaction rate and hydrolysis degree of milk fat in starch 
gels were higher than that of control sample, except for RF-gel (2:1 w/w), in which 
gelatinisation was insufficient due to the shortening effect of milk fat. For example, the 
control lipid emulsion showed a hydrolysis degree of 25.1 ± 1.6%, while the lipolysis degree 
was 78.3 ± 0.0% in the RF-gel (3:1 w/w). In regard to kinetics, the lipolysis reaction rate 
constant 𝑘2 for lipid emulsion was 0.016 min–1, and whereas, those (𝑘1) for starch hydrolysis 
were 1.77×10–2 (WS), 4.02×10–2 (CS) and 3.78×10–2 (RS) min–1. The difference in 𝑘1 may be 
related to such factors as amylose-amylopectin composition and starch-lipid complexes [276], 
swelling power and aqueous solubility [418], endogenous flour lipid [419], starch particle size 
[420], cooking degree and starch gelatinisation [421]. For instance, wheat starch hydrolysed 
slower than rice and corn starch, and whereas, rice starch exhibited comparable digestibility to 
corn starch, consistent to the starch digestibility of control samples in a previous report [419]. 
This can be explained by the mechanism of milk fat hydrolysis. Lipolysis, a bio-interfacial 
process, is mainly governed by the binding of the lipase-colipase-bile salt complex on the 
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surface of lipid droplets. Hence, by engineering oil-water interfaces, both the displacement by 
bile salts and the adsorption of lipase onto lipidic substrates can be modulated [422]. In 
addition to interfacial properties, other factors impact the lipolysis velocity and degree, 
including the emulsion structure [423] and stability [424], physical state (solid or liquid 
[425]), the extent of lipid emulsification [426], lipid sources [427] and molecular composition 
such as chain length [428, 429] and saturation [430]. 
Gastric pH and salts can alter both the size and the structure of particles, which further affect 
the intestinal digestion. However, gastric digestion contributes to only a minor proportion (10 
– 30%) of the total phospholipid hydrolysis [426, 431] and takes place at pH 1.5 – 3, which is 
incompatible with the present titration quantification since both gastric acid and free fatty 
acids consume titrant. Therefore, only intestinal digestion was surveyed in this study, as also 
commonly performed by recent reports on lipid digestion [309-311]. 
In the present study, through stabilization of lipid droplets in starch gels, milk lipid 
digestibility was improved. For instance, the lipolysis degree increased by ca. two times in 
RF- and CF-gels (3:1 w/w) and by ca. three times in WF-gel (3:1, w/w), compared to that of 
control sample. In terms of mechanism, milk lipids comprise mainly of the stearic acids, oleic 
acids, and palmitic acid fatty acids, which are easy to coalesce or flocculate from dispersion to 
solid state during 37˚C hydrolysis. During the digestion of milk fat, there have been 
observation of coalescence [432], disk-like aggregation of native milk fat observed by CLSM 
due to a decrease in the charge of the milk fat globule membrane [398], or lipid droplet 
destabilisation during gastrointestinal digestion [433]. Secondly, for milk fat-loaded starch 
gels, with disintegrating of the starch gels, the released milk fat was exposed to lipase 
gradually. Therefore, both starch and milk lipids became hydrolysed concomitantly. In 
addition, compared to control sample, the surface areas of milk fat globules in starch gels 
were improved, as they were less likely to aggregate. Further, lipase adsorption in starch gels 
may be enhanced as well. Therefore, the milk lipid digestibility was enhanced as a result of 
colloidal structural change, consistent with a previous report by Mun et al. [403], in which 
mung bean starch gel-stabilized lipids hydrolysed to a greater extent than the lipids without 
stabilisation by starch gel. 
The free fatty acid release predicted with the above multiple reaction model was consistent 
with the measurement in the samples of RF- and CF-gels (3:1 w/w), except for WF-gel 
(Figure 8-2d). For the hydrolysis degree of RF- and CF-gels (3:1 w/w) in the first 30 min and 
at final point (2 h), there was insignificant (p > 0.05) difference between experimental data 
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and predicted value, and whereas, for other time slots, the prediction model lacked fitness. For 
WF-gel (3:1 w/w), the prediction was significant different from the measurement, probably 
due to the simplification of the stepwise model. However, it has been found that the degree of 
lipid hydrolysis 𝑥 changed with both reaction rate constants 𝑘1 and 𝑘2 (Figure 8-2e), which 
provides a way to regulate lipolysis by modulating starch digestion rate, for example, 
changing starch digestibility (i.e. resistant, slow or rapid digestion starch), source (rice, corn 
or wheat), and starch-milk fat mass ratio. 
     
   
   
Figure 8-2: Pancreatic-lipase-catalysed lipolysis of milk fat in starch gel.  
Pancreatic-lipase-catalysed lipolysis of milk fat in rice (a), corn (b) and wheat starch gel. Milk 



















































































simulation (e). Amylose-catalysed reaction constants: 𝑘1; lipolysis reaction rate: 𝑘2. RF-, CF- 
and WF-gel was denoted as the milk fat-load rice, corn and wheat starch gel, respectively. 
MFG represented milk fat globule emulsion (control). Starch gel 2, 2.5 and 3 were defined as 
the starch to lipid ratio (w/w) 2:1, 2.5:1 and 3:1, respectively. Dash lines of black ( ), 
blue ( ) and red ( ) in Figure 8-2e represented the observed lipolysis degree of RF-, 
CF- and WF-gel, respectively. Solid lines of black ( ), blue ( ) and red ( ) in 
Figure 8-2e represented the predicted lipolysis degree of RF-, CF- and WF-gel, respectively. 
Solid line in black ( ) in Figure 8-2e represented the measured data for CF-gel (3:1 
w/w), and whereas, Dash lines of blue ( ) and red ( ), solid lines of blue ( ) 
and red ( ) in Figure 8-2e represented the predicted lipolysis degree of CF-gel (3:1 w/w) 
at reaction rate constant of 3𝑘1−0.3𝑘2, 3𝑘1−3𝑘2, 0.3𝑘1−0.3𝑘2, and 0.3𝑘1−3𝑘2, 
respectively. 
8.3.5 Particle size and structural change during intestinal digestion  
As illustrated in Figure 8-3a and Figure 8-3c, the average particle size (𝑑3,2) of milk fat 
globules increased at the first 10 – 30 min, followed by a gradual decrease after one hour. The 
milk fat globule fluctuation in digestion fluid was also record by another lipolysis study [434]. 
Apart from particle size change, their distribution patterns also varied during digestion, with 
broader distribution span (Figure 8-3b and d), where the smaller particles signalled the 
disintegration of milk fat globules, and whereas, the bigger particles indicated aggregations. 
After half an hour, new peaks emerged in pancreatic lipase-catalysed milk fat dispersion in 
Figure 8-3b, reflecting the aggregation  of milk fat globules. The lipid aggregates were also 
observed by Mun et al [403, 435], likely due to the change of pH and or ion strength. This 
may also explain the delayed digestion of milk fat emulsion, compared to the milk fat 
stabilized in starch gels, where hydrolysis of starch gel was synchronous with that of milk fat. 
During the first 30 min, the inner droplets coalesced, leading to the increase of particle size 
and the population of large particles. As reflected by the PSD analysis in Figure 8-3d, the 
aggregation was detected at the early stage, followed by coalescence in the middle and clear 
emulsion at the end. This morphologic change was consistent with the microscopy analysis in 
Figure 8-3e – Figure 8-3g, as also observed similarly by optical microscopy [309, 417] and 
CSLM analysis [436, 437]. The ImageJ statistics showed that the milk fat in CF-gel (3:1 w/w) 
started with approximately 3.97 ± 1.39 μm, and changed to 2.59 ± 0.29 μm at 40 min and 2.29 
± 0.83 μm at the end. 
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Notes: Milk fat particle size (𝑑3,2, surface-area-based mean diameter) change during digestion 
was for MFG control (a) and milk fat containing starch gels (b), respectively. Milk fat particle 
size distribution was illustrated in MFG control (c) and CF-gel (3:1 w/w) (d), respectively. 
RF-, CF-, WF-gel were denoted for milk fat containing corn, rice and wheat starch gel (3:1 
w/w), respectively. Morphology change of milk fat in 0, 40 and 120 min (from left to right), 
as stained by Sudan black, was illustrated for RF- (e), CF- (f) and WF-gel (g) (3:1 w/w), 
respectively. Scale bar for (e – g) was 20 μm. 
8.3.6 Implementation of barrier properties of hetero emulsions  
Lipophilic compounds such as curcumin, carotene, and α-tocopherol are unstable in aqueous 
solution but can be solubilized in a lipid dispersion. Emulsion-based food matrices have been 
designed as vehicles of bioactive compounds in foods and biopharmaceutical industries. For 
instance, β-carotene-laden lipids have been incorporated into hydrogels to improve its bio-
accessibility, since β-carotene has poor aqueous solubility and chemical stability [288]. Also, 
starch granule Pickering emulsions have been used to deliver lipophilic curcumin, augmenting 
encapsulation stability [406]. In the present study, starch particle-stabilized lipid emulsions 
may also be utilized to carry fat-soluble compounds, and the hydrocolloid-based 
encapsulation can be produced by freeze drying (i.e. lyophilisation) or spray drying [438]. 
The bioavailability of many lipophilic compounds (e.g. polyphenolic, carotenoids, vitamin A, 
D, E and K) entrapped in lipid droplets, is dependent upon lipid digestibility, which is related 
to colloidal structure. For example, a starch nano-emulsion was used to deliver phenolic 
compounds from date palm pit [439]. Similarly, mixed emulsions can be used to protect 
functional food ingredients [401]. Additionally, the release rate of encapsulation content is 
proportional to that of carrier lipids [440]. 
8.4 Conclusion 
Milk fat globules were filled into starch gels to regulate lipolysis kinetics in the present study. 
The milk fat-loaded starch gels generally enhanced the process of lipolysis by avoiding the 
coalescence of lipid dispersion, creating more surface area, and promoting surface activity for 
lipase binding to substrates. The lipolysis kinetics may be predicted by a multistep reaction 
model. In addition, the rheological characteristics of starch gels were measured to assess their 
impacts on fatty acids release. Milk fat lipolysis degree increased in the order of testing gels 
(2:1 w/w) < gels (2.5:1 w/w) < gels (3:1 w/w), in line to the order of starch gel viscosity. In 
general, milk fat stabilized in starch gels was two to three times more digestible than milk fat 
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without gel stabilization. With the disintegration of starch gels, milk fat was released from the 
gels concomitantly, followed by subsequent lipolysis, leading to increases of both reaction 
rate and hydrolysis degree of milk fat, especially for those milk fat-loaded starch gels (3:1 
w/w). Hence, an energy food recipe (starch to milk fats 3:1, w/w) is recommended for athletes 
or sport foods. The results obtained in this study provide useful means of preparing new lipid 
matrices to encapsulate lipophilic nutraceuticals or to increase milk lipid digestibility in 
energy foods.   
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Chapter 9: Manufacturing Milk Phospholipid-Enriched Dairy 
Ingredients 
Chapter 9 is published as:  
o Zhiguang Huang, Haotian Zheng, Charles S. Brennan, Maneesha S. Mohan, Letitia 
Stipkovits, Lingyi Li and Don Kulasiri. Manufacturing Milk Phospholipid-Enriched Dairy 
Ingredients. Foods. 2020 (submitted). 
Abstract: Milk phospholipids (MPLs) have been used as ingredients for food fortification in 
products such as bakery products, yogurt, and infant milk formulas because of their technical 
and nutritional functionalities. Starting from either buttermilk or beta serum as the original 
source, this study assessed four typical extraction processes and have found that the life-cycle 
carbon footprints (CFs) of MPLs were 87.40, 170.59, 159.07, and 101.05 kg CO2/kg MPLs 
for membrane separation process, supercritical fluid extraction (SFE) by CO2 and dimethyl 
ether (DME), SFE by DME, and organic solvent extraction, respectively. Thus far, membrane 
separation remains the most efficient way to concentrate MPLs, yielding almost full recovery 
rate and 11.1 – 20.0% purity. Both SFE and solvent extraction processes are effective to purify 
MPLs to high purity (76.8 – 88.0% w/w). This approach offered a new parameter to assess the 
process intensity and energy efficiency to manufacture MPLs in large-scale.  
 
Keywords: Milk phospholipids; buttermilk; life-cycle assessment method; carbon footprint; 
supercritical fluid extraction; membrane separation 
  
9.1 Introduction 
Milk phospholipids consist of a subclass of polar lipids—glycerophospholipids and 
sphingolipids [13]. Glycerophospholipids comprise of a glycerol moiety with two fatty acids 
esterified at positions of sn-1 and sn-2 and a hydroxyl group at sn-3 position, linked to a 
phosphate group and a polar moiety [13]. The molecular structure of the latter determines the 
types of glycerophospholipids, namely phosphatidylcholine (PC), phosphatidylserine (PS), 
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phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidyl-glycerol (PG), and 
phosphatidic acid (PA) [14]. Sphingolipids consist of a sphingosine backbone (2-amino-4-
octadecene-1,3-diol), connected to a fatty acid via an amide bond and a polar head. 
Sphingomyelin (SM), a prominent subclass of sphingolipids, has a phosphocholine residue 
[13]. In raw bovine milk, the diameters of milk fat globules (MFGs) are around 0.2 – 15 µm; 
these MFGs are enveloped by approximately 15 nm thick tri-layer MFG membrane (MFGM) 
[80, 441]. The composition of MFGM is 30 – 75% for polar lipids, and 25 – 70% for protein, 
respectively [45]. MPLs are within the MFGM constructing its backbone. MPLs represent 0.4 
– 1% of the total milk lipids [54], which change with season, lactose stage, and feed [82]. 
MPLs have exhibited nutraceutical properties due to their profile of subclasses. MPLs contain 
high proportions of SM [442] and PS [443] (24 and 12%, respectively), subclasses which are 
virtually absent in other sources, such as soy (0 and 0.5%, respectively) and egg yolk lecithin 
(1.5 and 0%, respectively) [48]. PS, comprising 15% of the total phospholipid pool, is 
associated with resuming memory and releasing stress, and will be replaced by inactive 
cholesterol as brain ages [12, 444]. SM has been found to be effective in inhibiting colon 
tumours [445]. Also, MPLs have been implicated to mitigate the risks of Alzheimer’s disease 
and repair cognitive ability [446], restore immunological defences, reduce the incidence of 
cardiovascular diseases [447, 448], and reduce cholesterol absorption and total liver lipids 
[449]. In addition, MPLs may narrow the gap between formula-fed and breastfed infants 
concerning neurodevelopment, infectious diseases, and cholesterol metabolism [450, 451]. 
Phospholipid-coated fats, e.g. human breast MFGs, will be more easily digested and absorbed, 
not only due to the size of MFGs, but also for the ratio of MFGM proteins to phospholipids 
[452]. Bovine MPL-enriched ingredients may be used to produce breast milk analogues. For 
instance, one formula recipe consists of subclasses by a weight-relative ratio of SM > PC > 
PE > PS > PI, with 21.1 – 29.7% SM and 10.2 – 13.3% PS (both based on total MPLs, similar 
to those of human breast milk (37.5% and 9%, respectively) [50]. Another infant formula 
comprises of 150 mg/L MPLs [453], mimicking that of breast milk (15 – 20 mg/dL milk [50], 
0.3 – 1.0% of the total lipids [454]). 
In addition to nutritional value and health benefits, MPLs have been technologically 
functional in food systems, for example, MPLs have been used in the preparation of 
liposomes [455], constructing vesicles of bioactive compounds [456], they are also food 
emulsifiers and surfactants, foaming agents, texture improvers for bakery goods, and may 
improve moisture retention for yogurt [457, 458]. 
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Much research works and reviews regarding fractionation of MPLs have been published, for 
instance, fractionation from buttermilk (BM) and beta serum (BS) [457], isolating MFGs by 
washing and centrifugation [45], and membrane separation of polar lipids [442]. However, 
there is no standard large-scale manufacturing process adapted by the overall dairy food 
industry. This is due to many reasons. First, the native MFGM as the original source of MPLs 
is fragile. Shearing and turbulent fluid flow can cause damage to the MFGM [459]. These 
treatments are commonly involved in handling raw milk on farms, in transportation, in silos at 
manufacturing plants, and during cream separation. Damage to the MFGM may cause 
associated materials including MPLs to deplete from the native MFGs to the aqueous phase of 
milk. Therefore, more than half the portion of MPLs in raw milk are lost in skim milk [460, 
461]. Second, uncertainties and variables are involved in the MPL fractionation processes. For 
example, cream washing for removing non-MFGM associated proteins may be performed 
before butter churning for increased yield or concentration of MPLs in the resulting BM or in 
the retentate of BM after tangential filtration. However, the cream washing procedure may 
interestingly only sometimes cause a significant change to the MPL composition in BM from 
unwashed cream [462, 463]. Although the detailed mechanism for explaining the 
phenomenon is not clear, it may relate to the stringency of different washing processes. 
Zheng’s group revealed that different washing procedures induce various degrees of damage 
to MFGM. Therefore, washing may alter the composition of MPL in the fat phase of the 
washed cream [80, 464]. This study aims to assess different dairy streams rich in MPLs, to 
evaluate their extraction processes, compare their process intensity and efficiency, and to 
estimate their life-cycle carbon footprints (CFs) using ISO 14067 and greenhouse gas (GHG) 
protocols. 
9.2 Milk Phospholipid Extraction from Dairy Products 
9.2.1 Dairy By-Products Rich in Phospholipids 
Commercial MPL products are usually derived from dairy products, such as BM [317], BS 
[442], acid cheese whey BM [465, 466], whey protein phospholipids concentrate (WPPC) 
[467] or whey BM [468]. Dairy streams in Table 9-1 comprise of 2.29 – 26.02% MPLs on a 
dry matter (DM) basis, varying with sources and processes.  
BM is the product that remains after the removal of butter by churning cream and that may 
have been concentrated and/or dried as butter milk powder [469], as illustrated in Figure 9-1. 
Acid BM, a by-product of lactic butter, is made by churning cultured cream. Also, whey BM 
is produced by the churning of whey cream during cheese making [470]. WPPC is a by-
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product during microfiltration (MF) of whey for manufacturing WPI. The permeate phase 
(milk fat discriminated phase) from this process goes forward for WPI manufacturing and the 
fat remaining phase (retentated phase) containing residual whey proteins is further 
concentrated for producing WPPC. A standard WPPC is comprised of more than 12% fat and 
50% protein (DM), and less than 8% ash and 6% moisture according to American Dairy 
Products Institute (ADPI) 2015 [467].  
BM, the serum phase resulted from the churning of cream, comprises of milk proteins and 
residual fat [317]. In terms of protein, lactose, ash and DM contends, BS and BM are very 
similar to those of cream products (Table 9-1) [18]. For instance, BM (FDC ID 454974) 
protein content is 3.33%, same as that of cream (FDC ID 495516). Though the fat content of 
BM is only one tenth of cream, MPLs of BM are 4 – 27-fold of raw milk, as shown in Table 
9-1. The empirical equation 𝑀𝑃𝐿 = 0.0137 × 𝐹𝐶 provides an estimation of the MPL content 
(g/L) of dairy product, where 𝐹𝐶 is the fat content of cream [52]. For instance, the estimated 
BM MPL content of anhydrous milk fat (AMF) from 80% cream, and of butter from 40% 
cream, is 1.1 and 0.55 g/kg, respectively. Whey BM, a by-product of whey butter, comprises 
of 6-fold the MPL content of raw milk in Table 9-1 [468]. 
BM and BS, the most abundant source of MPLs [471], have been underexplored or even 
treated as a waste stream [36]. For instance, a New Zealand-based dairy manufacturer used 
two-thirds of their BM for standardization, only one-tenth for BM powder (BMP), and their 
annual potential to produce MPL concentrate was 320 metric tons [36]. The annual BM 
output in Canada was 14.1 metric kilotons (18% of butter, 0.5% of bulk liquid [472]), 
compared to 20 kilotons in Belgium, 16 kilotons in Denmark, and 124.5 kilotons in German 
[473]. In 2013, approximately 5.2 million tons of BM was produced worldwide, similar to 
that of butter [317]. Worldwide, the annual BMP productivity was estimated as 410 kilotons 
(ca. 9.5% of butter), respectively, which has downstream applications in producing ice cream, 
baked goods’ ingredients, low-fat Cheddar cheese, reduced-fat cheese, pizza cheese [470], or 
in replacement of skim milk powder for low-fat yogurt [474].  
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Notes: Unit, g/100 g; MPLs, milk phospholipids; BS, beta serum; BM, buttermilk; BMP, BM 
powder; WPPC, whey protein phospholipid concentration; CM, cream; DM, dry matter; 
*lactose; **wet basis; Ref., reference. 
9.2.2 Commercialized Milk Phospholipid Products and Concentrate 
Phosphoric 500/600/700 and Gangolac 600 (products manufactured by Fonterra) comprise of 
34, 75, 62, and 15% MPLs, respectively, representing one source of highly-purified MPLs 
[31, 55]. Arla Foods Amba have implemented the phospholipid-rich dairy milk concentrated 
commodities for infant milk formulas and skin care. It has been claimed that Lacprodan® 
MFGM 10 supports physiological development of the infant gut and provides infants with 
similar health benefits to breast milk because of their similarities in fatty acid profile [56]. 
Arla dairy products PL 20/75 consists of 20% and 75% MPLs, respectively [57].  
As illustrated in the patents in Table 9-2, both filtration and solvent extraction are validated 
processes to manufacture MPLs. Acetone and supercritical CO2 are effective solvents for 
defatting processes. Tatua [58] and Synlait [59] have concentrated MPLs to 5 – 12.8% (w/w, 
DM basis). Lecico has implemented membrane separation to produce Lipamine M20 (20% 
purity) [60]. 
Table 9-2: Proprietary/patented manufacturing technologies of milk phospholipids. 
Applicant Input Technology used MPL content Reference 
Fonterra BSP SFE CO2 defat, hi-pressure DME extract 65.7 – 75.5 [480] 
Meggle BSP SFE CO2 defat, hi-pressure ethanol extract ~98.5 [481] 
Owen John BSP SFE CO2 defat, ethanol co-solvent extract PI/PS lost [482] 
Merchant & Gould Cream UF, DF 27.7 – 38.8 [483] 
Marc Boone BM UF 5 – 20 kDa ~2.84 [484] 
Land O’Lakes BM, BS UF, defat by SFE CO2 >30 [485] 
Morinaga Whey BM MF 0.2 µm, defat by SFE CO2 ~22 [486] 
Snow Brand  - Extract by acidic ethanol, defat -  [487] 
Enzymotec - Extract by ethanol & hexane, acetone defat ~24 [50] 
Cargill - Extract by alcohol (C1 – C3), acetone defat - [488] 
Svenska BMP Extract by ethanol & n-heptane, acetone defat ~70 SM [489] 
Notes: kg/100 kg products; MPLs, milk phospholipids; BM, buttermilk; BMP, BM powder; 
BS, beta serum; BSP, BS powder; MF/UF, micro/ultra-filtration; DME, dimethyl ether; PI, 
phosphatidylinositol; PS, phosphatidylserine; SM; sphingomyelin; SFE, supercritical fluid 
extraction.  
9.2.3 Laboratory Extraction of Milk Phospholipids 
Intact MFGM makes up 2 – 6% of the total mass of MFG [457]. However, MFGM represents 
60 – 70% of the total milk phospholipids [5]. Raw bovine milk comprises of 0.2 – 0.4 g 
MPLs/kg, and raw milk is generally a laboratory source of MPLs [45, 46]. Intact MFGs can 
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be isolated with low-speed centrifugation. The cream layer from raw milk skimming can be 
washed with phosphate buffered saline (PBS; pH 6.8, 0.1M, 1:10, v/v) and centrifuged at 390 
g for 10 min at 10°C. The final cream layer after three washes is the large MFG fraction 
[475]. Different from isolating intact MFGM, Sanches-Juanes et al [2] ruptured MFGM and 
recrystallized milk lipids, and starting from raw milk, they washed cream with 0.15 M NaCl 
solution and precipitated casein by centrifugation at 5000 g.  
Cream washing is a step to remove casein from cream and to clarify MFGs [36]. After 
centrifugation, casein will precipitate, with lipid stratification at the top layer [476]. Also, 
calcium, naturally present in casein micelles, can form a complex between MFGM and the 
casein micelles through its binding to phospho-casein and phospholipids of MFGM, leaving 
impurities with MPLs [490]. In addition, washing causes severe loss of phospholipids, almost 
60% per wash [463]. Hence, washing facilities for separating MPLs are costly and energy-
intensive [36], thereby mainly for laboratory purpose [45, 476, 491].  
For analysis purpose, MPL samples are usually prepared by solvent extraction. The Folch [62] 
and Bligh [63] methods use chloroform and methanol to dissolve lipids. Other lipophilic 
extraction formulas include the Mojonnier solvents [492], dichloromethane [61], and 
ammoniacal ethanolic solution of lipids with dimethyl ether and light petroleum in the Röse-
Gottlieb extraction [51, 64]. Total lipid content in samples can be determined with a 
gravimetric assay, Gerber-van Gulik butyrometer, infrared spectroscopy according to an 
International Dairy Federation (IDF) method [51], or gas chromatography equipped with a 
flame ionization detector [65].  
To determine MPLs and their subclasses, solid-phase extraction can fractionate polar lipids 
from non-polar lipids. Silica gel bonded cartridges or silica gel plates can be used for such 
purpose [35]. The obtained MPLs can be solvent dried by vacuum and stored at –20˚C before 
using [66]. In addition, chloroform and methanol are also valid elution solvents [67]. Total 
MPLs can be measured using the IDF molybdate assay [68], Fourier transform infrared 
spectroscopy [69] or fluorescence assay on cleaved choline group [70]. Both nuclear magnetic 
resonance of 31P and chromatography can quantify MPLs and their subclasses [71, 72]. High-
performance liquid chromatography is more acceptable than thin layer chromatography, using 
such detectors as ultraviolet absorbance, evaporative light-scattering detector and mass 
spectroscopy [456]. 
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9.3 Processes for Industrial Manufacturing of Milk Phospholipids 
9.3.1 Solvent Extraction 
Many kinds of polar solvents have been used to extract MPLs, such as ethanol and alkanes 
[50, 487]. To separate casein from MPLs, proteins can also be denatured thermally or in an 
acid solution (pH 4.6) [47, 51], the aggregated particles are subsequently filtrated. Regarding 
fractionation of MPL from WPPC, ethanol (70% v/v) at 60 – 80°C denatures proteins, after 
filtration the MPL concentration is ca. 45.8% in the filtrate in Figure 9-2a [47]. This notable 
method used no toxic solvent. However, the incompleteness of phospholipid recovery may be 
a concern [47].  
Compared to 58.1% recovery by ethanol, tertiary amine CyNMe2 (N,N-
dimethylcycloexylamine) yielded a 99.96% recovery rate of MPLs. At various solvent-sample 
weight ratios, the lipid extraction was conducted at ambient temperature. The dissolved MPLs 
in the amine were released by bubbling CO2 at atmospheric pressure, which converts 
CyNMe2 into the carbonate salt in Figure 9-2b. By injecting nitrogen and removing CO2, the 
carbonate salt regenerated into the amine form for reuse (Figure 9-2b). Though the recovery 
rate for BM was as high as 99.96 ± 1.2%, the extraction rates for BS and concentrated BM 
were only 7.57 ± 0.59% and 77.27 ± 4.51%, respectively. In addition to input sensitivity, the 
amine may interact with dairy components and cause toxic consequences [493], and chemical 
facilities required may be incompatible in a dairy factory setting.  
MPLs can be dissolved in ethanol and alkanes [50, 488, 489], and may not dissolve in 
acetone, ethyl acetate, and 2-pentanone [50, 488, 489]. Lipid BMP (100 g) dissolved in 
ethanolic hexane (1:4 v/v, 800 mL) under constant agitation at 45°C for 2 hours will produce 
an extract. The permeate of vacuum filtration can then be vacuum-dried at 1 kPa (Figure 
9-2c). The residue (ca. 20 g) is then defatted twice with 120 mL acetone, and the resulting 
acetone insoluble (AI, ca. 7 g), mainly polar lipids, is in the final step vacuum dried again at 1 
kPa [50]. However, acetone poses a degree of toxicity, as acetone residue in defatted MPLs 
may reach 5 – 10 ppm. Further, acetone can form a mesityl oxide via a condensation reaction, 
causing an off-flavour [494]. Hence, toxic residues in acetone-insoluble fractions need 
analysis and monitoring.  
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Figure 9-2: Process flow diagram of solvent extraction unit. 
Notes: (a) adapted from [47]; (b) [493]; (c) [50]. BMC, buttermilk concentrate; MPL, milk 
phospholipid; AI, acetone insoluble; WPPC, whey protein phospholipid concentrate (liquid, 
reconstituted from powder). 
9.3.2 Supercritical Fluid Extraction 
Supercritical CO2 and ethanol co-solvent can be used to extract MPLs effectively, yielding 
purities of 26.26% and 16.88% from WPPC and BMP extractions, respectively (Figure 9-3a). 
The SFE operation can be conducted at 50 – 60°C [495] and 350 – 550 Bar [477]. The SFE 
co-solvent (CO2 and 20% ethanol) caused full extraction of polar lipids, including PE, PC, 
and SM. However, both PS (i.e. the vital compounds for cognitive function) and PI were not 
extracted, as reported separately [49, 482]. Therefore, the co-solvent method may be an 
invalid industrial process due to incompleteness of PS/PI recovery. In addition to co-solvents, 
near critical dimethyl ether (DME, 20 – 30% solubility) and supercritical CO2 are able to 
dissolve polar and neutral lipids, respectively [480]. 
Supercritical fluid DME have been used to extract polar lipids, resulting in a yield of 69.1 – 
77.8%. The SFE process shown in Figure 9-3b can accept both liquid (<45% lactose, DM 
basis) and powder input [480, 496]. This unit can work with CO2 and DME in two-stages, 
extracting neutral and polar lipids, separately. In addition to its two-step operation, this unit 
































































non-polar lipids in the SFE chamber. Through two-stage de-pressurization, lipids are 
separated from the protein fraction, whereas, vaporized DME will be compressed and 
condensed for reuse (Figure 9-3b). This method feathers non-toxicity, compact skid, feeding 
flexibility, and high content of MPLs (65.7 – 75.5 g MPLs per 100 g DM). However, MPL 
recovery rate (69.1 – 77.8%) needs further improvement. 
 
 
Figure 9-3. Process flow diagram of a supercritical fluid extraction unit.  
Notes: (a) adapted from [477]; (b) [496]; WPPC, whey protein phospholipid concentrate; BS, 
beta serum; BM, buttermilk; BMP, BM powder; DME: dimethyl ether; SFE, supercritical 
fluid extraction. 
9.3.3 Filtration to Enrich Milk Phospholipids 
BM or BS is composed of milk fat, casein and whey protein, lactose and ash. The particle size 
(Figure 9-4c) ranges from 0.4 – 4 µm for MFGM fragment or phospholipid micelles [260], 
0.02 – 0.3 µm for casein, 0.03 – 0.06 µm for whey protein, and 0.002 µm for lactose and ash, 
respectively [497]. The size of MFG is around 0.2 – 15 µm [441]. As illustrated in Figure 
9-4a, the MF unit removes lactose and whey protein, and UF separates the smaller casein 
proteins from MPLs. Due to the size overlap of casein micelles and MPL particles, their 
separation is usually incomplete. Casein micelles disintegrate into peptides and amino acids in 
the proteolysis unit [52, 317], and hydrolysates enter into permeates during the subsequent UF 
operation [49, 52]. Alcalase (E.E. 3.4.21.62), a serine-type endoprotease with esterase 
activity, catalysed amino esters at pH 7.5 and 35 – 60˚C [49], while tryptic and peptic 
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9.3.4 Typical Processes to Extract Milk Phospholipids 
In brief, there are three options for large-scale manufacturing of MPLs, including solvent 
extraction [50, 489], SFE [480, 496], and proteolysis plus membrane concentration [49, 52, 
64, 317]. Membrane concentration of MPLs have yielded 20% (w/w, DM basis) purity by 
Lecico [60] and Arla [48]. Tatua [58], Westland and Synlait [36] have extracted MPLs from 
BS powder (2.28%, w/w, DM basis), achieving approximately 12.8% (w/w, DM basis) purity 
by membrane filtration. The proteolysis and UF unit recovers MPLs completely [49, 64, 317] 
and cost-effectively [36]. This process is more efficient to produce MPL concentrate than SFE 
and solvent extraction. Whereas, SFE and solvent extractions are effective steps to 
manufacture high purity MPLs. Therefore, these three processes feature high recovery rate, 
facility availability, and food compatibility, representing current, best-available industrial 
practices (in Table 9-3). 
Table 9-3. Process to purify MPLs and achieved purity.  
Reference  Input Technology used Purity Recovery 
(%) 
[496] BSP SFE: CO2 300 bar 40°C, DME 12.9  75.7 (5.9-fold) 69.1 
[496] BSP SFE: DME 40 bar 50°C 12.9  66.8 (5.2-fold) 62.9 
[477] WPPC SFE: 350 Bar CO2, 20% ethanol, 60°C 2.2  26.3 (11.9-fold) PS/PI lost 
[477] BMP SFE: 550 Bar CO2, 15% ethanol, 60°C 2.0  16.9 (8.6-fold) PS/PI lost 
[478] BMC SFE: CO2 defat 2.2  7.8 (3.5-fold) 100 
[478] BMC SFE: CO2 defat 2.2  9.2 (4.2-fold) 100 
[260] BMC SFE: CO2 defat 9.6  19.7 (2.1-fold) 100 
[468] BMC SFE: CO2 defat 7.2  12.0 (1.7-fold) 100 
[493] BM Solvent : BM (6:1 v/v) extraction - 87.5 
[493] BM Solvent : BM (12:1 v/v) extraction - 99.9 
[493] BS Solvent : BS (12:1 v/v) extraction  - 7.6 
[52] Whey BM Proteolysis, UF/DF 300 kDa 40°C 0.3  8.6 (28.7-fold) 95 – 99  
[52] Whey BM Proteolysis, UF/DF 300 kDa 40°C 0.4  11.4 (27.1-fold) 95 – 99 
[52] Whey BM Proteolysis, UF/DF 300 kDa 40°C 0.5  14.0 (26.4-fold) 95 – 99 
[49] BMP Proteolysis, UF/DF 50 kDa 50°C 1.3  11.1 (8.5-fold) 100 
[317] BMP Proteolysis, UF/DF 50 kDa 50°C 0.8  6.2 (7.8-fold) 100 
[499] BM MF 0.2 µm 1.5 67 
[260] BM MF 0.8 µm 9.6 - 
[463] BM MF/DF 0.5 µm 50°C 1.4  2.5 (1.8-fold) 88.8 
[463] BM MF/DF 0.5 µm 50°C 1.4  4.1 (2.9-fold) 89.7 
[478] BMP MF/DF 0.45 µm 9°C 1.2  2.2 (1.8-fold) 60.87 
[478] BMP MF/DF 0.45 µm 9°C 1.5  2.2 (1.5-fold) 87.34 
[478] BMP MF/DF 0.45 µm 9°C 0.5  0.9 (1.7-fold) 90.12 
[478] BMP MF/DF 0.45 µm 9°C 0.3  0.7 (2.3-fold) 80.24 
[465] CWBM UF 0.15 µm cellulose acetate 1.8  2.3 (1.3-fold) 41.9 
[465] CWBM UF 0.15 µm cellulose acetate, TA 1.8  4.7 (2.7-fold) 98.4 
[468] CWBM UF/DF 10 kDa 2.07.2 (3.6-fold) - 
[466] CWBM TA, wash at pH 7.25, UF/DF 55°C 2.0  10.7 (5.4-fold) >90  
Notes: unit: g MPLs/100 g dry product; BM, buttermilk; BS, beta serum; BMP, BM powder; 
BSP, BS powder; CWBM, cheese whey BM; WPPC, whey protein phospholipid concentrate; 
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BMC, BM concentrate; DME, dimethyl ether; SFE, supercritical fluid extraction; MF/UF/DF, 
micro/ultra/dia-filtration; TA, thermal aggregation. 
9.4 Carbon Footprint 
9.4.1 Life-cycle Accessment Method of Carbon Footprint  
ISO 14040 life-cycle assessment (LCA) is an internationally accepted methodology to 
calculate a product’s environmental footprint [500]. Life-cycle carbon footprints (CFs) of 
dairy products cover the direct emission from the dairy factory (scope 1), the energy carrier 
footprint for factory operations (natural gas, steam, power, nitrogen, and compressed air in 
scope 2), and the raw material, packaging and logistics in scope 3. In addition, life-cycle CF 
comprises of the emissions from the dairy farm (up-stream) and distribution centre (down-
stream) [501]. The boundaries are set as shown in Figure 9-5a. The CFs of MPL products 
were reported as equivalent CO2 emission for one kg of MPLs, according to the ISO 14067 
reporting standards [502]. 
The CF of BM (baseline CF, 1.10 kg CO2/kg BM powder) was cited directly from data in 
Canada derived from the ULICEES model [472], which follows by IPCC methodology [503], 
and covers emissions like methane [472], nitrous oxide [504], and carbon dioxide using the 
F4E2 model [505], and uses allocation matrix to partition six inventory flows (i.e. fuel, power, 
raw milk transportation, alkaline/acid, water and waste water) to 11 major dairy products 
[506].  
Although MPL may be isolated from different dairy food streams, BM is used as the starting 
material to account for the CF of MPL-enriched products. The CF of MPLs is a sum of BM 
CF (as the baseline) and the CF of extracting MPL from BM at dairy factories, assuming that 
the BMP input is 100 kg (1.3%, w/w, DM basis). Both proteins and lipids in MPL 
concentrates acquire CFs according to a previous method [501]. However, only MPLs were 
considered as the target ingredients, without calculating that of protein in the MPL fractions.  
The CF of BM concentrate (BMC) by membrane separation (MS) was calculated by the 
equation: 𝐶𝐹𝐵𝑀𝐶 = 𝐶𝐹𝐵𝑀 + 𝐶𝐹𝑀𝑆, where 𝐶𝐹𝐵𝑀𝑐, 𝐶𝐹𝐵𝑀 and 𝐶𝐹𝑀𝑆 were CF of BMC, BM and 
MS, respectively. The CF of MPL products by SFE or solvent extraction was calculated by 
the equation 𝐶𝐹𝑀𝑃𝐿𝑠 = 𝐶𝐹𝐵𝑀𝐶 + 𝐶𝐹𝑆𝐹𝐸  or𝐶𝐹𝑀𝑃𝐿𝑠 = 𝐶𝐹𝐵𝑀𝐶 + 𝐶𝐹𝑆𝑜𝑙, where 𝐶𝐹𝑀𝑃𝐿𝑠, 𝐶𝐹𝐵𝑀𝐶 , 
𝐶𝐹𝑆𝐹𝐸  and 𝐶𝐹𝑆𝑜𝑙  were CF for MPL product, BMC, SFE and solvent extraction process, 
respectively, as illustrated in Figure 9-5b. 
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The normalized CF of product by membrane separation was as high as 87.4 kg CO2/kg BMC, 
since the BMC comprised of only 11.05% MPLs. The CFs for products by SFE and solvent 
extraction were much higher than their baseline (𝐶𝐹𝐵𝑀𝐶), because of the intensive process 
during purification. As shown in Table 9-4, the CFs of fractions by SFE are 170.59 and 
159.07 kg CO2/kg MPLs for CO2/DME co-extraction and DME extraction, respectively. 
CO2/DME co-SFE exhibited comparably higher environmental impact to supercritical DME 
extraction, due to the direct emission from co-SFE. Solvent extraction demonstrated less 
environmental impact and a higher MPL recovery rate than SFE. However, the obtained 
products by solvent extraction are less food-compatible than SFE unit-extracted products. 
Table 9-4. Normalized carbon footprints of milk phospholipids. 
Process Membrane  SFE (CO2/DME) SFE (DME) Solvent extract  Unit 
Reference [49] [480, 496] [480, 496] [50] - 
Input BMP BMC BMC BMC - 
Input amount 100.00 100.00 100.00 100.00 kg 
Input purity 1.3 5.7 6.8 12.3 g/100 g DM 
Product BMC MPLs MPLs MPLs - 
Product amount 11.76 5.13 6.56 13.98 kg 
Product purity  11.05 76.80 66.80 88.00 g/100 g DM 
MPL yield  100.00 69.10 67.40 100.00 % 
Power 17.48 512.85 655.68 - kWh 
Material Alcalase 0.03 
CO2 1,000.00 





Thermal energy 13.10 - - - MJ 
Power CF factor 0.1567 0.1567 0.1567 0.1567 kg CO2/kWh 









Thermal CF factor 0.06 - - - kg CO2/MJ 
CF of power 2.74 80.36 102.74 - kg CO2 
CF of material 0.16 82.00 32.00 167.95 kg CO2 
Thermal CF 0.72 - - - kg CO2 
Utility CF 3.62 162.36 134.74 167.95 kg CO2 
BM/BMC baseline 110.00 498.17 594.31 1074.99 kg CO2 
Product CF 9.66 128.80 111.19 88.93 kg CO2/kg  
Normalized CF 87.40 170.59 159.07 101.05 kg CO2/kg MPLs 
Notes: BM, buttermilk; BMC, BM, concentrate; MPLs, milk phospholipids; C6, hexane; 
DME, dimethyl ether; SFE, supercritical fluid extraction; UF/DF, ultra/dia-filtration; CF, 
carbon footprint. Membrane filtration power consumption: 1.486 kWh/kg products [507]; 
Canada power CF factor: 0.1567 kg CO2/kWh [508]; DME, reusable hexane and ethanol CF: 
0.16 kg CO2 /kg solvent; reused acetone CF: 0.42 kg CO2/kg solvent [509]; DME CF 1.01 
kg/kg; 84% reuse [510]; baseline of BM: 1.1 kg CO2/kg BMP [472]; SFE CO2 reuse 95% 
[511]; SFE CO2/DME power cost estimation 100 kWh/kg extract [512].  
MPLs of proteolysis and filtration process carry 87.40 kg equivalent CO2/kg product, much 
higher than all the milk fat products (Table 9-5). With less CF than SFE and solvent 
extraction, membrane separation is the most efficient process among three accounted 
processes, in terms of process intensity, energy consumption and environmental impact. In 
addition, this process is compatible with most dairy factories, since membrane units have 
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already been commonly used facilities for whey protein concentration. Membrane separation 
is a necessary step to concentrate BM into BMC. Then BMC can be purified by SFE (DME). 
The relevant processes with significant MPL CF include membrane filtration, evaporation and 
spry drying, SFE and solvent recovery, offering opportunities to reduce the CF of the final 
products. For example, 0.1-µm polymeric spiral-wound MF membranes have been used to 
separate casein from milk, exhibiting higher energy efficiency at 0.024 (MF) and 0.015 (DF) 
kWh/kg permeate than that of graded permeability membrane (0.143 and 0.077 kWh/kg 
permeate for MF and DF, respectively [507]. Also, permeate flux, volume concentration ratio, 
transmembrane pressure, and temperature all had an impact on the energy efficiency of 
membrane UF, ranging from 0.26 – 0.33 kWh/kg retentate [513]. Another approach to reduce 
the environmental impact is to improve the purity of MPLs during filtration by differentiating 
the particle size of casein micelles (i.e. hydrolysis) from MFGM fragment and applying 
proper membrane filtration subsequently.  
Table 9-5. Comparison of carbon footprint of MPLs in commercial dairy products.  
Dairy products CF  Scope 1 Scope 2 Scope 3 Country Reference 
Raw milk  1.10 - - - Canada [472] 
Bulk liquid 1.00 0.870 0.065 0.065 Canada [472] 
Yogurt 1.50 1.083 0.252 0.165 Canada [472] 
Whole milk 1.12 0.843 0.173 0.104 China [514] 
Powder milk 10.10 - - - Canada [472] 
Butter  7.30 - - - Canada [472] 
BM  1.10 - - - Canada [472] 
Cheese 12.40 - - - Italy [501] 
Cheese 5.30 - - - Canada [472] 
Cheese 8.80 - - - Sweden  [515] 
BM  BMC: UF/DF 87.40 - - - - [49] 
BM  BMC  MPLs: SFE CO2/DME 170.59 - - - - [496] 
BM  BMC  MPLs: SFE DME 159.07 - - - - [496] 
BM  BMC  MPLs: Solvent extract 101.05 - - - - [472] 
Units: kg CO2/kg product MPLs; milk phospholipids; BM, buttermilk; BMC, BM 
concentrate; DME, dimethyl ether; SFE, supercritical fluid extraction; UF/DF, ultra/dia-
filtration; CFs, carbon footprints.  
9.5 Conclusion 
This paper identified three dairy streams for milk phospholipid (MPL) manufacture at an 
industrial scale: buttermilk, beta serum, whey protein phospholipid concentrate. The life-cycle 
CFs of MPLs were 87.40, 170.59, 159.07 and 101.05 kg CO2 /kg MPLs for membrane 
separation process, CO2/DME supercritical fluid extraction, SFE by DME, and organic 
solvent extraction, respectively. The extracted products comprised of 11.1, 76.8, 69.9, and 
88.0% MPLs, with recovery rate at 100, 69.1, 67.4 and 100%, respectively. In conclusion, the 
combined process of proteolysis and UF is a preferred available process to enrich MPLs, with 
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full recovery of MPLs and the relatively low CF. SFE by dimethyl ether is the most effective 
method when needing high purity (ca. 66.8%) MPL products, at the cost of a high CF. This 
study provided insights into the best available industrial practices to extract MPLs and 




Chapter 10: Conclusion  
10.1 Summary 
In this thesis, two research chapters (Chapter 4 and Chapter 5) dealt with milk polar lipids and 
three (Chapter 6, Chapter 7, and Chapter 8) with milk fats. The related milk lipids were in the 
forms of either nutrient complexes (Chapter 4, Chapter 6, and Chapter 7) or within food 
matrices (Chapter 5 and Chapter 8), and the interactions between milk lipids and food 
ingredients (e.g. bioactive compounds or starches) were explored. This thesis demonstrated 
the effectiveness of milk phospholipid-based phytosomes as nutrient vesicles (Chapter 4), 
since a high complexing index of 98.52 ± 0.03% was obtained for phytosomes. Following 
vesicle properties of milk phospholipids, their digestibility and catalytic enzymes were 
compared with triacylglycerol. The results provided a basis to incorporate milk phospholipids 
into functional recipes, to enhance the physicochemical, nutritional and antioxidant activity of 
fortified foods (Chapter 5). In contrast to polar lipids, lipase-treated milk lipids were 
formulated into breads, strengthening dough and improving product textural properties 
(Chapter 6). Furthermore, milk lipid hydrolysates were applied to prepare amylose-fatty acid 
inclusion complexes, effectively yielding resistant starches (Chapter 7). In Chapter 8, starch 
gel-stabilized milk lipids were more digestible than those in dispersion, and therefore, this 
food matrix can be implicated to speed up lipid digestibility and increase endurance for 
athletes. The final research chapter (Chapter 9) dealt with the process development of 
extracting milk phospholipids from industrial streams including buttermilk and beta serum. 
Overall, by complexing/interacting with antioxidants and starches, milk phospholipids/lipids 
have generated new nutritional functionalities in food systems, which can be utilized to 
deliver nutrients, regulate digestibility of starches/lipids, or produce fortified foods.  
10.2 Conclusion 
The findings on milk phospholipids study in this thesis work demonstrate three aspects: 
Firstly, milk phospholipids, although being minor constituents (ca. 1% of milk lipids) of tri-
layered milk fat globule membrane, have exhibited vesicle ability to carry bioactive 
compounds with phytosomal complexes. The differences in encapsulation efficiency of two 
vesicles can be explained by their structural differences. In liposomes, bioactive compounds 
are trapped inside the bilayer or the core of milk phospholipids micelles, and whereas, 
phytosomes are integrated, stable structure (details as Section 4.4 in Chapter 4). Secondly, the 
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reaction rate of milk phospholipid lipolysis was faster than that of triacylglycerols, due to the 
differences in the hydrocolloid structures of the two emulsion matrices. Thirdly, although 
antioxidant activity of milk phospholipids was evidenced by in vitro assays, but their cellular 
antioxidant activity was very limited (details as Section 5.4 in Chapter 5).  
The present study on milk lipids confirmed three major findings: Firstly, milk neutral lipids 
(e.g. triacylglycerol) in the core of milk fat globule, as predominant components of milk fat 
globules (ca. 98% milk lipids), could be conjugated with wheat starch, as texture improver 
and anti-staling agent for baked goods (details as Section 6.4 in Chapter 6). As a consequence 
of increased dough porosity, loaf volume and tenderness were improved in light of lipid 
lubrication and aeration mechanism during dough mixing. Further, the complexed amylose 
did not take part in gelatinisation, and therefore, upon cooling after baking, the complexed 
amylose will not recrystallize and participate in the staling of the bread crumb, thereby 
maintaining tenderness in storage. The staling process was delayed since the starch-lipid 
complexes hindered the amylopectin re-crystallisation and firming rate of crumb. In addition, 
the surface milk fats reduced the water holding capacity of starches due to their 
hydrophobicity and thus swelling and solubilisation of starches was also reduced. Inside the 
granules, the complexed amylose could be restricted from leaching-out during heating 
compared to free (non-complexed) amylose, thereby the amylose hydrolysis rate was delayed. 
Secondly, milk lipids could complex with corn, rice and wheat starches as resistant starch for 
diabetes. Besides, starch gel-stabilized milkfats demonstrate greater digestibility than milk 
lipids in dispersion, and therefore, they can be used to produce energy foods for athletes with 
optimal starch-to-milkfats ratio at 3:1 (details as Section 7.4 in Chapter 7). Thirdly, the starch 
particle-laden interface generally enhanced the process of lipolysis by avoiding the 
coalescence of lipid dispersion, creating more surface area, and promoting surface activity for 
lipase binding to substrates, thus speeding up the lipid digestibility compared to milk fat 
dispersion. The lipolysis kinetics can be predicted by a multistep reaction model (details as 
Section 8.4 in Chapter 8).  
10.3 Technical relevance and significance of thesis findings 
The significance to the field of milk phospholipids can be elaborated as follows: Firstly, to 
our knowledge, this is the first report of on preparation of milk phospholipid phytosomes and 
their functionalities. Phytosomes made out of milk phospholipids showed significantly higher 
encapsulation efficiency than liposomes, and therefore, they have potential functionalities in 
ingredient delivery systems and fortified foods, for instance, infant milk formulas (details in 
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Chapter 4). Secondly, the impact of polarity of milk lipids on lipolysis kinetics was examined, 
in addition to other important factors such as fatty acid chain length, saturation degree of fatty 
acids, hydrocolloid structure. Thirdly, milk phospholipids demonstrated in vitro antioxidant 
activity, which adds new insight on the design of milk phospholipid-fortified functional foods 
(details in Chapter 5).  
The results on milk lipids studies provide evidence for new applicability of dairy fat products. 
Firstly, using milk fats as bread textural improver and anti-staling agent was explored in 
Chapter 6. This study provides a feasible way to improve bread quality and nutritional 
properties using milk lipids. Secondly, milk fatty acid-starch complexes provide an 
economical approach to produce low glycaemic response foods for diabetes using widely 
available food resources and an empirical equation was validated to predict the complexing 
indexes of milk fatty acid-starch complexing index (Chapter 7). Starch-stabilized milk lipids 
showed that showed greater lipolysis degree than milk fat emulsion, which was verified with a 
multiple reaction model. The findings of this study provide a feasible way to regulate lipolysis 
reaction rate with multiple reactions, and thus offer a basis to formulate milk fat-containing 
starchy, energy foods (Chapter 8).  
For practical implementation of this thesis work, the results of this thesis can be used to 
develop milk lipid-based encapsulation systems (Chapter 4 and Chapter 8) in food and 
biopharmaceutical applications, lower starch digestibility for diabetes (Chapter 6 and Chapter 
7), improve milk fat digestibility for prolonging of endurance of athletes (Chapter 8), and 
enhance the quality of baked goods (Chapter 6), as elaborated separately in below paragraphs. 
The complexation of milk phospholipids with antioxidants can be utilized as functional 
delivery systems, and whereas, the interaction and complexation of milk lipid-starch 
modulated digestibility of lipids/starches bring about applicability for making resistant starch 
and energy foods for diabetes and athletes, respectively.  
10.4 Recommendations for further research directions 
This thesis demonstrated functionalities of milk phospholipids/lipids in food systems. Milk 
phospholipid phytosomes showed higher encapsulation efficiency than liposomes, and 
whereas, milk phospholipids were found more digestible than triacylglycerol. In contrast, 
milk lipids were incorporated into bakery products, improving their physiochemical and 
nutritional properties. Furthermore, lipase-modified milk lipids can form complexes with rice, 
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corn and wheat starches, and produce resistant starch-based foods. Finally, starch-stabilized 
milk lipids showed greater lipolysis reaction rate than milk lipid dispersion.  
In regards of future research interests for phospholipids, there have been emerging interests 
using them as improvers of cognitive performance or interventions of dementia such as 
Alzheimer disease, since milk polar lipids are more nutritionally-balanced than those from 
soya. Therefore, the neuro-functionalities of milk phospholipids may constitute the object of 
future studies.  
On the other hand, further aspects regarding milk lipids and their interactions with protein and 
polyphenols, for instance, can be explored. The milk lipid-proteins interaction can be 
considered to understand their roles in modulating nutrient digestion and absorption. 
Additionally, milk lipids-polyphenol complexes can survive gastrointestinal digestion, 
increasing polyphenol bio-accessibility but decreasing fat absorption, for example. These 
complexes may also have beneficial effects on gut health. Regardless, interesting research 
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